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The aortic valve has a complex dynamic structure that undergoes changes through out the 
cardiac cycle in response to the hemodynamic forces surrounding it. These forces include 
shear and bending stresses, pressure, fluid flow and tensile strain. A thorough 
understanding of the effect of these forces on cells within the valve leaflets will elucidate 
the correlation between mechanical stimuli and various disease states. In addition, this 
information may have implications for the design of a tissue engineered heart valve.  
 The current study focuses on developing a sterile ex vivo organ culture system to 
grow intact native aortic heart valves and characterize their biological properties in 
response to physiological forces duplicated in the system. Left ventricular function in the 
system was attained by a piston pump while aortic compliance was achieved by a 
compliance tank to cushion the disturbances in the pressure waveform. A membrane 
chamber separated the sterile and unsterile parts of the system. Oxygen exchange in the 
system was provided by a gas exchanger placed in the compliance tank. The system 
developed was shown to be sterile and capable of simulating physiological flow and 
aortic pressure waveforms at a cardiac output of 3.8-4.2 L/min and pressures of 120/80 
mmHg (systolic/diastolic). Valves were cultured in the system at 37oC for 48 hours. 
Biological properties were evaluated by measuring the differences in total leaflet 
collagen, sGAG and elastin content between the cultured and control (fresh and statically 
incubated) leaflets. Hemotoxylin and Eosin staining was used to examine cusp 
morphology. Endothelial cells on the surface of the leaflets were observed by scanning 
electron microscopy. α-smooth muscle actin immunohistochemistry (IHC) was used to 
indicate the expression of actin by smooth muscle cells. Proliferating cells were identified 
 xvii
by 5-bromo deoxy uridine (BrdU) IHC and apoptotic cells in the valve leaflets were 
detected by activated caspase-3 IHC. Experiments with nine porcine aortic valves showed 
that the differences in collagen, sGAG and elastin contents were not significant (p>0.05) 
between the cultured and fresh valve leaflets while a significant decrease (p<0.05) in 
sGAG and elastin contents were observed in static control leaflets. The cultured valves 
maintained the structural integrity of the leaflets while preserving the native morphology 
and cell phenotype. Cell phenotype in leaflets incubated statically under atmospheric 
conditions decreased compared to fresh and cultured valve leaflets, indicating the 
importance of mechanical forces in maintaining the natural biology of the valve leaflets. 
ECs were retained on the surfaces of cultured leaflets with no remodeling of the leaflets. 
BrdU results showed no detectable cell proliferation in the cultured leaflets, which was 
consistent with the controls. The number of apoptotic cells in the cultured leaflets was 
significantly (p<0.05) less than in the statically incubated leaflets and comparable to fresh 
leaflets. 
 The organ culture system was shown to retain the native leaflet cellularity, 
extracellular matrix composition and cell phenotype with no significant remodeling 
within 48 hours. Therefore, the native biological and physiological functionality of 
porcine aortic valves was maintained ex vivo. 
 
Key words: Organ culture system, Flow and pressure waveforms, Porcine aortic valve 







Valvular heart disease is a serious clinical condition that is caused by dysfunction of one 
or more of the heart’s four valves. About five million people in the United States alone 
are diagnosed with valvular heart disease each year [Shappell, 2004]. According to the 
American Heart Association’s 2003 Heart and Stroke Statistical Update, valvular heart 
disease is responsible for nearly 20,000 deaths each year in the United States and is a 
contributing factor in about 42,000 deaths [Shappell, 2004]. The majority of these cases 
involve disorders of the aortic valve (causing 63% of deaths) and the mitral valve (14% 
of deaths). Deaths due to pulmonic and tricuspid valve disorders are more rare (0.06% 
and 0.01% of deaths, respectively).  
Surgical intervention to treat valvular disorders involves heart valve repair or 
replacement. Typically these replacements involve the use of mechanical valves, 
bioprosthetic valves or homografts. The first mechanical prosthetic heart valve was 
implanted in the aortic position in 1960. Since 1952 about 50 different mechanical 
designs have originated worldwide [Vagale, 2004]. Mechanical heart valves (MHVs) 
offer greater durability (30 years or more) and lower resistance to flow; however, there is 
a risk of thrombosis and hemolysis necessitating lifelong anticoagulation therapy for 
MHV recipeints. On the other hand, bioprosthetic (tissue) valves made from xenografts 
or allografts have many advantages over MHVs. The valves have better hemodynamics 
than MHVs since their design approximates that of the native valves. Also, patients 
implanted with bioprosthetic valves or allografts do not require anticoagulants, since the 
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valves do not cause blood cell damage and consequent thromboembolic events. However, 
durability of the valves is limited due to structural dysfunction caused by tissue 
degradation [Sacks, 2002; Angell, 1989; Hilbert, 1999]. Donor availability is an 
additional problem in case of allografts. The Ross procedure, first performed in 1962, is 
an autograft alternative to aortic and mitral valve replacements in which the pulmonary 
valve is transferred to the aortic or mitral position. This procedure has shown excellent 
clinical results, which may be due to the ability of the viable pulmonary leaflet cells to 
adapt to the aortic/mitral environment without eliciting any immunogenic responses. This 
suggests that a heart valve substitute that has the ability to adapt to different mechanical 
environments and which is both durable and immunocompatible is required for valve 
replacement.  
Heart valves, created in vitro from cells seeded onto suitable scaffolds, may serve 
as possible replacement option for diseased valves. Tissue engineering is a new domain 
in which techniques are being developed to transplant autologous cells onto a cell matrix, 
which can be a biodegradable scaffold, or an acellularized heterograft. Ultimately this 
promising technique could lead to the creation of a new functional autologous tissue that 
is capable of remodeling its structure and can grow with the patient. A formidable 
obstacle to the creation of implantable tissue engineered heart valves is their structural 
failure due to inadequate mechanical properties in withstanding hemodynamic stresses of 
the aortic position [Dumont, 2002]. This can be overcome by developing constructs with 
improved mechanical and biological properties in ex vivo organ culture systems, prior to 
implantation, which provide physiological environments for the growth of the tissue.  
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Mechanical forces such as shear and bending stresses, transvalvular pressure and 
cyclic flexure act on the aortic valve during the cardiac cycle; however, the biological 
response of the valves to these forces remains unknown. It has been inferred from 
previous studies that shear stresses, pressure, and cyclic stretching during the cardiac 
cycle affect cell behavior and extra cellular matrix (ECM) composition of the aortic valve 
leaflets [Boulogne, 1999; Weston, 2001; Xing, 2004]. These studies have shown that 
mechanical forces regulate the biosynthetic activity of the valvular cells and facilitate 
matrix production for maintaining a natural valvular architecture. However, these forces 
in isolation could not maintain the native cell phenotype of the valve leaflets. Hence, 
studying the effects of physiological mechanical forces on valve leaflet biology ex vivo 
provides an understanding of the mechanical factors required to sustain the native cell 
phenotype of the leaflets. Furthermore, the results obtained from the work can be used to 
elucidate various disease mechanisms of the aortic valve. Thus, the focus of this thesis 
was to design a sterile ex vivo organ culture system that is capable of maintaining 
physiological mechanical conditions and to study the biological responses of porcine 





2.1. Structure and function of the heart and aortic valve 
2.1.1. Function of the heart during the cardiac cycle 
The cardiovascular system consists of the heart, blood vessels, cells, and plasma of the 
blood [Silverthorn, 2001]. The heart is situated in the middle of the chest with its long 
axis oriented from the left upper abdominal quadrant to the right shoulder. The weight 
and size of the heart depend on age, sex, weight, and general nutrition. The adult male 
human heart weighs approximately 325gm while the female heart weighs 275gm. The 
heart pumps blood through the vessels, and the valves serve to direct the flow in one 
direction preventing back flow, or regurgitation. The heart must pump blood at a 
sufficient rate to maintain an adequate and continuous supply of oxygen and other 
nutrients to the brain and other vital organs. Oxygen-depleted blood returns from the 
body via the vena cava to the right atrium and through the tricuspid valve to the right 
ventricle. It then goes through the pulmonary valve, pulmonary artery and to the lungs. 
Oxygenated blood from the lungs returns via the pulmonary veins to the left atrium and 
through the mitral valve to the left ventricle. It then goes through the aortic valve to the 
aorta and finally to the whole body (Figure 2.1).  
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Figure 2.1: Anatomy of the heart. [Scott, 1998] 
 
 
The events during the cardiac cycle are illustrated in Figure 2.2.  The cycle is divided into 
seven phases. In the first phase (0.11s), the atria contract ejecting blood into the 
ventricles producing a rise in ventricular pressure. In response to this pressure increase, 
the A-V valves (mitral and tricuspid) close as the blood starts to flow back into the atria 
[Klabunde, 1999]. At the onset of systole, which is typically 1/3 of the cardiac cycle 
(0.35s), ventricular isovolumetric contraction (0.05s) occurs with the closing of the aortic 
and pulmonary valves. In the rapid ejection phase (0.09s), as soon as the pressure in the 
left ventricle exceeds the pressure in the aorta, the aortic valve opens and blood flows 
rapidly from the ventricle into the aorta. Following rapid ejection, the rate of outflow 
from the ventricle decreases, and the ventricular and aortic pressures start to decrease in 
the reduced ejection phase (0.13s). At the end of systole, during the isovolumetric 
relaxation phase (0.08s), the ventricular ejection decreases to zero. The left ventricle 
pressure falls below the pressures in the aorta and pulmonary artery, which causes the 
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aortic and pulmonary valves to close (beginning of diastolic phase). Once the ventricular 
pressure falls below the atrial pressure the A-V valves open and ventricular filling begins. 
During this period, the flow of blood from the aorta to the peripheral arteries continues, 
and the aortic pressure slowly decreases. This rapid ventricular filling phase (0.11s) is 























A healthy heart with a normal cardiac output pumps approximately 5 to 6 L/min 
of blood at a cardiac rate of 70 beats/min and has a stroke volume of 75mL. The normal 
Cardiac cycle 
 
Phase 1    Atrial contraction 
Phase 2    Ventricular Isovolumetric    
contraction 
Phase 3    Rapid ejection 
Phase 4    Reduced ejection 
Phase 5    Isovolumetric relaxation 
Phase 6    Rapid ventricular filling 




LV Press,  left ventricular pressure 
a, a-wave; c, c-wave; v, v-wave 
LVEDV,  left ventricular end-diastolic 
volume 
LVESV,  left ventricular end-systolic volume
LV Vol,  left ventricular volume 
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aortic pressure is 120 mm Hg (systolic)/ 80 mm Hg (diastolic). During exercise, the heart 
beats both faster and stronger to increase cardiac output by three to four times the normal 
output. The left side of the heart is subjected to higher pressures compared to the right 
side, hence the mitral and aortic valve account for about 95% of the valve replacement 
procedures throughout the world. 
 
2.1.2. Structure and function of the aortic valve leaflets 
The aortic valve opens widely to allow blood flow into the aorta and closes completely to 
prevent backflow into the ventricle. The valve opens and closes approximately 103,000 
times each day and approximately 3.7 billion times in its life span [Thubrikar, 1990]. It 
consists of three half-moon-shaped pocket-like flaps of delicate tissue, referred to as 
cusps or leaflets. When the aortic valve is closed, the cusps are perfectly aligned and 
separate the left ventricle from the aorta. Along with the three leaflets there are three 
sinuses, which form a bulging cavity behind the leaflets and are called the sinuses of 
Valsalva (seen in Figure 2.3). At the lower margin, the sinuses become continuous with 
the left ventricle, and at the upper margin they become part of the ascending aorta. The 





Figure 2.3: Figure shows aortic valve in closed (left) and open (right) positions. The 





Figure 2.4: Anatomy of the aortic valve. The figure on the left shows leaflet cusps and the 
one on the right shows the direction of blood flow through the valve. The aortic surface 






The three leaflets are named according to the sinuses that open into the coronary 
arteries. The left and right coronary leaflets have sinuses containing ostia that open into 
the right and left coronary arteries, which supply blood to the heart. The non-coronary 
(posterior) leaflet has a blind sac behind it [Thubrikar, 1990] (Figure 2.4). The surfaces of 
the leaflets are named based on the anatomical positions that they face when the valve is 
closed. The surface of the leaflet that faces the left ventricle is called the ventricular 
surface, and the opposite side that faces the aorta is called the aortic surface. Between 
these two surfaces is the spongiosa. The average thickness of the leaflets is about 0.6 mm 
and varies considerably over the surface [Cataloglu, 1976]. The structure of the valve has 
a direct bearing on its function. During systole, the commissures, points of attachment of 
adjacent leaflets, pull outward and cause the leaflets to open. Simultaneously, the base of 
the valve moves inward causing a decrease in the base perimeter. Depending on the 
ventricular contraction, the open valve has a stellate-shaped, triangular or normal circular 
orifice. In diastolic phase, vortices that are developed in the sinuses during systole along 
with the inward motion of the commissures and outward movement of the base close the 
valve. During valve closure, the sinuses act as shock absorbers and prevent damage to the 
leaflets due to normal stresses as the stresses are transmitted from the leaflets to the aortic 
wall through stress-sharing. The impact of stresses is also reduced due to the elasticity of 
the aortic root.  
 The composition of the native heart valve is highly complex and well-evolved to 
meet the extraordinary demands placed on it. Both blood-contacting faces of the leaflet 
are composed of endothelial cells, sandwiching between them three distinct layers 
consisting of ICs and varying amounts of ECM components. Among the extracellular 
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components are collagen, elastin and glycosaminoglycans (GAG). Endothelial cells on 
the aortic valve leaflet are arranged in a circumferential pattern (from one end of the 
commissure to the other end); i.e., perpendicular to the blood flow, while, in an artery 
endothelial cells are aligned in the direction of blood flow [Deck, 1986]. The valvular 
endothelium like the vascular endothelium serves as a barrier against platelet and fibrin 
deposition. They express a variety of metabolites and proteins that may affect the 
function of fibroblasts within the leaflet matrix. Apart from these, ICs populate the matrix 










Figure 2.5: Schematic of the aortic valve leaflet structure. [Scott, 1998] 
 
The composite layer structure of the aortic valve leaflet, consisting of the fibrosa, 
spongiosa, and ventricularis between the aortic and ventricular surface, respectively, 
imparts incredible durability, flexibility, strength, and fatigue resistance to the native 
valve (Figure 2.5). Furthermore, the presence of living cells allows dynamic modification 
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of the ECM components to adjust for changing hemodynamics. The fibrosa, is 
mechanically the strongest layer of the leaflet and principally bears the stress of diastolic 
pressure because of the thickness and density of tissue in this layer. It is arranged as a 
series of parallel tendinous cords, which are aligned perpendicular to the direction of 
flow. Its collagenous fibers run mainly in the circumferential direction and gives strength 
to the tissue to withstand the mechanical loading. This directionality results in a structure 
that is considerably stiffer in the circumferential direction than in the radial direction 
(from the base to the free edge of the leaflet). A matrix of elastin surrounds the collagen 
bundles to maintain the valve's microstructure during unloading. There are about 19 
different types of collagen present in the body and valve leaflets consist of collagen types 
I, III and V [Gilbert, 1996]. Collagen forms long uninterrupted fibrils that are composed 
mainly of proline, hydroxyproline and glycine in a triple helical structure. Elastin, as the 
name implies, is considerably less stiff than collagen. It is a coiled hydrophobic structure 
consisting mainly of alanine, valine, leucine, and glycine. Because elastin molecules are 
hydrophobic they are able to slide over one another or stretch to maintain structural 
integrity and provide recoil [Welgus, 2003]. In the fibrosa, towards the free edge, tissue is 
prominently arranged in the form of chords. In the basal region, the connective tissue of 
the leaflet more consistently forms sheets of fibers that are slightly crosswoven.  
 Beneath the fibrosa lies the spongiosa, which is a loose, watery connective tissue 
of varying thickness, fiber composition, and cellularity. The semi-fluid nature of this 
layer gives the leaflet considerable plasticity. It consists of radially-oriented collagen 
fibers and cells. Since the fibers and cells of the core tissue are sparse, its bulk consists of 
connective tissue, principally glycosaminoglycans (GAG) and water. GAGs are 
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unbranched heteropolysaccharides consisting of N-acetylgalactoseamine or N-
acetylglucoseamine and uronic acid. There are seven types of GAG that are of 
physiological importance, two of which, Chondroitin and Dermatan sulphate, are found 
in the aortic valve [King, 2003]. The principle function of the spongiosa is to dampen the 
vibrations in the fibrosa associated with leaflet flexion during closure. 
 At the ventricular surface of the leaflet, elastin and collagen fibers make up a thin, 
often bipartite layer called the ventricularis. It consists of a superficial elastin layer and a 
deeper circumferential layer of collagenous fibers. The ventricular surface of the leaflet is 
smooth in contrast to the ridged aortic surface as it is important for maintaining laminar 
blood flow during systole. The elastin of the ventricularis enables the cusps to decrease 
their surface area when the valve is open and stretch to form a large coaptation area when 
backpressure is applied. Although the pressure differential across the closed valve 
induces a large load on the cusps, the fibrous network within the cusps effectively 
transfers the resultant stresses to the aortic wall and annulus, a ring of tissue that 
surrounds and supports the aortic orifice. 
 
2.2. Heart valve diseases and surgical alternatives 
Heart valves regulate one-way flow of blood through the four chambers of the heart. 
Failure in the valves on the left side of the heart can cause accumulation of fluid in the 
lungs or pulmonary edema. Failure in the valves on the right side are rare, but can occur 
as a result of some forms of congenital heart disease or long-term left-sided heart failure 
and can cause fluid accumulation in the body, particularly in the legs, abdominal cavity, 
and the liver [Guyton, 1991]. Heart valve disease can be the result of the natural aging 
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process where the valve “wears out”, which is often accompanied by calcium deposition 
in the leaflet tissue resulting in stenosis or regurgitation. Less commonly, rheumatic fever 
and endocarditis can cause heart valve damage. Additional cases involve congenital heart 
valve defects or improper closing of the mitral valve leaflets leading to blood leakage into 
the left atrium. These valve diseases can greatly interfere with the heart's ability to pump 
blood. Treatment for valvular heart disease depends on the type and severity of the 
diagnosis. Many patients can be treated successfully with medications such as ACE 
(Angiotensin-Converting Enzyme) inhibitors to decrease the workload of the heart by 
widening the blood vessels, antiarrhythemics, antibiotics, anticoagulants, diuretics to 
lower excess fluid levels in the body, or inotropes to increase the force of the heart’s 
contractions [Shappell, 2004]. If medications are not successful, interventional 
procedures such as percutaneous balloon valvuloplasty, valvulotomy or open heart 
surgery may be necessary.  
 
2.2.1. Aortic valve diseases 
Aortic valve disease can be caused by stenosis, regurgitation, or a combination of both. In 
elderly patients, calcium deposits and the growth of fibrous tissue can damage the aortic 
valve. Congenital defects (about 2%), such as infants born with a bicuspid aortic valve 
instead of a tricuspid valve, can lead to severe stenosis or regurgitation after functioning 
normally for years. Valve disorders can also be caused by abnormalities in the aorta 
causing enlargement, Marfan syndrome, which is a connective tissue disorder, 
inflammatory diseases such as ankylosing spondylitis, and less commonly Reiter's 
syndrome [Nishimura, 2002].  Abnormal valve function produces either pressure 
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overloading due to restricted valve opening or volume overloading due to inadequate 
valve closure. Untreated aortic valve disease can eventually result in heart failure, severe 
infection, and even sudden death. 
 Valvular aortic stenosis and regurgitation affect about five out of every 10,000 
people in the United States [MayoClinic, 2003].  Stenosis results in chronic left 
ventricular pressure overloading. At any stage of life, the natural history of aortic stenosis 
largely reflects the functional integrity of the mitral valve. As long as adequate mitral 
valve function is maintained, the pulmonary bed is protected from systolic pressure 
overloading imposed by aortic stenosis. The pressure overloading on the left ventricle 
may thicken and enlarge it causing hypertrophy over the years, subsequently increasing 
the load on the heart [Novaro, 2002]. The pressure overload weakens the heart muscle 
leading to congestive heart failure. Aortic regurgitation may occur due to leaflet 
pathology or aortic root disease. As a dominant isolated lesion, aortic regurgitation 
usually occurs due to prolapsed leaflets caused by a bicuspid aortic valve. Infective 
endocarditis involving a bicuspid valve may cause aortic regurgitation from loss of 
coaptation or perforation of a cusp. Chronic aortic regurgitation predominantly causes 
volume overloading of the left ventricle, which is usually well tolerated for long periods 
of time, possibly even decades [Novaro, 2002]. Eventually, the heart begins to fail 
producing shortness of breath and fatigue. 
 Unlike the mitral valve, which can often be repaired, the aortic valve usually 
requires replacement. The most commonly used replacement devices are mechanical and 
bioprosthetic valves with homografts and autografts less commonly used.  From 1990 to 
2000, the choice of valve replacements indicated by the Society of Thoracic Surgery 
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(STS) Registry for patients less than 60 years of age with aortic valve disease was: 
mechanical valve in 77% of patients, bioprosthetic valves in 13%, homograft valves in 
5%, and Ross procedure in 5% [Pettersson, 2003].  
 
2.2.2. Mechanical valves 
A mechanical valve is a device constructed from man-made materials that is used to 
replace patients own damaged or diseased heart valves. The first mechanical valve, 
developed in 1961, was the “ball and cage” design (Figure 2.6.a), which is still in use 
today. A number of other designs have been tried since then, primarily those with a single 
disk or two tilting disks (Figure 2.6.b) and bileaflet valves (Figure 2.6.c) [Thubrikar, 
1990]. More than 60 percent of heart valve replacements have been made with 
mechanical prostheses due to their excellent durability and superior hemodynamics which 
offer minimal resistance to flow [Travis, 2002]. Although the modern mechanical valves 
are designed to attain the closest approximation to central flow achieved in a natural heart 
valve, they are regurgitant, allowing small amounts of backflow between the leaflets as in 
the case of bileaflet valves [Cabalka, 1995]. Further, the turbulent fluid mechanics 
through these valves causes damage to blood cells. Possible thrombus formation initiated 
by disturbed flow patterns necessitates lifelong anticoagulant therapy [Travis, 2002]. 
Small stagnant regions near the hinges sometimes lead to bacterial infections causing 













Figure 2.6: Pictures of mechanical heart valves: a) Starr-Edwards ball and cage valve b) 




Many different valve designs with different materials of construction have 
evolved to reduce thrombus formation and decrease the mechanical stresses that can 
cause blood cell damage. Several synthetic polymers have been tested as leaflet materials 
such as silicone, polyolefin rubbers and polytetrafluoroethylene [Hilbert, 1987]. 
Polyurethane valves are capable of achieving more than 800 million cycles (~ 20 years of 
“normal” function) in laboratory fatigue testing [Bernacca, 1996]. Valve leaflets 
constructed of a commercially available polyetherurethane when implanted in sheep 
showed superior valve function to that of bioprosthetic valves [Wheatley, 2000]. Thus, 
polymeric valves could offer a clinical advantage with the promise of improved durability 
compared to bioprostheses and low thrombogenicity compared to mechanical valves.  
 
2.2.3. Bioprosthetic valves 
Bioprosthetic valves are tissue valves made of animal tissue (i.e. xenografts) and are 
easily and readily available. These were introduced in the early 1970s as an attempt to 
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avoid some of the disadvantages of mechanical valves [Talman, 1995]. Flexible, 
trileaflet, biological tissue valves mimic their natural counterparts more closely than 
mechanical heart valves. Their central flow characteristics offer better hemodynamic 
efficiency, and their biological surfaces enhance thromboresistance as compared to 
mechanical prostheses [Thubrikar, 1990]. The valves are chemically treated to make the 
tissue less immunogenic and thus less likely to incite an allergic or immunological 
reaction in the recipient. As a result, the tissue comprising the valve is non-viable, and 
therefore, subject to degeneration with time. Bioprosthetic valves are commonly 
employed in elderly patients for whom the risk of bleeding complications are high and in 
those whose desired way of life precludes the discipline of anticoagulation therapy [Jin, 
2002]. Bioprosthetic valves are categorized into either stented or stentless valves. Stented 
valves are composed of leaflets sutured to sewing rings, which are either metallic stents 
made of elgiloy or plastic stents made of polypropylene and covered with cloth (e.g. 
Dacron) [Thubrikar, 1990]. Calcification, perforation, abrasion of the leaflets along the 
attachments of the commissural posts, and paravalvular leakage are major disadvantages 
of a stented biological valve [Gross, 1999].  Furthermore, a rigid stent is obstructive and 
carriers the hazards of infection, hemolysis, and embolization. Also the stent and sewing 
ring take up valuable space along the perimeter of the orifice so that the opening from the 
heart to the aorta is smaller than that provided by the stentless bioprostheses. 
 Stentless, or unstented, valves do not contain a true sewing ring; therefore, long-
term durability and hemodynamic results are better than with stented bioprosthetic valves 
of a similar size [Gross, 1999]. The removal of the stent has several advantages: (a) a 
larger valve can be implanted into a given size of aortic annulus (b) the distensibility and 
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dynamic nature of the aortic annulus is preserved (c) less calcification occurs compared 
to stented valves and (d) it is possible to remodel the native aortic root and preserve the 
sinotubular junction [Jin, 2002].  Studies have confirmed that stentless valves have lower 
pressure gradients and a greater effective orifice area than stented valve do soon after 
implantation [Del Rizzo, 1996]. However, the implantation of these valves requires 
greater surgical skill for increased durability of the valves. 
Commercially available bioprosthetic valves are shown in Figure 2.7. Valves 
explanted from animals are available in various sizes to fit patients from different age 
groups. Pericardial valves have a significantly higher area available for blood flow 
compared to porcine valves of the same size [Purinya, 1994].  At the same flow rate, the 
pericardial valve has higher performance indices, and lower pressure gradients than the 
porcine valve of the same size [Cosgrove, 1985]. 
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Figure 2.7: Pictures of bioprosthetic heart valves: (Left-right) Toronto stentless porcine 
valve, Edwards prima plus stentless bioprosthesis (Model 2500P), Carpentier-Edwards 
perimount pericardial (model 2700) and porcine (model 2625) bioprosthesis 
[EdwardsLifesciences, 2004], Hancock porcine valve (model 250), Ionescue-Shiley 




The biological tissues are usually fixed with 0.625% glutaraldehyde buffered to a 
pH of 7.4 [Purinya, 1994]. This treatment induces collagen cross-linking thereby 
preserving the tissue by preventing digestion by enzymes or bacteria, and eliminating 
tissue rejection [Thubrikar, 1990]. Leaflet fixation also stiffens the tissue unintentionally, 
alters internal shear properties, increases shear stiffness, stress relaxation and hysteresis, 
and causes substantial dehydration, all of which lead to valve failure due to calcification 
or tissue tearing [Talman, 1995; Talman, 2001]. Aminooleic acid (AOA), a detergent that 
covalently binds to aldehyde residuals and remains within pretreated bioprosthetic tissue, 
has been demonstrated to prevent porcine valve calcification and protect valvular 
hemodynamic function [Chen, 1994; Gott, 1997]. AOA significantly reduces the 
diffusion of calcium ion, which is one of the important steps in the calcification of valves. 
Studies with ethanol, an anticalcification agent, have shown that apart from complete 
inhibition of cusp calcification, ethanol pretreatment inhibits aortic wall calcification 
[Lee, 1998]. Other agents such as aluminium chloride or biphosphonates significantly 
inhibited bioprosthetic aortic wall calcification [Lee, 1998]. These methods, although 
effective in reducing calcification, do not prevent disruption of collagen fibers. Collagen 
fibers exposed to blood flow are damaged and cannot be repaired due to lack of viable 
cells within the leaflet. This can be overcome by seeding the leaflets with fibroblasts, 
which are capable of maintaining the valve’s native structure [Zund, 1997].  
 
2.2.4. Allograft valves 
Allograft (or homograft) valves obtained from a donor are also used as an option for 
valve replacements. This type of aortic valve replacement was initiated by Ross in 1962, 
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and over the past decades the allograft has become a well-known aortic valve substitute 
[Takkenberg, 2002]. Although early allograft valves were variably sterilized in ethylene 
oxide and preserved in β-propriolactone, irradiated, or freeze-dried, subsequent 
developments in preservation techniques including antibiotic use, improved culture 
media, and freezing have led to the use of cryopreserved allograft valves. The most 
common cryopreservation method involves freezing the valve in dimethyl sulfoxide and 
storing it in liquid nitrogen [Kitagawa, 2001]. Aortic valve replacement with 
cryopreserved allograft valves achieved excellent early results (~3 years), although 
eventual failure of these tissues is common. 
 Several studies suggest that allograft valve viability associated with 
cryopreservation techniques is recognized as one of the most influential factors in long-
term durability of cryopreserved allograft valves [Angell, 1989; O'Brien, 1987]. The 
specific cell population of greatest importance in determining the long-term viability of 
the valves is likely to be the fibroblasts since they participate in valve remodeling through 
collagen metabolism and improve competency and durability of the cryopreserved valves 
[Koolbergen, 1998; Song, 1997]. It has been reported that apoptosis occurrs in cuspal 
ECs and ICs of implanted cryopreserved allograft valves, and this might lead to their loss 
of cellularity [Hilbert, 1999]. Loss of the endothelium adversely affects the underlying 
fibroblasts by accelerating graft deterioration due to increased capacity for thrombus 
formation. Comparison of explanted cryopreserved allograft valves with aortic valves 
removed from short-term and long-term transplanted hearts showed that cryopreserved 
allograft valves are morphologically nonviable with flattened collagen [Mitchell, 1998]. 
The presence of procollagen and the α1-(I) procollagen gene expression in allograft aortic 
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valves after implantation for 3 days suggested donor fibroblast viability [Lupinetti, 1997]. 
Although the collagen synthesis ability was preserved, reduction in protein synthesis 
ability may have a significant impact on the long-term cellular viability. Thus these 
valves are unlikely to grow, remodel, or exhibit active metabolic functions, and their 
usual degeneration cannot be attributed to immunologic responses. 
 
2.2.5. Autograft valves 
The use of a patient’s pulmonary autograft to treat aortic valve disease, initiated by 
Donald Ross in 1967, has a high success rate since the valves are living tissues with 
intact cells. The diseased aortic or mitral valve is replaced with patient’s pulmonary valve 
and the excised pulmonary valve is then substituted with an allograft pulmonary valve. 
The complexity of the Ross procedure is balanced by its advantages of excellent 
hemodynamics, potential for a permanent replacement for the aortic valve, and 
elimination of anticoagulation therapy. Long-term durability of the procedure requires 
appropriate geometric matching of the aortic and pulmonary roots. However, concerns 
over the development of insufficiency of the pulmonary autograft have limited its 
application in adults [Fullerton, 2003]. Follow-up studies have shown that 20 years after 
the procedure, 80% of patients were alive, 85% of them did not require reoperation, and 
75% were free from any other event including endocarditis, degeneration of the 
pulmonary autograft, and death [St.PatrickHospital, 2004]. The Ross procedure results in 
significant improvement in left ventricular wall thickness and outflow tract velocity, 
which is not seen in allograft aortic valve replacements [Jones, 1998]. Hence the 
procedure is potentially used in patients with complex left ventricular outflow tract 
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obstruction. The procedure has a number of unique advantages in neonates and infants as 
the valves are non-thrombogenic and have the ability to grow with age because of the 
anatomical and biological similarities between pulmonary and aortic valves. The clinical 
success of the autograft valves and their suitability for pediatric population has lead to the 
construction of tissue-engineered heart valves with the idea that constructs having 
anatomical and biological properties as that of native aortic valves have a similar 
functionality as that of aortic valves. 
 
2.2.6. Tissue engineered heart valves (TEHV) 
The optimal prosthetic heart valve would involve construction from autologous tissue, 
which may provide the valves with the ability to grow and repair and thereby increase 
their durability without the risk of rejection [Zund, 1997]. Tissue engineering is a new 
domain in which techniques are being developed to transplant autologous cells onto a cell 
matrix, which can be a biodegradable scaffold or an acellularized heterograft leading to 
the creation of new functional tissue that can foster remodeling in an active manner. To 
date, tissue engineering techniques have been used to produce skin substitutes [Ng, 
2001], blood vessels [Solan, 2003], cartilage [Freed, 1994], bone [Zhang, 2003], liver 
[Hasirci, 2001], pancreas, neural substitutes, heart valves [Zund, 1997], myocardial 
patches, ligaments, tendons, and kidneys using biodegradable polymer scaffolds. Of 
these, the products that are marketed in the United States are Transcyte (ATS/1997), 
Dermagraft (ATS/2001), Appligraf (Organogenesis/1997) and Orcel (Ortec/2001) for 
skin; Carticel (Genzyme/1997) for cartilage repair; and Synergraft (Cryolife Inc., 1999) 
for heart valve replacement. Several approaches have been used to engineer these tissues. 
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For example, Auger et al [L'heureux, 1998] used human vascular smooth muscle cells, 
fibroblasts and endothelial cells cultured in a mandrel to produce a tissue-engineered 
blood vessel, which exhibited a burst strength of 2000 mmHg. Microencapsulation of 
insulin-secreting cells using a poly L-lysine (PLL) membrane surrounding calcium 
alginate microbeads has been used to create a bioartificial pancreas [Tziampazis, 1995]. 
Heart valve leaflets have been constructed using a polymeric scaffold composed of an 
outer non-woven mesh made from pure polyglycolic acid (PGA) and an inner layer with 
a woven mesh from a PGA copolymer consisting of 90% PGA and 10% polylactic acid 
(PLA) seeded with human fibroblasts and aortic ECs [Zund, 1997]. 
 Tissue engineering of heart valves has progressed dramatically in three different 
arenas: a biodegradable stented valve seeded with autogenous cells, a decellularised 
allograft, and xenograft valves that are either seeded, or those that repopulate by adaptive 
remodeling in vivo [Elkins, 2003]. Tissue engineered pulmonary valve leaflets created 
from autologous sheep cells cultured on PGA scaffolds implanted in growing sheep (for 
up to 11 weeks) grew in parallel with native tissue of the maturing animal and did not 
demonstrate dilation or thinning with increased tensile strength and collagen content 
[Shinoka, 1995]. However, this method required leaflet replacement that is surgically 
challenging. During the remodeling period, the mechanical properties of the constructs 
were not as strong as the native tissue. In the second approach, decellularized porcine 
aortic valves were recellularized by seeding with human neonatal dermal fibroblasts 
[Zeltinger, 2001]. A pneumatic flow bioreactor imposing leaflet mobility with fluid flow 
facilitated the attachment of fibroblasts to the scaffold and colonized the decellularized 
porcine matrix. During the 8-week culture process, the fibroblasts were metabolically 
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active, mitotic, and synthesized human extracellular matrix proteins. This study suggests 
that an in vitro approach could be used for cellular growth; however, the mechanical 
integrity of the construct remains questionable. The next step in this approach involves 
the functional testing of this new valve either in vivo in an animal model or in vitro under 
physiological conditions in a bioreactor. In the third method of developing a TEHV, 
decellularized canine aortic and pulmonary valves maintained leaflet mobility, exhibited 
no inflammation, and were repopulated by host cells at the valve base and partially 
endothelialized when implanted in vivo for one month [Wilson, 1995]. However, 
endothelialization in humans is not a spontaneous process which may contribute to graft 
failure. These studies show that cell-cell interactions, growth factors, flow conditions, 
shear stress and combinations of these are important for the function of a TEHV. 
 Synergraft, the first TEHV made from porcine aortic tissue was evaluated in vitro 
in a dynamic bioreactor and in vivo by implantation in sheep weanlings. In vitro studies 
showed that the valve exhibited a larger orifice area and lower gradients equivalent to a 
normal human aortic valve [Goldstein, 2000], and in vivo studies showed that the leaflets 
were stable with up to 80% matrix recellularization with host fibroblasts and no 
calcification over 150 days. Studies with pediatric patients showed that the xenogenic 
collagen matrix elicits strong inflammatory response in humans, which is non-specific 
early on and is followed by a lymphocyte response. Structural failure of the graft 
occurred within 1 year, which suggests that the valves were not optimal for implantation 
in humans [Simon, 2003]. A TEHV must incorporate the complex microstructure of a 
native valve to be durable and have long-term functionality. The optimal approach would 
be to fabricate the cusps from building blocks of collagen fiber bundles surrounded by 
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tubes of elastin, linked together by elastin sheets and struts and GAGs that bind water to 
impart the gelatinous consistency. 
 
2.3. Hemodynamic forces on aortic valve 
2.3.1. Forces on aortic valve 
The anisotropic property of aortic valve leaflets has potentially significant effects on its 
mechanical behavior and failure mechanisms. Understanding these mechanical forces is 
crucial to the development of a TEHV. The aortic valve undergoes complex deformations 
during each cardiac cycle thus exposing the valve leaflets to transvalvular pressures, 
shear and bending stresses, and cyclic flexure as the leaflets load and unload. 
Experimental studies, discussed in the following paragraphs, have been performed to 
measure the mechanical forces on the valve leaflets, to study the function of the valves, 




In vivo the pressure on the leaflet varies from systole to diastole, thereby changing the 
stress and, consequently, the length of the leaflet. Under normal hemodynamic 
conditions, the closed valve supports a transvalvular pressure of 80-120 mmHg acting 
perpendicular to the leaflet area (normal stress). This force is supported by the lamina 
fibrosa layer of the leaflet and is transmitted from the collagen fibers to the cells within 
the tissue that are aligned with the collagen fibers. The pressure acting on the leaflets is 
usually estimated in terms of stresses assuming the tissue to be homogeneous [Thubrikar, 
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1990]. The leaflet, however, is inhomogeneous, anisotropic, nonlinear, and viscoelastic 
with a complex geometry. 
 In vivo studies using a marker-fluoroscopy technique with radiopaque markers 
placed on canine aortic valve leaflets were conducted as early as 1980. The stresses were 
estimated from the change in position of these markers using equations for membrane 
stress assuming a cylindrical geometry. The membrane stresses in the circumferential 
direction of the leaflet were 1.7 g/mm2 during systole and 24.5 g/mm2 during diastole 
[Thubrikar, 1990]. In another study finite element formulation was used to analyze the 
stresses. Based on a pressure of 114.7 mmHg and a human aortic valve leaflet thickness 
of 0.6 mm, the maximum principle stress was found to be 22.35 g/mm2, which is 
comparable to the in vivo study [Cataloglu, 1976].  
 
Shear Stress 
Aortic valve shear stress is an important factor in the synthetic activity of the valvular 
cells and also in cell adhesion. Shear stress is experienced by the ventricular surface of 
the leaflets during systole when blood flows past the leaflets and on the aortic surface 
during diastole when blood pools into the sinuses. An estimate of these stresses aids in 
understanding effect of stresses on leaflet cellular function and in elucidating cellular 
responses [Weston, 1999].  
  Tissue degradation and failure due to calcification of the leaflets has been 
associated with regions of high shear and bending stresses in the leaflets during valve 
opening and closing [Wheatley, 1987]. Various in vitro studies were performed to 
estimate the shear stresses on the aortic valve using bioprosthetic and mechanical valves. 
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Techniques such as Laser Doppler velocimetry (LDV) and Hot film anemometry (HFA) 
were used to measure near-wall velocities downstream of the valves. Using LDV, the 
highest shear stress found in a 29 mm Hancock stented porcine aortic valve under 
pulsatile flow conditions was 29 dyne/cm2 at 45 mm downstream of the valve [Walburn, 
1984]. Measurements under steady flow conditions for 21 and 25 mm polymeric trileaflet 
valves showed that the aortic wall shear stresses were 200–500 dyne/cm2 at 40 to 60 mm 
downstream of the valve [Woo, 1986]. Experiments using the HFA technique with a 27 
mm Ionescu-Shiley bovine pericardial valve under pulsatile conditions yielded a stress 
value of 29 dyne/cm2 at 30 mm downstream of the valve [Nandy, 1987]. These studies 
calculated the shear stress downstream of the valve rather than the stress on the leaflet 
surfaces. However, shear stresses on the leaflet surfaces are critical for understanding the 
functionality of valvular leaflet cells. 
 In order to estimate the shear stresses on the leaflet surface, LDV measurements 
were performed using a polymeric (polyurethane) trileaflet valve under pulsatile 
conditions [Einav, 1990]. Shear stress on the leaflet surface at peak systole was found to 
be 800–1800 dyne/cm2. In a recent study by Weston et al [Weston, 1999], two-
component LDV measurements were conducted using a polyurethane valve. 
Measurements were taken inside the valve as well as downstream of the valve. The 
maximum wall shear stress inside the valve was found to be 79 dyne/cm2 while the wall 
shear stress measured 83 mm downstream of the valve was 10-17 dyne/cm2 at a flow rate 
of 7.5 L/min. At a flow rate of 22.5 L/min the shear stress was 52-104 dyne/cm2. These 
values are an order of magnitude less than those found in earlier investigations. 
Bioreactors designed taking these stress values into account can be used to study the 
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responses of valvular cells to mechanical forces and the signaling cascades for 
inflammation involved in the valve leaflets, without damaging the endothelium lining. 
 
Bending Stress 
The change in leaflet curvature during the cardiac cycle gives rise to bending stresses, 
shearing, or buckling [Thubrikar, 1990]. The collagen chords in the leaflet structure are 
free to bend in the circumferential direction without significant resistance from the elastic 
fibers aligned in the radial direction.  Bending stress is both tensile and compressive with 
the leaflet on the convex side experiencing tensile stress while the concave side 
experiences compressive stress. During bending, the belly of the leaflet undergoes 
reversal of curvature due to loading and unloading of the valve while the zone of 
attachment acts as a hinge facilitating leaflet movement. The bending stress increases 
with an increase in leaflet stiffness causing early failure of some bioprosthetic valves.   
Thubrikar used the radiopaque marker technique to calculate the bending strains 
in vivo in canine aortic valves. The bending strains, calculated from modulus of elasticity, 
thickness and radius of the leaflet, were found to be 2% during systole and 2.2% during 
diastole in the circumferential direction [Thubrikar, 1990]. In vitro experiments using 
dip-cast polyurethane trileaflet valves were performed to determine values for bending 
strain and stress at the free edge of the leaflet under physiological pulsatile conditions. 
The bending was greatest during the opening phase corresponding to a maximum strain 
and stress of 14.5% and 1.22 MPa, respectively. During the closing phase the maximum 




Stretching is important for a leaflet as it allows the leaflet to extend and form a coaptive 
seal with the other two leaflets. It is required for the maintenance of an adequate 
coaptation area. Leaflet stretch may be lost at a relatively rapid rate for reasons that are 
not yet understood [Thubrikar, 1990]. The first and most rapid change starts in late 
adolescence. The stretch during this period is halved from 80% to 40% over a time span 
of 15 to 25 years. This corresponds to a linearized reduction of approximately 4% per 
year in stretch rate. Between the ages of 25 and 40 the stretch remains approximately 
constant at a value of about 40%. After age 40, the stretch continues to decline at a 
slower linearized rate of about 1% per year until age 58 [Christie, 1995a]. Thus, a valve 
from 15-year-old donor has about four times more stretch than one from a 58-year-old 
donor. The tissues become less extensible with increasing age because collagen 
fibrillogenesis increases the diameter of some of the constituent fibrils in discrete steps. 
Thus, larger numbers of thick collagen fibrils will require greater force to produce the 
same extension, causing a reduction in stretch. 
 In vivo studies done by Thubrikar measured the change in leaflet length in the 
circumferential and radial direction during the cardiac cycle in canine aortic valves. He 
observed that the leaflet in both the circumferential and radial directions is longer during 
diastole than during systole. The leaflets elongate by 11% in the circumferential direction 
and 31% in the radial direction from systole to diastole [Thubrikar, 1990]. This is because 
the collagen in the circumferential direction provides greater tensile strength than that in 
the radial direction, which is mainly composed of elastic structures. Porcine aortic valves 
stretched in vitro using a “Tensilon” tensile stress testing machine showed elongations in 
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the leaflets to be 33% and 60% in the circumferential and radial directions, respectively 
[Missirlis, 1978]. Barratt-Boyes et al [Christie, 1995b] have measured the biaxial 
properties of pulmonary and aortic valve leaflets during extension in the fresh and 
gluteraldehyde fixed states. For the pulmonary leaflets, radial stretch was greater than 
that in the aortic leaflets and circumferential stretch was similar. Thus, the ratio of radial 
to circumferential stretch was 6.0±1.1 for the aortic leaflets and 9.0±1.8 for the 
pulmonary leaflets. After fixation in 0.2% gluteraldehyde, the ratios in the aortic leaflets 
were the same except with significantly reduced stretches in both directions. Purinya et al 
[Purinya, 1994] studied the biomechanical and structural properties of the explanted 
bioprosthetic valve leaflets. Eighty months after implantation, the pericardium valve 
became more extensible and ultimate strain increased 2.5 times while that of the porcine 
bioprosthetic valve increased from 13 to 22%. These studies do not infer the response of 
native tissue to cyclic stretch in the leaflets; hence, it is interesting to look at this 
stretching effect on native valve biology. 
  
2.3.2. Cellular responses of aortic valve to mechanical loading 
The cell types that are predominantly found in aortic heart valve leaflets are ECs and ICs. 
These cells show force-dependent responses to pressure, shear and bending stresses, and 
cyclic stretch during the cardiac cycle. Previous studies have shown that scaffolds seeded 
with valve cells maintain natural cell phenotype and extracellular matrix composition 
when cultured under dynamic conditions in vitro. When implanted in vivo these 
constructs appear to be capable of remodeling and potential growth. To understand this 
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relationship several studies have been performed with cells and native tissue from 
different species, which are discussed below.  
 
Pressure  
ECs are of significant importance to tissue engineered cardiovascular constructs as they 
help in regulating vascular tone, inflammation, thrombosis and vascular remodeling. ECs 
transdifferentiate to replenish ICs and maintain homeostasis by regulating the interaction 
between blood and ICs. In blood vessels, these cells are oriented in the direction of blood 
flow. However, studies with aortic valves have shown that ECs on both the aortic and 
ventricular sides are arranged perpendicular to the direction of flow. A study done with 
adult mongrel dogs has shown that the ECs were arranged in a circumferential pattern on 
the ventricularis side instead of aligning in the direction of systolic blood flow. This 
suggests that the endothelium lining is governed by diastolic blood pressure [Deck, 
1986]. Tokunaga et al [Tokunaga, 1987] exposed cultured umbilical vein ECs and 
smooth muscle cells (SMC) to increasing pressures and found that EC growth was 
maximum at 80 mmHg and minimal at atmospheric pressures. The cells degenerated at 
120 mmHg with marked degeneration at 160 mmHg. Growth of SMCs on the other hand 
was not influenced by ambient pressure and steady growth continued throughout the 
culture period. In another study, when cultured bovine aortic ECs were exposed to 
atmospheric, static (135 mmHg), or pulsatile pressures (160/110 mmHg), EC number 
significantly decreased at both pressure conditions. To further study this effect, EC 
conditioned media from the three pressure conditions were transferred to static cultured 
EC. There was a significant cell growth inhibition in the control EC group suggesting that 
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ECs exposed to pulsatile pressure secrete autocrine factors with growth inhibitory 
properties [Vouyouka, 1998]. This suggests that cells are affected by the magnitude and 
type (steady or pulsatile) of pressure. In studies by Hishikawa et al [Hishikawa, 1994] a 
static pressure of 120 mmHg enhanced DNA synthesis in SMC, but inhibited it in ECs 
suggesting that the pressure effect may also be cell type specific. Studies carried out in rat 
aorta showed that under hypertension there was an increase in proliferation of ECs, 
SMCs and fibroblasts within the vessel wall [Owen, 1985]. ECs and fibroblasts’ 
proliferation was decreased at the end of 30 days while the SMCs continued to 
proliferate. 
 Large arteries subjected to hypertension undergo changes such as increased 
stiffness and collagen content [Iwatsuki, 1977]. Recent studies have examined the effect 
of pressure on heart valves. Willems et al [Willems, 1994] studied the effect of 
hypertension on Wistar Kyoto rats’ tricuspid, mitral and aortic valves by intrarenal aortic 
ligation thus increasing the ventricular pressure overload. The results showed an increase 
in DNA synthesis and mRNA amounts of both collagen type I and III while maintaining 
the cell phenotype when compared to sham aortic ligation and normal rats. In vitro 
studies on porcine aortic valves leaflets exposed to static pressures of 100, 140 and 170 
mmHg for 48 hours showed that there was an increase in collagen synthesis at elevated 
pressures. An increase in collagen synthesis of 37.5% and 90% in leaflets subjected to 
140 and 170 mmHg, respectively, was observed when compared with leaflets subjected 
to atmospheric pressures. No significant difference in DNA or sGAG synthesis was 
observed at elevated pressures; however, DNA synthesis at 100 mmHg decreased. α–
SMC actin declined during the experiments, although no significant difference was 
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observed between the pressure and control groups [Xing, 2004]. Further studies are 
required to study the effect of pressure on valvular cells under static and pulsatile 
conditions to understand the influence at the gene level. 
 
Shear stress 
Studies of the effect of shear stress on cellular functions were initially performed to 
understand the thromboembolic complications associated with cardiovascular prostheses. 
Platelet activation was thought to be associated with certain physical forces. A rotational 
viscometer was used to apply graded levels of shear stress to platelet-rich plasma, which 
showed that the platelets were extremely sensitive to shear stress and increased the 
possibility of thrombus formation due to action of physical forces on circulating platelets 
[Brown, 1975]. In studies involving endothelium damage in stenotic regions, it was 
observed that acute shear stresses created by reducing the lumen of the rat aorta by 20-
25% resulted in a loss of ECs within 3 minutes with no significant increase in damage 
after one hour [Joris, 1982]. A similar study was done to observe the shape of ECs related 
to local wall shear stress. ECs in aortic stenosis regions (high shear stress regions) created 
by reducing the cross-sectional area to 70% were elongated [Levesque, 1986]. Also, 
another study showed that cultured ECs exposed to steady laminar shear stress elongate 
and align in the direction of flow [Dewey, 1981]. Studies with porcine ECs from the aorta 
and aortic valve subjected to 20 dynes/cm2 steady laminar shear stress for up to 48 hours 
showed that the aortic valve ECs were aligned perpendicular to flow. However, the aortic 
ECs, were aligned parallel to flow [Butcher, 2004b]. This suggests that valvular ECs 
exhibit different characteristics from vascular ECs. 
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 ECs are immediate recipients of shear stress, and their responses are transmitted 
through the cytoskeleton to the SMC, which regulate EC number in the vessel wall. Many 
studies have been done to profile ECs subjected to turbulent and laminar shear stresses. It 
has been found that in regions subjected to disturbed shear stresses, both pro- and anti-
atheroscelerotic transcript profiles coexisted, suggesting that the region is primed for 
inflammation even if it is not active [Passerini, 2004]. Studies with human dermal 
fibroblasts exposed to a shear stress of 80 dyne/cm2 in a flow chamber showed that the 
cells did not align in the direction of flow [Jouret, 1997].  Exposing human cardiac leaflet 
fibroblasts to a stress of 40 dyne/cm2 showed that the cells under culture proliferated at 
96 hours but did not show any elongation or orientation under steady laminar shear 




The effects of cyclic stretch have been studied previously in cell culture with osteoblasts, 
chondrocyctes, fibroblasts, ECs, vascular SMCs, valvular ICs, and cardiomyocytes. 
Many strain devices were developed to impose uniaxial or biaxial stretching. Sotoudeh et 
al developed a strain device to impose dynamic and equi-biaxial strain to cultured bovine 
aortic ECs. The device was tested by measuring luciferase activity, which was 
chimerically transfected onto ECs. When stretched by 15% or more in area, cells showed 
significantly increased lucifrease activity at different membrane locations confirming that 
strain was uniform and biaxial across the membrane [Sotoudeh, 1998]. To test the 
dynamic flexure of native and tissue engineered valves, a bioreactor has been developed 
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to subject the tissue to uniaxial cyclic flexure [Englemayr, 2003]. The reactor can be used 
to test different specimen materials of interest in tissue engineering. 
Many investigators have studied the effects of stretch on cardiomyocytes because 
mechanical stress has been considered to be one of the major causes of physiological 
development and growth of the heart as well as cardiac hypertrophy. When subjected to a 
cyclic stretch of 120% at a frequency of 30 cycles/min, embryonic rat cardiomyocytes 
along with intracellular myofibrils oriented parallel to the stretch direction during the first 
12 hours of initiation [Kada, 1999]. Henriëtte et al [Jonge, 2002] have examined the effect 
of cyclic stretch (30 cycles/min and 20% elongation) as well as endothelin-1 (ET) on rat 
neonatal ventricular myocytes. After 24 hr stimulation by ET-1 or cyclic stretch, the 
myocytes responded by developing hypertrophy. David et al studied the altered gene 
expression in perfused arterial segments exposed to cyclic flexure ex vivo [Vorp, 1999]. 
RT-PCR analysis demonstrated that E-selectin and MMP-1 were consistently and 
significantly down-regulated in the specimens subjected to 4 hr of cyclic bending in a 
perfusion system.  
ECs lining the lumen of blood vessels or the heart valve leaflets are subjected to 
strain by pulsatile blood pressures and shear forces on them. Cyclic stretching of intact 
vessels under normal transmural pressure in the absence of shear stress induces within a 
few hours, realignment of endothelial actin stress fibers in the circumferential direction. 
Sipkema et al studied the effect of cyclic axial stretch of rat arteries on endothelial 
cytoskeletal morphology and vascular reactivity [Sipkema, 2003]. Concomitant with the 
morphologic alteration, the sensitivity to the endothelium-dependent vasodilator was 
significantly decreased in the stretched vessels. Hence, similar to cultured cells, ECs in 
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intact vessels subjected to cyclic stretching reorganize their actin filaments almost 
perpendicular to the stretching direction. Chaubey et al have studied the effect of stretch 
in the expression of cytoskeletal proteins, vimentin and desmin and ECM protein, 
fibronectin in aortic and pulmonary valve IC [Chaubey, 2003]. The expression of 
vimentin was unaltered by stretch whereas desmin upregulated in aortic and pulmonary 
interstitial cells. Fibronectin was unaltered in aortic valves but was downregulated in 
pulmonary valves.  
Mechanically induced ECM remodeling plays a crucial role in tissue engineering 
of load-bearing structures, such as heart valves and cartilage. Driessen et al did some 
study on collagen fibre remodeling [Driessen, 2003]. They hypothesized that collagen 
fibre reorientation was induced by macroscopic deformations and the amount of collagen 
fibres was assumed to increase with the mean fibre stretch. Also the collagen fibres align 
in a direction to avoid mechanical stimulus under cyclic deformation. However, there 
must be a limit in the sensitivity of the cellular response to the mechanical stimulus. A 
cell and its intracellular stress fibers orient approximately in the same direction under 
cyclic deformation. Some research has also been done to measure the stress-strain 
properties, elongation in the leaflets during each cardiac cycle and structural changes in 
the leaflets of native aortic, mitral and pulmonary valve leaflets.  
 
2.4. Bioreactors for native and engineered constructs 
Tissue engineered cardiovascular devices offer the possibility of developing a patient 
specific implantable device that has a potential to grow and remodel with native tissue 
without risk of rejection. However, concerns over patient safety during the graft 
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remodeling in vivo has prompted its testing ex vivo using a bioreactor. Thus, the graft can 
be completely remodeled prior to its implantation in the patient. Many studies have been 
carried out to simulate physiological environments ex vivo in order to study cellular and 
tissue responses to mechanical conditions during creation, physiological conditioning, 
and testing of cells, tissues, scaffolds and organs to aid in the development of tissue 
engineered blood vessels and heart valves.  
Bioreactors are being used as integral parts of artificial organs such as excorporeal 
liver assistant device, artificial kidney, etc. to produce artificial organs such as dermal, 
epidermal skin grafts, cartilage, bone, blood vessel, heart valves, etc. to amplify cell 
cultures ex vivo; and to seed cells efficiently with few chances of nutrient and oxygen 
depletion. Physically interactive bioreactors are used for investigating biomechanical 
regulation of cell function under controlled physiologically relevant conditions and for 
the development and regeneration of cell-matrix constructs for tissue engineering 
[Ingham, 2003]. The simplest and commonly used bioreactor is the culture dish as it 
provides a sterile, easy to use, static and economical method of amplifying cells. 
However, the disadvantage of this system is that, scale-up is limited to use of multi-well 
culture dishes which require manual handling. Also if the tissue thickness exceeds 10 
microns then nutrient and oxygen diffusion becomes a limitation which can partly be 
overcome by the use of spinner flasks with filters for gas exchange [Martin, 2004]. 
Although static loading of cells in a monolayer or seeding onto scaffolds is commonly 
used, it leads to non-native phenotypic expression of proteins, low seeding efficiencies, 
and non-uniform distribution of cells within the scaffolds. These drawbacks of static 
cultures can be overcome by perfusion bioreactors, which exploit the principle of 
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convective transport for production of 3D uniformly seeded scaffolds. Also, the ex vivo 
microenvironments of such bioreactors are biomimetic and guide cell organization, 
control cell-matrix interactions, and provide appropriate structural and mechanical 
features.  
 An early usage of bioreactors in cardiovascular research was to seed vascular cells 
on acellular constructs. Under pulsatile flow conditions cell retention and adhesion on the 
scaffold along with the mechanical strength improved compared to static conditions. The 
first tissue-engineered vascular graft was produced by Weinberg and Bell [Weinberg, 
1986]. A multilayered tube consisting of cultured bovine EC, SMC, and fibroblasts were 
mixed to construct blood vessels. Seliktar et al [Seliktar, 2001] developed a system for 
dynamic conditioning of collagen-gel blood vessel constructs. The tubular constructs 
were cultured with SMC seeded on collagen-gel over thin walled silicon tubes inflated 
with cultured medium under pneumatic conditions. The constructs were exposed to 
inflation and deflation of the conduits at a frequency of 1 Hz for periods of 4 and 8 days. 
This imparted a cyclic strain of 10% onto the cell-seeded constructs. At the end of 8 days, 
the SMC oriented circumferentially and distributed homogeneously throughout the 
thickness of the vessel wall. Also, the ultimate tensile strength of the vessel was found to 
be within the range of the human aorta while that of the static cultures was lesser. In 
another study, Niklason [Niklason, 1999] developed a blood vessel construct seeding 
PGA scaffolds with porcine aortic SMC in a pulsatile bioreactor for approximately 24 
weeks. The vessel’s histological appearance was similar to that of the native vessels and 
exhibited burst strength of nearly 2000 mmHg as compared to 300 mmHg of nonpulsed 
constructs. Teebken [Teebken, 2002] used seeded xenografts to produce small diameter 
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vascular grafts. Decellularized porcine aortas were seeded with EC isolated from human 
saphenous vein and cultured in a pulsatile perfusion bioreactor. The EC grew to form a 
monolayer on the lumen. Stable biomechanical properties were achieved at physiological 
perfusion pressures in vitro. These studies suggest that physical stimuli improve cell and 
tissue growth. Also bioreactors that mimic physiological conditions produce constructs 
with better mechanical properties and morphological characteristics as compared to those 
developed in static cultures. 
 It has been demonstrated from previous studies that, in vivo, architecture, 
development, and function of the cardiovascular tissues are intimately related to their 
hemodynamic environment. Pulsatile blood flow gives rise to both radial and 
circumferential strain while steady flow causes normal and shear stress on the walls of 
the vessels. These forces impact the alignment and sensitivity of the cells to biochemical 
signals for growth, maintenance, and repair [Niklason, 1999; Seliktar, 2001; Teebken, 
2002; Weinberg, 1986]. An early study to produce TEHV involved initial static seeding 
on polymeric constructs in vitro and then in vivo implantation for its development. The 
major disadvantage of such tissue engineered valves was progressive structural valve 
deterioration resulting in stenosis or regurgitation. Hence bioreactors simulating heart 
valve dynamics have been developed to improve the structural and mechanical properties 
of the engineered valves. An in vitro flow system was developed by Jockenhoevel et al 
[Jockenhoevel, 2002] to investigate the impact of laminar flow on ECM formation and 
tissue development. The system provided a cross flow arrangement of main flow induced 
by a dialysis roller pump. PGA scaffolds were seeded with myofibroblasts from human 
aortic regions and incubated for 14 days under static conditions. The tissue was then split 
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into two groups; one group was exposed to shear stress for 14 days while the other was 
maintained under static conditions. The in vitro system maintained stable cell culture 
conditions and collagen production increased significantly (1.5 times) compared to the 
static culture conditions. This study suggests that dynamic mechanical environment is 
required for attaining significant fibroblast activity.  Dumont et al [Dumont, 2002] 
developed a bioreactor consisting of two major parts, a silicone left ventricle and an 
afterload consisting of compliance and resistance, with the valve placed in between the 
two. Stroke volume output was accomplished by means of compression and 
decompression of the left ventricle. Using controllable resistance, compliance, stroke 
volume and frequency, different pressures and flow rates were obtained. Using the 
bioreactor, they obtained physiological aortic pressures and maximum flow rate of 3.44 
L/min. However, the bioreactor was not tested for sterility, nutrient limitation (especially 
oxygen limitation) and viability of the tissue grown in it. A similar attempt to develop a 
sterile pulsatile bioreactor with adjustable flow and pressure levels was made by 
Hoestrup et al [Hoerstrup, 2000b]. The system consists of two principle chambers, an air 
chamber and a fluid chamber. The two chambers are separated by a silicon diaphragm. 
The fluid chamber was divided into two compartments; the lower of the two was 
connected to the top perfusion compartment through a tube. The tissue engineered valve 
was fixed on the top of the tube into the perfusion chamber. Media flow was directed 
from the bottom compartment through the tube to the mounted tissue engineered valve. 
Pulsatile flow was attained by pumping air into the air chamber which displaces the 
silicon diaphragm periodically between the two chambers. The air-driven system was 
connected to a respirator which functioned as an air pump. By adjusting the stroke 
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volume and ventilation rate of ventilator a flow rate of 50 to 2000 ml/min and pressures 
of 10 to 240 mmHg were achieved in the bioreactor. Though a wide pressure and flow 
rate ranges could be attained by the system, the flow rate values were not in the 
physiological range and the system did not address the issue of O2 transport. A trileaflet 
valve created using PGA scaffolds coated with P4HB was grown in the bioreactor 
[Hoerstrup, 2000a]. The leaflets showed mobility with synchronous opening and closing 
within the bioreactor and all the leaflets were intact, pliable and competent during valve 
closure compared to those grown in static culture, which were fragile and were losing 
structural integrity after 14 days. The leaflets which were grown in the bioreactor showed 
organized layered cellularity with dense outer layer and less cellular inner layers at the 
end of 14 days. Also the tissue had a confluent smooth surface with cell orientation in the 
direction of flow. In contrast rough surface was observed for static cultured tissue. The 
collagen content increased 129% compared to the native tissue after 14 days and leveled 
off at 85% at the end of 28 days. GAG was found to be 60% of the native tissue after 14 
days and increased a little at the end of 28 days. In a similar study Sodian et al [Sodian, 
2000] created a trileaflet heart valve using polyhydroxyalkanoate. Valves cultured in the 
bioreactor showed that cells were viable and ECM formation was induced after exposure 
to pulsatile flow. The engineered valves produced by the methods above, when implanted 
in vivo in sheep model showed patency up to 16-20 weeks and later developed 
regurgitation due to improper coaptation. Thus, further studies must be done to design a 
bioreactor that will provide the mechanical environment required for the stimulation of 
the cells to develop the functional characteristics similar to native valvular cells. A better 
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understanding of the response of native valvular cells to mechanical forces experienced 
by the heart valves during the cardiac cycle will enable a better bioreactor design. 
 Studies to understand the biology of native heart valve leaflet tissue and cells in 
response to individual cardiac hemodynamic forces have been carried out over the past 
few years by many investigators. Weston et al [Weston, 2001] developed a system to 
study the effects of steady and pulsatile flow (10 L/min and 20 L/min) and laminar shear 
stress (1, 6, 22 dyne/cm2) on native porcine aortic valve leaflets. The results showed that 
exposure to bulk flow or shear stress environment for 48 hours maintained the collagen, 
GAG and DNA synthesis at native synthetic levels; however the synthesis increased 
significantly when leaflets were subjected to static incubation. A difference in protein 
synthesis in the leaflet tissue was observed as compared to freshly excised tissue when it 
was exposed to shear stress. These results suggest that fluid flow maintained the synthetic 
activity of leaflets at normal levels. A study done to investigate the effects of constant 
pressure on biology of aortic valve leaflets showed an increase in collagen synthesis at 
hypertensive pressures when compared to statically incubated leaflets [Xing, 2004]. 
These studies demonstrate that leaflet tissue show varied responses to different 
physiological forces in isolation. In both these studies, it was observed that the leaflets 
were unable to preserve α-smooth muscle actin immunoreactive cells, which suggests 
that other mechanical forces, such as bending or stretch caused by back pressure may be 
required to preserve cell phenotype. To attain this, aortic valve leaflets anchored to the 
aortic root need to be subjected to physiological forces in vitro and their response to these 
forces needs to be characterized. 
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2.5. Rational for the research 
Aortic valve leaflets consist of a matrix of collagen, elastin fibers, proteoglycans and 
glycoproteins that along with the cells populating the matrix sustain the dynamic 
behavior of the valves by undergoing changes in synthetic activity. ICs lie within the 
matrix and play a vital role in maintaining the functionality of the valves. They are 
myofibroblastic in nature and exhibit contractility and secrete ECM components 
(collagen, elastin and GAG). ECs are present on the leaflet surfaces and are critical for 
maintaining nonthrombogenicity, transport of nutrients, and transduction of mechanical 
and biochemical signals to the ICs via the ECM. Constant production, remodeling, and 
adaptation of these cells and matrix ensure the functional integrity of the aortic valve. 
The cellular elements of the valve leaflet exhibit different phenotypes specific to the role 
performed. Consequently, it has been shown that phenotype of vascular SMC was altered 
with changes in culture conditions, mechanical or biochemical stimulation [Stegemann, 
2003a; Stegemann, 2003b]. Reduction in α-SMC actin expression was observed with 
valvular ICs in 3D gels under static culture [Butcher J.T., 2004; Butcher, 2004a] which 
was similar to that seen in 3D vascular cells gel culture [Stegemann, 2003b]. This 
suggests that mechanical forces along with matrix interaction play a significant role in 
modulating cell phenotype. Porcine aortic valve ECs subjected to 20 dyne/cm2 of steady 
laminar shear stress showed different organization of focal adhesion complexes and cell 
alignment than static cultures, suggesting the influence of mechanical forces on valvular 
EC behavior [Butcher, 2004b]. Studies on native aortic valve leaflets subjected to 
mechanical forces showed that fluid forces, laminar steady shear stress and constant 
pressures at physiological levels reduced the expression of α- SMC actin of valvular ICs 
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compared to native levels [Weston, 2001; Xing, 2004]. From this it can be said that 
altered or absence of certain mechanical forces such as cyclic strain or bending stresses 
leads to loss of contractile phenotype of the cells.  
The results from above studies suggest that the lack of an appropriate mechanical 
environment induces a change in the physiological characteristics of the aortic valve 
tissue. To address this issue, an ex vivo organ culture system will be used to study porcine 
aortic heart valves. The system should be able to maintain sterility with physiological 
cardiac output (4.2 L/min) and mean pressure (100 mm Hg), while providing sufficient 
oxygen transport to the native porcine aortic valves. The advantage of this system is that 
cells are maintained in their natural 3-D matrix, in contrast to typical 2-D in vitro cell 
culture studies, and the mechanical environment can be closely controlled, unlike in vivo 
models. Native porcine aortic valves will be cultured in the system under sterile 
conditions for 48 hours and quantitatively compared for ECM components (collagen, 
sGAG and elastin) with fresh valve leaflets and leaflets incubated under static conditions 
for 48 hours. Qualitative comparison of the leaflets will be done to look at morphology, 
changes in cell phenotype, retention of endothelial cells, cellular proliferation and 
apoptosis.  
The results obtained from this study may elucidate the understanding on the 
effects of hemodynamics on cell-cell interactions, mechanotransduction mechanisms in 





Studies on the role of hemodynamic forces in regulating the biological properties of 
aortic valve leaflets are important in understanding the normal function of the valve 
leaflets and also to elucidate failure mechanisms that are implicated in various valvular 
diseases. To date, a complete understanding on the biological characteristics of valve 
leaflets subjected to normal physiological and pathological mechanical conditions has not 
been attained. The identification of the mechanisms of valve failure due to adverse 
mechanical conditions is an area requiring research. 
The native aortic valve offers minimal resistance to fluid flow when open and 
minimal backflow into the left ventricle when closed. It experiences shear and bending 
stresses, fluid and pressure forces, and cyclic flexure during each cardiac cycle. The 
transvalvular pressure difference during valve closure generates large stresses on the 
valve leaflets, which are distributed to the aorta through the fibrous skeleton. Under 
pathological conditions, the inability to reduce these large stresses causes further 
deterioration of the valve resulting in the need for repair or replacement. Studies have 
already been performed in our laboratory to study the effects of laminar shear stress, and 
constant and cyclic pressure on the valve leaflets. These studies showed differences in 
cell phenotype when compared with native aortic valves, suggesting that the lack of 
appropriate mechanical forces such as bending stresses, or cyclic flexure alter the native 
biological property of the valves.  
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 The hypothesis of this research work is that exposure of native aortic valves 
to normal hemodynamic conditions in an ex vivo sterile organ culture system should 
maintain the cellular/biological functionality and phenotype of the valve leaflets. The 
hypothesis is addressed by specific aims: 1) developing a sterile organ culture system that 
simulates the hemodynamics of aortic valves under normal physiological flow and 
pressure conditions; 2) comparing aortic valve leaflet biology between the valves 
cultured in the system for 48 hours and fresh aortic leaflets, and leaflets incubated under 
static, atmospheric conditions in medium for 48 hours. 
 
3.1. Aim 1: Development of the sterile ex vivo organ culture system 
The focus of this aim is to design a sterile ex vivo organ culture system that is easy to 
assemble and compact enough to be placed inside an incubator. The system must satisfy 
the following criteria: It should: 1) be closed to maintain sterility; 2) maintain 
physiological pressures (mean of 100 mmHg) and cardiac output (3.8 – 4.7 L/min) for a 
period of 48 hours; and 3) maintain the viability of aortic valve leaflets by providing 
sufficient oxygen transport to the valve. The system developed should be able to evaluate 
the biological characteristics of native aortic valves under physiological and pathological 
conditions for extended periods of time. To achieve this, the system will be tested for 
physiological flow and pressure waveforms for a period of over 48 hours. The sterility of 
the system will be checked by operating the system aseptically for 96 hours, while 




3.2. Aim 2: Effect of mechanical forces on the biology of porcine aortic valves 
The focus of this aim is to study the biological properties of native porcine aortic valve 
leaflets cultured in the organ culture system under normal physiological conditions for a 
period of 48 hours. Native valves when cultured ex vivo in the system are hypothesized to 
have similar biological characteristics to those of fresh aortic valves. Total collagen, 
sGAG and elastin content of the cultured valve leaflets will be measured and compared to 
fresh and statically incubated leaflets to evaluate the ECM composition of the leaflets. 
Further Hematoxylin and Eosin staining will be performed to examine the leaflet 
morphology and structural integrity. Immunohistochemical stains will be used to study 
cell phenotype by observing the expression of α- smooth muscle actin produced by 
smooth muscle cells, cell proliferation by 5-bromo deoxyuridine labeling of the cells, and 
cell apoptosis by activated caspase-3 antibody. Presence of endothelial cells will be 







MATERIALS AND METHODS 
 
4.1. Construction of the organ culture system 
The organ culture system was designed to mimic the systemic circulation in order to 
create an in vitro mechanical environment that simulates the in vivo hemodynamic 
environment. The arterial, capillary and venous systems constitute the systemic 
circulation of the human body. The arterial system must maintain a relatively high 
pressure in order to establish coronary circulation during the diastolic phase of the 
cardiac cycle. The elastic nature of the arteries acts as compliance, called the Windkessel 
effect that provides a cushioning effect for the pressure waveform preventing excess 
pressure build-up and also helps maintain the pressure at the required level with the help 
of the arterioles. The arterial system ends in arterioles, which form a large peripheral 
resistance by acting as strong muscular control valves through which blood is released 
into the capillary system. The blood from the capillaries is collected by the venous 
system which acts as a storage place for blood controlled by venous constriction [Guyton, 
1991]. Since the heart pumps blood via a pulsatile cycle into the arterial system, the flow 
and pressure waveforms show a pulse with peak values corresponding to the pressure and 
flow conditions in the arterial system. The physiologic waveforms are depicted in Figure 
4.1. The area beneath the flow waveform denotes stroke volume which is 70 mL for a 
normal, resting adult. Retrograde flow occurs during valve closure for approximately 
30msec. The systolic/diastolic pressure for a normal, resting adult is 120/80 mmHg. 
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Figure 4.1: Schematic of flow and pressure waveforms in the ascending aorta of adult 




4.1.1. Design criteria and initial design of the organ culture system 
The primary design consideration when constructing the organ culture system was to 
mimic the cardiac cycle of the systemic circulation to allow ex vivo studies on native 
aortic heart valves. For this purpose, the system must be sterile and closed to the 
atmosphere in order to avoid contamination and enable extended study periods. The 
design criteria governing the construction of the organ culture system are as follows:  
1) Physiological flow and pressure conditions: The system must be capable of 
providing proper flow and pressure waveforms as shown in Figure 4.1 with a 
cardiac output of 3.7 – 4.2 L/min and a mean pulsatile pressure of 100 mmHg 
(120/80 mmHg systolic/diastolic) at a frequency of 1.167 Hz for the duration of 
an experimental run when operated under normal hemodynamic conditions. 
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2) Temperature, pH and oxygen exchange: The media inside the system must be 
maintained at a temperature of 37oC and at a pH of 7.4 for optimal growth of the 
aortic valve tissue. There should not be nutrient limiting conditions, especially O2, 
in the system. Preliminary studies with aortic valves suggest that valvular cells 
undergo apoptosis when oxygen is insufficient in the system. Hence, an O2 
exchange rate greater than the uptake rate of the aortic valves is necessary, and 
must be maintained at all times in the system by exchange of 5% CO2 gas. 
3) Sterility: The system is required to be sterile to prevent contamination of the 
tissue. For this purpose the system should be closed. It must also be fast and easy 
to assemble to avoid tissue damage caused by long ischemic periods between 
harvesting of the valve and placement in the organ culture system. 
4) Size: The closed system must be placed in an incubator and maintained at a 
temperature of 37oC. Thus, the system size is limited to the size of the incubator, 
which is 65 × 60 × 45 cm3 (width × depth × height). A smaller size also facilitates 
using less volume of media to fill the system. 
The initial design of the organ culture system, alternatively called a flow loop, was 
developed by I.H.A.Willems in our laboratory [Willems, 2002]. The prototype flow loop 
evolved as a result of a series of non-sterile experiments to attain proper pressure and 
flow waveforms. The flow and pressure waveforms in the ascending aorta, which arise 
due to the interplay between the ventricular contraction and the peripheral resistance and 
compliance of the systemic circulation, can be attained by simulating these forces with a 
piston pump and two valves to mimic the aortic and mitral valves in vivo. Figure 4.2 




Figure 4.2: Initial design of the flow loop.1) Hancock® II stented bioprosthetic aortic 
valve 2) Björk-Shiley mechanical mitral valve 3) Reservoir 4) Capacitance reservoir 5) 
Clamp 6) Pressure transducer 7) Ultrasonic flow probe and 8) Pumphead. Flow direction 




The loop was made by connecting series of Tygon®, acrylic and polyvinyl 
chloride tubing with rigid sanitary connectors. A piston pump (Superpump SPA3891, 
Vivitro systems Inc., Victoria, BC) was used to simulate left ventricular function in the 
loop and to drive the media through the loop. The loop was connected to the pump via a 
custom-made pump head (J.M. Machining, Lawrenceville, GA) that was constructed to 
have a male and a female part so that a flexible membrane could be incorporated to 
separate the sterile and non-sterile parts of the flow loop. A latex sheet of 0.02" thickness 
was placed between the two parts to maintain this separation. A Hancock® II stented 
bioprosthetic aortic valve was mounted in an in-house built valve holder and a Björk-
Shiley mechanical mitral valve was mounted in a custom-built (J.M. Machining, 
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Lawrenceville, GA) valve holder. An acrylic reservoir was used to provide the aortic 
compliance to attenuate oscillations in the flow and pressure waveforms and to avoid 
pressure build-up during piston movement. Injecting air into the reservoir with a syringe 
allowed the pressure to be varied, thus providing the proper flow and pressure 
waveforms. A capacitance reservoir, also made of acrylic, was filled with fluid and was 
used to provide the required diastolic pressure and to simulate venous pooling. 
Regulation of venous return was achieved by injecting air into the compliance with a 
syringe. A stainless steel clamp placed upstream of the mitral valve simulated the 
peripheral resistance found in the arterioles at the entrance to the capillary system. By 
tightening or loosening the clamp, the desired aortic pressure was attained. Downstream 
of the aortic valve, a gage pressure transducer (CDX III, Maxxim Medical, Athens, TX) 
interfaced to a bridge amplifier (CD 12, Validyne Engineering, Northridge, CA) was used 
to measure aortic pressure and an ultrasonic flow probe (H20XL, Transonic Systems, 
Ithaca, NY) was used to measure the flow rate which was displayed on a digital flow 
meter (T110, Transonic Systems, Ithaca, NY). The entire system was placed inside an 
incubator maintained at 37oC. The piston pump along with the pump head was placed 
outside the incubator (Fisher scientific, Suwanee, GA) and was connected to the rest of 
the flow loop through a hole at the back of the incubator.  
 Experiments done with a bioprosthetic valve in the flow loop showed that the 
flow and pressure curves were in the physiological range with mean values of 4.2 L/min 
and 100.5 mm Hg (123/78 mm Hg), respectively. The system was also tested for sterility 
for a period of 48 hours. However, the design was not robust enough to be used with 
native aortic valves. Most of the components of the loop were unfit for repeated 
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autoclave cycles, and leaks arose near the compliance and capacitance reservoirs and 
pump head during operation. Also, assembling the loop took a long period of time, and 
the entire process was tedious. The aortic valve holder was unsuitable for native aortic 
valves since it required the use of the valve along with a piece of the aorta to support the 
leaflets. Without this support the aorta bent over the leaflets obstructing leaflet movement 
during the systolic phase of the cardiac cycle. Also, the system did not provide any means 
to oxygenate the medium to maintain viability of the valve tissue. Due to these design 
limitations, many components of the system required significant modifications including 
the aortic valve holder, compliance and capacitance reservoirs, pump head, and tubing. 
 
4.1.2. Final design of the organ culture system 
The design of the flow loop and some of its components were changed to simplify the 
system assembly, reduce the risk of contamination, and maintain the viability of the valve 
leaflets. Based on the observations of the initial design, the aortic valve holder was 
changed significantly for ease of assembly and to provide a leak proof seal. The valve 
holder was divided into three parts called the inflow, central and outflow parts. The 
design was adopted from a previous model of the holder developed by I.H.A.Willems. 
The model developed by him was big, required 24 screws for assembly, and leaked. The 
new model was reduced in size to accommodate a native aortic valve with a 25mm aortic 
root diameter and a 51mm (2.0") aorta. The material of construction was stainless steel to 
sustain multiple autoclave cycles. The valve was held in place by suturing the aortic root 
to a polypropylene ring with an inner diameter of 1". The annulus of the central part of 
the valve holder was constructed to have two different diameters. The inflow side of the 
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central component has an annulus diameter of 1.3" spanning a depth of 0.5", which then 
decreases to 1" for the rest of the length. The increased diameter of the annulus was to 
accommodate the coronary arteries of the valve, which were ligated to avoid back flow of 
the media. The outflow part of the holder was designed so that excess aorta could be 
slipped between the central and outflow parts to avoid bending of the aorta over the 
leaflets. Detailed designs of the valve holder are given in the appendix A. The 
components were sealed together by two C-clamps, which wrapped around the gaps 
between the inflow and central parts and outflow and central parts to provide a tight seal. 
Gaskets were placed between the components to avoid leakage of the media. 
 
                                      
Figure 4.3: Schematic of the inlet, central and outlet parts from left to right respectively. 




 Another design flaw of the original flow loop was that the compliance and 
capacitance reservoirs were difficult to assemble since the central cylinder had to be 
carefully positioned between the two gaskets to prevent leakage. This type of alignment 
was cumbersome and tedious to achieve and often leaked after undergoing an autoclave 
cycle. To avoid this process the two reservoirs were replaced with a 500 mL spinner flask 
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(Bellco Glass Inc., Vineland, NJ) as the compliance chamber, which was easier and 
quicker to assemble. A 1" diameter hole was made in the lid of the flask to allow the 
media to flow into the compliance tank. Neoprene rubber O-rings were placed on either 
side of the hole to prevent leaks. The loop was filled with media through one of the side 
arms of the tank via a two port assembly (Bellco Glass Inc., Vineland, NJ). One of the 
two ports was connected to the media reservoir, which is a 2 L glass bottle (Bellco Glass 
Inc., Vineland, NJ) using Pharmed tubing (Colepalmer, Vernon Hills, Illinois), and the 
other port had a biofilter (VWR, Suwanee, GA) attached to it through the tubing. Air was 
injected into the tank through the latter port to build up pressure in the system. Once the 
required pressure was reached, the tubing was clamped to prevent loss of pressure in the 
flow loop. After loop was filled with media, the tubing was clamped to prevent leakage 
of media back into the reservoir and also to prevent loss of pressure in the flow loop. On 
the other arm of the compliance tank, another two port assembly was fitted at the mouth, 
and silicon tubing was connected between the two ports inside the tank to serve as a gas-
exchanger in the system. The diameter of the silicon tubing was 0.16", and the tubing was 
coiled inside the compliance tank and held in place by three hollow, 1" diameter 
polyvinyl chloride tubes. One end of the port was connected to a gas/liquid rotameter 
(Omega Engineering, Inc., Stamford, CT), which was in turn connected to a 5%CO2 + 
95% air cylinder (Southeast specialty gases, Atlanta, GA) to provide oxygen to the 
system. A gas biofilter was placed at the other end of the port to enable contamination 
free exit of the spent gases. By partially closing the exit port with a clamp, the pressure 
inside the flow loop could be maintained at the required level for the duration of the 
experiment. Since the silicon tubing was immersed in the media in the compliance tank, 
 57
gas-exchange to the surrounding media took place across the tube wall and was 
transported throughout the media by flow of the liquid in the system. Thus, sufficient 
oxygen could be provided to the tissue while maintaining the mechanical performance of 
the system. 
 Another potential place for leakage in the initial design of the flow loop was the 
pump head. The original design required careful placement of the latex membrane 
between the male and female parts of the pump head, which were held in place by four 
stainless steel screws. If the screws were not aligned properly, the parts would not fit 
tightly enough to hold the latex together. Often the membrane slipped causing the pump 
head to leak and allowing the media to mix with the water, thus causing contamination in 
the system. To avoid this, a membrane chamber was designed which was separated from 
the pump head. The new chamber was designed so that it could be placed inside the 
incubator to maintain the temperature of the media at 37oC throughout the flow loop. The 
membrane chamber consisted of two parts, made from poly carbonate, with the edges 
grooved to grip the latex membrane tightly as shown in Figure 4.4. The media circulates 
from one port of the membrane chamber into the aortic valve holder and returns to the 
chamber through the other port via the mitral valve holder. The two components of the 
chamber were fixed together using three screws, which reduced the assembly time and 
also provided leak proof separation of the sterile and non-sterile parts of the flow loop.  
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Figure 4.4: Drawing of membrane chamber. The left part is connected to the loop and the 
right part is connected to the pump head. (not to scale). Detailed designs with dimensions 




Apart from the changes in the design of components in the system, additional changes 
were also made to the flow loop to withstand the high temperature (121oC) and pressure 
(15psig) of the autoclave. The Tygon tubing was replaced by a 1" inner diameter Silicon 
reinforced tubing (Colepalmer, Vernon Hills, Illinois) with tygon tubing used only at two 
places: downstream of the aortic valve and the compliance tank. Silicon reinforced tubing 
was thick and less flexible compared to the tygon tubing to be clamped by the flow 
probe. This prevented the measurement of flow rate downstream of aortic valve as the 
ultrasound flow probe could not measure the flow signal. Also it was difficult to build up 
resistance in the system downstream of the compliance tank. Hence tygon tubing was 
used at these two places. The final configuration of the flow loop was rectangular as 
opposed to the triangular configuration seen in the initial design due to incorporation of 
the membrane chamber, elimination of resistance chamber and change in the design of 
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compliance chamber. The final setup of the flow loop required a media volume of 1.5L to 
obtain physiological waveforms and also to completely immerse the gas-exchanger in the 
media. Figures 4.5 and 4.6 show the schematic and picture of the final design of the flow 
loop, respectively. Parts of the flow loop such as the latex sheet and support ring required 









PP = Piston pump    MC = Membrane chamber 
AV = Aortic valve    MV = Mitral valve 
MR = Media reservoir   C = Compliance tank 
GE = Gas-exchanger     F = Biofilter 
 
 
Figure 4.5: Schematic of the final design of the flow loop. The flow direction is indicated 
by the arrows. The sterile part of the system is indicated by the dashed box. Media is 
shown in red and gas-exchanger is shown in green. Flow and pressure signals are 
































4.1.3. Signal input and data acquisition 
The mechanical performance of the system was evaluated by comparing the flow and 
pressure curves with in vivo data. The fluid was circulated through the loop by a piston 
pump that was controlled by an input signal from a waveform generator (HP33120A, 
Hewlett – Packard, Palo Alto, CA). The input signal was programmed in the waveform 
generator using software (Benchlink Arb, Hewlett-Packard, Palo Alto, CA) that came 
with the generator. The input signal had a frequency of 70 beats/min (1.167 Hz) and is 
shown in Figure 4.7. 
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Figure 4.7: Input signal programmed in the wave form generator that is given to the 




A list of parameters used in the setting of waveform generator and trigger signal are 













Table 4.1: Parameters set programmed under Recall 1 menu in the waveform and trigger 
signal generators. 
 
Serial # Parameter Value 
1 Waveform Arb 
2 Frequency 1.167 Hz 
3 Amplitude 4.998 
Waveform generator 
4 Offset 0.000 
1 Waveform Step 
2 Frequency 1.167Hz 
3 Amplitude 4.000 
Trigger generator 




The mechanical performance of the organ system was also tested, in our laboratory, at 
various mechanical conditions such as hypertensive, severe hypertensive aortic pressures 
with mean values of 140 and 170 mmHg, respectively, at normal cardiac output (4.2 
L/min) and frequency of 1.167 Hz, and elevated cardiac output of 7.5 L/min at a 
frequency of 120 beats/min (2Hz) at mean aortic pressure of 100 mmHg [Warnock, 
2004]. The parameters programmed into the waveform generator and trigger signal were 
maintained the same for all aortic pressure conditions. While testing the performance of 
the system at elevated cardiac output at 2 Hz, the frequency value in the waveform and 
trigger generators was changed to 2 Hz keeping the remaining parameters constant in 




















Figure 4.8 Input signal at elevated cardiac rate of 2Hz, programmed in the wave form 




After feeding the required parameters to the signal generators, the flow loop was 
started, and data was acquired to generate flow and pressure waveforms. An in-house 
built interface box, or DAQ box was used to acquire the flow and pressure signals from 
the ultrasound flow probe (H20XL, Transonic Systems, Ithaca, NY) and pressure 
transducer (CE0344, Maxxim medical, Athens, TX), respectively. The DAQ box receives 
analog voltage signals from the transducers and transfers the signals to a PCMCIA data 
acquisition card (NI DAQCard-1200, National Instruments, Austin, TX). The card has 
eight different channels, which are synchronized by the trigger signal from the trigger 
waveform generator. During the data collection, channel one was used for flow, two for 
pressure, and the eighth was used for the trigger. The DAQ Card was plugged into a 
computer system, and the data was stored using in-house developed data collection 
program called DAQ-ANAL 2.2 based on LabVIEW 5.1 graphical user interface 
software (LabVIEW 5.1, National Instruments, Austin, TX). The sampling time was 2 
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msec and the data was collected and stored over 10 cycles then averaged over the cycles 
during data analysis. Data was stored in Excel spreadsheets using the data analysis 
function of DAQ-ANAL. Microsoft Excel was used to analyze and plot the waveforms. 
Flow and pressure signals, which were obtained as voltage signals, were converted to 
units of flow rate and pressure, using the conversion factors obtained from the flow probe 
and pressure transducer calibrations. 
 The flow loop used for calibration of the flow probe consisted of a rotameter 
located upstream of a bucket for water collection that was connected by polyvinyl 
chloride and tygon tubing with flow probe on it back to the rotameter. Water was 
circulated through the loop with a water pump (4E-34N, Little Giant Pump Co., 
Oklahoma City, OK) to drive the fluid through vertically up the rotameter. The water 
pump was placed in an ice filled container to reduce the heat generated by it. The flow 
rate through the rotameter was controlled by a variable transformer (CSA LR18948, 
Staco Energy Products Co., Dayton, OH) coupled to the water pump. The flow probe was 
fixed around the tygon tubing to record the flow rate on the flow meter. A voltmeter 
(Fluke 27, John Fluke MFG. Co., INC.,Everett, WA) was connected to the flow meter to 
read the voltage values corresponding to the flow rate value. By successively increasing 
the rotameter reading monitored by the movement of the float, the corresponding reading 
for flow rate and voltage were noted. A graph of voltage versus flow rate was plotted and 

































The pressure transducer was calibrated using a U-tube manometer. The transducer 
was attached to one of the limbs of the manometer tube by a connector, which was used 
to inject or remove the fluid from the manometer limb. A voltmeter was connected to the 
bridge amplifier to note the voltage values corresponding to the pressure in the 
manometer tube. The connector was initially open to the atmosphere to set the reading on 
the amplifier to zero. Once this was done, water was injected to a maximum height into 
the limb connected to the transducer. For decreasing water levels, the corresponding 
voltage readings were noted and a graph was plotted between pressure and voltage after 































Figure 4.10: Calibration curve for pressure transducer calibrated with water. 
 
4.2. Mechanical validation of the organ culture system 
Mechanical validation of the system was performed by conducting experiments using 
mechanical and bioprosthetic valves with water circulating in the system. Since the 
ultimate goal of the design was to study the functionality of native aortic valves, the 
system was tested for sterility of the medium over a period of 96 hours with a mechanical 
valve. The efficiency of the gas-exchanger was also tested to ensure that it provided 
oxygen to the medium at a rate greater than the oxygen uptake rate of the aortic valves. 
 
4.2.1. Physiological flow and pressure waveforms 
Mechanical testing of the flow loop was performed using a 25mm Starr Edwards ball and 
cage mechanical valve and 25mm pericardial bioprosthetic aortic valve. The loop was 
assembled as shown in Figure 4.5 and was connected to the pump head, which was 
attached to the piston pump. A 1" internal diameter polypropylene ring was placed 
around the mechanical or bioprosthetic valve to hold the valve in place. The loop was 
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placed in a vertical position with the help of two stands, and the flow probe was clamped 
around the tygon tubing downstream of the aortic valve holder. The pressure transducer 
was screwed onto a connector attached to an elbow joint at the end of the tygon tubing 
also downstream of the aortic valve. Once the loop was closed, it was filled with water by 
injecting air into the media reservoir through a biofilter.  After the flow loop was filled, 
the tubing from media reservoir was clamped. A clamp was also placed on the other port 
through which air was injected into the compliance tank. The tubing from the 5% CO2 
tank was then connected to the compliance tank and gas flow was regulated with a 
rotameter. Once all the connections were made, the waveform and trigger generators 
were switched on and set to the required parameters. The flow meter and bridge amplifier 
were turned on, and the piston pump was started. The amplitude of the piston was 
increased slowly until the desired flow rate of 4.2 L/min was attained and then the 
pressure in the loop was increased by clamping the tygon tubing downstream of the 
compliance tank and also by injecting air into the compliance tank through a syringe. 
Once the pressure in the loop attained a mean value of 100 mm Hg, which was monitored 
using DAQ-ANAL, the waveforms were recorded and saved on the computer. The 
consistency of the waveforms was tested for a period of 48 hours by recording the 
waveforms at regular intervals. The data collected was analyzed and averaged over all the 
cycles. The average values were plotted over the entire cardiac cycle (860 msec). The 
organ culture system was also validated at elevated mechanical conditions in our 
laboratory, which are summarized in Table 4.2 [Warnock, 2004]. 
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Table 4.2: Various mechanical conditions under which the organ culture system was 
validated with a Starr-Edwards ball and cage mechanical valve. * indicates data obtained 
by Warnock et al [Warnock, 2004]. 
 






Mass Transfer Rate 
(mg O2/sec) 
100 4.2 1.167 9.9023 × 10-5 
*140 4.0 1.167 1.95 × 10-3 
*170 4.0 1.167 8.02 × 10-4 




4.2.2. Sterility testing of the organ culture system 
In order to use the organ culture system to study the biology of aortic valves, the system 
must maintain valve viability during the entire experiment. An important consideration 
for achieving this is to maintain aseptic conditions in the system. For this a sterility test 
was performed for a period of 96 hours.  
 The organ culture system was assembled as shown in Figure 4.5 with the 
membrane chamber disconnected. A component of the membrane chamber, which was 
connected to the pump head, was packed in an autoclave pouch (VWR, Suwanee, GA) 
along with a latex membrane cut in a circle whose diameter was greater than the outer 
diameter of the membrane chamber. Aluminum foil was wrapped around the other part of 
the membrane chamber, which was connected to the loop. The connecter, to which the 
pressure transducer was fixed, was closed with a cap and all the biofilters along with the 
inlet to the 5% CO2 tank in the system were covered with aluminum foil. An empty 
media reservoir was connected to the system, ensuring that no section of the loop was 
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exposed to air. The entire assembly and other components required for the loop were then 
sterilized for a period of 15min in an autoclave. 1.5 L of Dulbecco’s Modified Eagle 
Medium (DMEM, Sigma, St.Louis, MO) supplemented with 1% antimycotic- antibiotic 
solution (Sigma, St.Louis, MO) filtered aseptically in a sterilized 2L glass bottle was the 
circulating media in the loop. A Starr-Edwards ball and cage mechanical valve, which 
was suspended in absolute ethanol overnight along with the pressure transducer and 
support ring, was used for the test. After the system was sterilized, the valve was placed 
in the valve holder with the support ring, and the system was filled with media. A small 
volume of media was taken for sampling in an Eppendorf tube (VWR, Suwanee, GA). 
The gas flow rate into the system was regulated and the flow rate and pressure values 
were adjusted to physiologic values and the waveforms recorded. The media was 
observed visually at regular intervals for macroscopic contamination. Contaminated 
media usually looks cloudy (turbid) often accompanied with a change in color from red to 
orangish yellow. The waveforms were recorded at different time points during the 
experiment to check the uniformity in the curves. At the end of 96 hours, the experiment 
was stopped and a sample of media was taken for analysis.  
Samples of the media were analyzed microscopically and also by measuring the 
absorption values. For microscopic analysis, a small drop of media was placed on a glass 
slide and cover slipped for viewing under the microscope to reveal any bacterial or fungal 
growth in the media. For quantitative analysis, the media samples were placed in 
triplicate in a micro well plate reader (Spectra Max Gemini Microplate 
Spectrofluorometer, Sunnyvale, CA), and the absorbance values were measured at a 
wavelength of 364nm. The absorbance values were then averaged and a paired t-test was 
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performed on the two samples with a p-value of < 0.05 considered significant. Microsoft 
Excel was used for analyzing the results. 
 
4.2.3. Gas-exchange in the organ culture system 
Oxygen transport is one of the most important considerations in designing an organ 
culture system. Preliminary experiments with native aortic valves in the system showed 
that significant cell death occurred within the leaflet tissue, which was attributed to O2 
deficiency in the loop. Because the flow loop is a closed system, a gas-exchanger was 
needed in the system to provide O2 to the tissue and maintain the viability of the native 
aortic valves. Soft silicon tubing (McMastercarr, Atlanta, GA) with an inner diameter of 
0.16" was chosen to provide gas exchange in the media. To find the amount of O2 
required in the system, the O2 uptake rate of the aortic valve was determined so that the 
amount of O2 transferred to the media would be sufficient to maintain valve viability.   
 The oxygen uptake rate of the aortic valve was calculated by measuring the 
dissolved oxygen content in the media with aortic valves cultured in it. Four aortic valves 
were excised from porcine hearts aseptically in a local abattoir (Holifield farm, 
Covington, GA) and transported to the laboratory in sterile, ice cold Dulbecco’s 
Phosphate Buffered Saline (DPBS, Sigma, St.Louis, MO) in a sealed container. The 
valves were trimmed to remove excess tissue and surrounding myocardium in a laminar 
flow hood (Fisher Hamilton, Two rivers, WI). Four sterile glass bottles were filled with 
400 mL of DMEM. The media was oxygenated until it reached saturation by passing 
5%CO2 + 95% air into it and measuring the dissolved oxygen (DO2) content using a DO2 
meter (ExTech Instruments, Tampa, FL). The aortic valves were then put in the media, 
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and the bottles were closed to prevent any oxygen transfer into the media from the 
atmosphere. The DO2 content was measured every hour for the first 8 hours and at 
regular intervals over the remaining 40 hours, and the values were tabulated. At the end 
of 48 hours, the valves were removed, and their wet weight was measured to normalize 
the uptake rate of O2. The pH of the media in all four bottles was also noted at the end of 
48 hours. The uptake trend of the valve was observed by plotting a graph between the 
DO2 value and time. The oxygen uptake rate of the valve was calculated by plotting DO2 
versus time for first 6 hours and measuring the slope from the plot. This calculation was 
employed as the DO2 content in the medium decreased linearly with time in the first 6 
hours and hence consumption rate was assumed to be constant. The equation used to 
calculate the uptake rate was, 
OUR = ∆ DO2/∆t  (4.1) 
Where OUR =  Oxygen uptake rate of the valve 
∆DO2 = Change in concentration of DO2 in the medium (mg of O2/ gm of tissue/ 
L of medium) 
            ∆t = Change in time (hour) 
The oxygen uptake rate of the valve was used as a limiting value to design the gas-
exchanger to provide the required oxygen to the media. The equations used for the design 
are as follows; 
    Q = V.A  (4.2) 
Where Q = Gas flow rate of the 5% CO2 
V = Velocity of the gas 
A = cross-sectional area of the silicon tubing 
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   = Π× diameter of silicon tubing × length of the silicon tubing 
 
    V = P (∆Pln) / Z  (4.3) 
Where P = Permeability of the silicon tubing (7961 cc × mm/ (cm2×sec×cm Hg)) ×10-10) 
∆Pln = Logarithmic mean of partial pressures of the gas (cm Hg) 
                = (Pin – Pout) / ln (Pin/Pout) 
Z = Thickness of silicon tubing = 0.79375 mm 
 
 The O2 transfer rate was arbitrarily chosen to be greater than the uptake rate. The 
assumptions made for this calculation were that the gas exchange was occurring at 
atmospheric conditions, and that almost all of the 5% CO2 gas was exchanged into the 
system.  The partial pressure of the gas mixture was calculated to be 151.62 mm Hg and 
based on the gas transfer rate the final pressure was calculated to be 0.66 mm Hg which 
gave a ∆Pln value of 27.766 mm Hg. The velocity of the gas was thus found to be 
2.785×10-6 cm/sec. Based on a trial and error procedure and using equation 4.2, the 
length of the silicon tubing to provide the required gas transfer rate was found to be 2 m 
at an inlet gas flow rate of 0.2 L/min.  
The above parameters were then used to design the gas-exchanger, and 
experiments were run to measure the actual gas-transfer rate in the system. The flow loop 
was assembled as shown in Figure 4.5 and filled with DMEM. The medium was degassed 
using N2 before passing 5% CO2 into the system. The DO2 values of the medium before 
and after degassing were noted. The DO2 reading every hour was noted until the 
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saturation limit was attained, and the values were tabulated. The gas transfer rate was 
then calculated based on the following equation; 
N = k (DO2,i – DO2,f)   (4.4) 
Where N = Gas-transfer rate into the medium (mg/sec) 
 k = Mass-transfer coefficient (cm/sec) 
 DO2,i = DO2 reading at time t = 0 
 DO2,f = DO2 reading at saturation time i.e., t = 4hours 
 
The mass-transfer coefficient was calculated by plotting a graph between the logarithm of 
percent saturation of O2 and time. The percent saturation values were obtained from DO2 
values using the equation; 
% saturation = 100- 100 (DO2,f –DO2,t)/DO2,f   (4.5) 
 The equation used to calculate the coefficient was; 
k = Slope/a   (4.6) 
Where a = interfacial area (mm-1) 
   = area/volume = 0.01676 mm-1 
 
The slope was obtained from the graph, and the mass-transfer coefficient was calculated 
using equation 4.6. The gas transfer rate was then obtained using equation 4.4. The O2 
uptake rate value was converted into the same units as that of the gas-transfer rate for 
comparison to test the efficiency of the exchanger setup. 
 Thus, the organ culture system was validated to satisfy the design criteria stated in 
section 4.1.1 before proceeding to the biological validation. 
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4.3. Biological validation of the organ culture system 
The objective of designing an organ culture system was to study the biology of native 
aortic valves in response to physiological hemodynamic forces. The final stage in the 
design was to test whether the native biological properties of aortic valve are preserved in 
the system when the valve is subjected to normal hemodynamic forces such as a flow rate 
of 3.8-4.5L/min and pulsatile pressure of 120/80 mm Hg. The valves were cultured in the 
organ culture system for a period of 48 hours under the mechanical conditions stated and 
were analyzed quantitatively and qualitatively by measuring total collagen, sGAG and 
elastin content in the leaflet tissue and performing immunohistochemical stains on the 
tissue sections, respectively.  
 
4.3.1. Experimental Procedure 
Porcine aortic valves were obtained from a local abattoir. Animals from which hearts 
were obtained were usually adult pigs weighing 300-400 lbs. However, no specific record 
about the age or weight was made during procurement. Once the heart was separated 
from the other organs of the animal, on-field dissection was carried out to isolate the 
aortic valve from the heart. The apex of the heart was cut first and then the pulmonary 
valve was separated from the aortic valve. Mitral tissue adjacent to the aortic valve was 
removed and discarded. The aortic valve was then washed with sterile ice cold DPBS to 
remove residual blood adhering to the valve and placed in DPBS for transportation. The 
ischemic time was typically 30 min of warm ischemia between death of the animal and 
valve removal and about 2 hours of cold ischemia when the valve was transported to the 
laboratory.  
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 After transporting the valve to the laboratory, it was trimmed to remove excess 
tissue and the surrounding myocardium. A support ring made of polypropylene was 
sutured tightly to the aortic root with 4/0 prolene blue monofilament sutures (Ethicon 
Inc., Somerville, NJ) to hold the valve in place in the aortic valve holder while circulating 
medium through the flow loop. The valve was soaked in DPBS throughout the suturing 
process, to prevent drying of the tissue. After the valve was sutured, the loop was 
assembled aseptically as shown in Figure 4.5. The organ culture system was autoclaved 
the day before the scheduled experiment. After the system has been autoclaved, it was 
placed in the laminar flow hood with UV light switched on and left overnight to prevent 
any possible contamination. Media required for the system was also prepared and 
sterilized and left at room temperature overnight.  
The media composition used for the system was 20.04 gm of DMEM, 5.55 gm of 
NaHCO3, 7.5 mg of 5- Bromodeoxyuridine (BrdU), 15 ml of antimycotic-antibiotic 
solution, 15 ml of Non-essential amino acids (NEAA), 18 µL of 1.5mM CuSO4, 3.9 mL 
of 0.113M Ascorbic acid ( Sigma, St.Louis, MO) and 1.5 L of deionized water. DMEM 
and NEAA provided the required nutrition for the cells, while NaHCO3 was used to 
obtain the required pH (7.2-7.4). BrdU was used in the media to mark the proliferating 
cells in the tissue. Antibiotics were used to prevent infection due to any microbial growth. 
Ascorbic acid is necessary for collagen synthesis in the tissue, while CuSO4 was used to 
reduce formation of anti-oxidants in the media. After the media was prepared, it was 
oxygenated by bubbling 5% CO2 gas into it for a period of 45 min. This process also 
established the pH within the physiological range (7.2-7.4). The media was then sterilized 
by filtering it with sterile filters (VWR, Suwanee, GA) using vacuum filtration technique. 
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Once the aortic valve was sutured to the support ring, the organ culture system 
was assembled by connecting the two components of the membrane chamber with the 
latex membrane between them. After connecting the medium reservoir to the system, the 
aortic valve was placed in the valve holder and the pressure transducer was connected 
downstream of the aortic valve holder aseptically. The entire system was maintained at 
37oC by placing it an incubator, which has been decontaminated prior to the experiment. 
The flow loop was then connected to the piston pump via the pump head and medium 
was filled into the system to prevent drying of the valve. The medium in the system was 
oxygenated by circulating 5% CO2 gas at a regulated flow rate. Once it was ensured that 
there were no leaks in the system and the connections were sufficiently tight, the pump 
head was filled with water, and the flow probe was clamped to the tygon tubing. The 
piston pump was started, and the flow rate was increased slowly over a period of two 
hours to prevent any leakage due to a sudden increase in flow and pressure in the system. 
After the flow rate was established, the pressure was increased in the system by injecting 
air into the compliance tank. After the flow and pressure values were stabilized, 
mechanical data was recorded using DAQ-ANAL at time, t = 0 hours. The loop was 
operated for a period of 48 hours with flow rates and aortic pressures acquired 
periodically every 12 hours to check the consistency in operating conditions. 
At the end of 48 hour period, the system was disassembled and the aortic valve 
was removed. The leaflets were excised from the valve by cutting along the attachment 
line. Each leaflet was then laid flat on the lid of a tissue culture plate and a rectangular 
piece of approximately 14mm × 5mm was cut from the belly region of the leaflet. This 
piece was in turn cut into four small pieces of approximately 3mm × 1mm for analysis. 
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Three of the four pieces were placed in 1.5 mL micro-centrifuge tubes (VWR, Suwanee, 
GA) and dried for 48 hours in a vacuum oven (Yamato Scientific America, San 
Francisco, CA) to be used for biochemical assays to quantify total protein content 
(collagen and elastin) and GAG. The fourth piece was placed in a tissue-culture plate and 
fixed in 10% buffered formalin (Fisher Scientific, Suwanee, GA) for a period of 24 hours 
to be used for histological studies.  
Fresh leaflets, isolated and processed immediately after harvest in the same 
manner as the cultured leaflets, were used as fresh controls, and leaflets cultured in media 
under static, atmospheric conditions for a period of 48 hours, were used as static controls. 
The static control leaflets were incubated in a 6-well tissue culture plate (VWR, 
Suwanee, GA) with 10 ml of medium at 37oC. All three sets of leaflets were processed 
following the same protocol to maintain the uniformity for analysis. The different 
analyses that the leaflets were subjected to are detailed in the following sections.  
 
4.3.2. Quantitative analysis 
Collagen, GAG and elastin are the major components of aortic valve leaflet tissue. 
Changes in the mechanical environment of the leaflets alter fibroblast activity, 
specifically protein (collagen and elastin) and sGAG synthesis [Weston, 2001; Xing, 
2004]. By measuring the leaflet collagen, sGAG, and elastin content, any significant 
differences in collagen, elastin and GAG due to changes in the mechanical environments 
can be identified.  
 The leaflets were dried over a period of 48 hours, and their dry weights were 
determined. Dry weight was used as a normalizing parameter to compare the data within 
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the leaflets from the three groups. The tissues were then digested with enzymes dissolved 
in buffer solutions for a period of 24-48 hours, and the dissolved tissue was used for 
analysis. Since the overall procedure for the assays is similar for all three endpoints the 
specific protocols are given in Appendix B.  
 
4.3.2.1. Collagen assay 
The collagen assay (Sircol collagen assay, Accurate Chem. & Scientific Corp., Westbury, 
NY) is a quantitative dye-binding method designed for the analysis of soluble collagen. 
The tissue was digested using pepsin, at a ratio of 1:3 of enzyme: tissue dry weight. The 
required amount of pepsin (Sigma, St.Louis, MO) was dissolved in 0.5 mL of 0.5 M 
acetic acid (Sigma, St.Louis, MO) and added to the tissue. The samples were then placed 
in a water bath at 60oC for 24 hours with occasional stirring. The collagen was converted 
to a soluble form, as pepsin cleaved part of the C-terminal non-helical region of the α-
chains that make up the triple helix of tropocollagen.  The samples were then assayed for 
pepsin-soluble collagen content, which will henceforth be referred to as total collagen 
content. The assay kit measured mammalian collagen, types I to IV. Collagen standards 
were prepared using acid soluble collagen, type I, supplied in the kit. Test samples and 
standard solutions in 0.5 M acetic acid were mixed in a Sircol dye reagent containing 
Sirius Red in 1.5 ml micro centrifuge tubes. The dye was mixed with the collagen with a 
vortex tube mixer (VWR, Suwanee, GA). Sirius Red is an anionic dye with a sulphonic 
acid side chain group that reacts with the side chain groups of the basic amino acids 
present in collagen thus forming a complex. After collagen-dye complex formation, the 
tubes were centrifuged to separate the complex pellet from the unbound dye. The 
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supernatant from the tubes was then removed, leaving the pellet at the bottom. A cotton 
bud was used to remove any remaining supernatant fluid from the tube. An alkali reagent 
was then added to these tubes and stirred to reconstitute collagen bound dye. Although 
the alkali dye solution is stable when exposed to light, the absorbance must be measured 
within 3 hours of preparation. The samples were placed in a 96-well plate reader, and the 
absorbance data was recorded at a wavelength of 540 nm. The data was collected as a 
text file and transferred to an Excel spreadsheet. A standard curve was plotted using the 
data from the blank and standard samples. The slope of the curve was used as a 
conversion value to calculate the collagen content of the test samples based on the 
absorption values. A R2 value of > 0.98 for the calibration equation was usually 
considered to give a good estimate, otherwise the assay was repeated. 
 
4.3.2.2. sGAG assay 
Sulfated glycosaminoglycans (sGAG) in the leaflet tissue were analyzed using Blyscan 
assay (Accurate Chem. & Scientific Corp., Westbury, NY) in a similar manner as 
collagen assay. sGAG assay measures the total sulfated glycan content present in a 
soluble form. The tissue was digested with protease (Sigma, St.Louis, MO), at a ratio of 
1:30 of enzyme: tissue dry weight. Protease dissolved in 0.5ml of 0.1M tris-acetate buffer 
with 10mM calcium acetate was added to each sample and incubated in the same manner 
as the collagen samples. sGAG (sulfated glycoaminoglycan) standards were prepared 
using chondroitin 4-sulfate supplied in the kit. The acetate buffer was used a reagent 
solution. Sample preparation was done the same way as described in the above section. 
Blyscan dye reagent containing 1,9- dimethly-methylene blue in an inorganic buffer 
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containing surfactants and stabilizers was added to all the tubes. Sufficient time was 
allowed for the dye to bind sGAG while stirring the samples on a vortex tube mixer 
(VWR, Suwanee, GA). Reaction between the dye and sGAG was carried out in the 
presence of excess unbound dye and an acidic pH thus producing dye-GAG complex. 
Tubes with samples containing sGAG turned purple/pink, and the complex precipitated, 
thus enabling separation from the unbound dye by centrifugation. The pellet was 
separated from the supernatant solution and dissolved in Blyscan dissociation agent to 
reconstitute the complex into a soluble form for measurement. Since the solution was 
light-sensitive, the absorbance measurement was performed within 3 hours of preparation 
at a wavelength of 656 nm. The measurement and data analysis methodology were the 
same as that for the collagen. 
 
4.3.2.3. Elastin assay 
 The Fastin elastin assay (Accurate Chem. & Scientific Corp., Westbury, NY) is also a 
quantitative dye-binding method for elastin analysis. However, the analysis method is 
slightly different from the collagen and sGAG assays. The dry samples of tissue were 
digested with proteinase kinase (Fisher Biotech, Suwanee, GA) at an enzyme 
concentration of 0.5 mg in 1 ml of buffer solution (5 ml of 50mM tris-HCl, 3.72 gm of 
0.1 M EDTA, 1.168 gm of 0.2 M NaCl  (Sigma, St.Louis, Mo) and 95 ml of dH2O) in 
each tube. Test and standard samples were prepared in the same manner as for the 
previous assays using bovine a-elastin standard. 1 ml of elastin precipitating agent was 
added to each of these samples and incubated in ice cold water overnight. The next 
morning the samples were transferred to ice and incubated for about 30 minutes to bring 
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the sample temperature to 0oC. The samples were then centrifuged to separate elastin as a 
gel, which was mixed with dye reagent along with 200µl of 90% saturated ammonium 
sulfate. The dye was then stirred for one hour to allow the dye to bind with the elastin. 
The Fastin dye reagent contains 5, 10, 15, 20- tetraphenyl-21, 23-porphrine in a water 
soluble form as the sulfonate (i.e tetra sulfonate) (TPPS). The dye binding to elastin 
followed a shape-and-fit phenomenon wherein the acidic dye was firmly retained by the 
basic amino acid side chain residues of elastin. After sufficient time was allowed for 
complex formation, the tubes were centrifuged and the pellet was separated from the 
supernatant. The pellet was then dissolved in the Biocolor dissociation agent and 
absorption values were measured at 513 nm. The analysis was done using the method 
described in the previous sections. 
 
4.3.3. Qualitative analysis 
Histological techniques were used to observe any changes in the morphology or cell 
phenotype of the cultured valve leaflets. Cell death and cell proliferation rates were also 
compared with the controls to see whether the ex vivo system induced any changes in the 
normal tissue behavior. Finally, both histology and scanning electron microscopic studies 
were done on the leaflet tissue to observe the endothelial cells in the three leaflet groups. 
This study was conducted to test the retention of ECs on the valve leaflets cultured under 
dynamic conditions. Since an intact endothelium is critical to maintain the normal 
functionality retention of the valvular cells. 
 Histology is the study of tissues using a variety of chromogenic techniques. 
Tissue pieces cut from the valve leaflets were fixed in 10% neutral buffered formalin for 
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24 hours to stabilize the proteins in the tissue and prevent further changes. Fixation 
inactivates the tissue and prevents activities such as decay, putrefaction and autolysis 
[Carson, 1990]. After fixation, the samples were placed in cassettes (VWR, Suwanee, 
GA) sandwiched between sponges (VWR, Suwanee, GA) to maintain the proper 
orientation during processing, and stored in 70% alcohol (Harleco, Gibbstown, NJ) until 
ready for processing. Processing includes dehydration, clearing and infiltration of the 
tissue, which was done in an automated processor, Path center (Thermo Electron Corp., 
Pittsburg, Pennsylvania). Dehydration of the tissue serves to remove all free water from 
the tissue. The dehydrant used was alcohol.  The next step, clearing, serves to link the 
dehydration and infiltration steps. The clearing agent used was xylene (Harleco, 
Gibbstown, NJ) as it is miscible with both the dehydrating agent and the infiltration 
medium. The final processing step, infiltration, is achieved using an embedding medium, 
which holds the cells and intracellular structures in their initial state when thin sections 
are cut. Paraffin wax (Fisher Scientific, Houston, TX) with a melting point of 55-58oC 
was used as the embedding medium. Excessive time in molten paraffin was limited to 
minimize tissue shrinkage and hardening. Once the tissue was processed, it was 
embedded in molds using the Embedder (Thermo Electron corp., Pittsburg, 
Pennsylvania). After the molds were cooled to solidify the wax, the blocks were removed 
from the molds and stored at room temperature until sectioning. The blocks were 
sectioned using a rotary microtome (Micron, Richard Allen Scientific, Kalamazoo, MI). 
The blocks were initially cooled using ice, and the cooled blocks were then fit into the 
chuck of the microtome, which moved up and down, sectioning the tissue to the desired 
thickness of 5µm. The sections obtained as a ribbon were placed in a water bath at 37oC 
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to reduce compression in the paraffin section. The sections were then placed on a glass 
slide (VWR, Suwanee, GA) and dried overnight at 37oC in an oven (VWR, Suwanee, 
GA). Prior to staining, sections were deparaffinized in a xylene substitute and rehydrated 
using decreasing grades of alcohol. 
 The histological study presented here consists of tinctorial and 
immunohistochemical stains. Hematoxylin and Eosin, which is a basic stain, is most 
widely used for its simplicity and ability to demonstrate different tissue structures. A 
more elaborate discussion of the stain will follow in the next section. 
Immunohistochemical stains were performed to observe the cell phenotype by identifying 
smooth muscle cells secreting α-smooth muscle actin, von Willebrand Factor secreted by 
endothelial cells, 5-Bromodeoxyuridine incorporated into proliferating cells, and 
apoptotic cells identified by activated caspase-3.  
 Immunohistochemistry is a technique used to identify cellular or tissue 
constituents (antigens) by means of antigen-antibody interactions [Bancroft, 2002]. The 
site of antibody binding can be identified either by direct labeling of the antibody, or by 
using a secondary labeling method. During fixation and processing of the tissue, it is 
possible for antigen epitopes to become masked by formalin cross linking.  This cross 
linking can make the antibodies inaccessible to antigen sites; hence antigen retrieval is 
performed by employing proteolytic enzyme digestion. The enzymes used for these 
studies were protease and proteinase K. Digestion of the tissue sections in these enzymes 
allows antibody penetration by exposing the antigen sites. The sections were then 
blocked in 1% gelatin (JT Baker, Fairlawn, NJ) -phosphate buffered saline (PBS, Roche, 
Indianapolis, IN) or normal whole serum from the species in which the secondary 
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antibody was raised. This was done to prevent non-specific background staining, which 
may occur when the antibody attaches to highly charged collagen and connective tissue 
and is recognized when the secondary antibody is applied. After removal of the blocking 
agent, the primary antibody was applied, and the sections were incubated in a humid 
chamber to prevent evaporation of reagents. After removal of unbound antibody, the 
secondary antibody in the appropriate concentration along with normal serum from the 
same species as that of the secondary antibody were applied to the tissue sections. The 
secondary antibody recognizes the heavy polypeptide chain of the primary antibody and 
binds specifically to the antigen-antibody complex. The secondary antibody is 
biotinylated and is capable of binding to Avidin-Biotin-enzyme complex (ABC), which 
in turn links to the substrate. The sections were then washed to remove unbound 
secondary antibody and incubated with ABC. The free sites of avidin in ABC form a 
biotin-avidin linkage with the secondary antibody. Following incubation with ABC, the 
sections were washed and a substrate was applied. The enzyme affiliated with the ABC 
complex chemically modifies the substrate and in the process, the substrate’s 
conformational state changes and develops an observable color.    
Some of the stains in the current study were done using an immunofluorescent 
technique. This technique has the potential to define antigen-antibody interactions at the 
sub-cellular level and also within the histological topography of the tissue sections In this 
technique, avidin D- fluorochromes were used in conjunction with biotinylated secondary 
antibodies, which absorb radiation as visible or ultraviolet light causing the molecules to 
attain an excited state leading to electron redistribution and emission of radiation at a 
different wavelength within the visible spectrum. The fluorochromes used in this study 
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were avidin D –Texas red and avidin D- fluorescein. A brief discussion of the individual 
stains will be presented in the following sections, and the protocols are given in 
Appendix C. 
 
4.3.3.1. Hematoxylin and Eosin stain 
The hematoxylin and eosin stain has widespread applicability to tissues from different 
sites due to the simplicity of the stain. The stain can be performed progressively or 
regressively. The difference between the two methods is the use of acid alcohol, which 
serves as a differentiation agent in the staining procedure. For the current study, a 
regressive method was employed. This stain clearly demonstrates different tissue 
structures. Hematoxylin stains cell nuclei blue with good intra nuclear detail, while eosin 
stains all other tissue components in varying shades of pink and red. The dyes used in the 
stain are water or alcohol based. Hence the tissue sections were first deparaffinized by 
subjecting the slides to xylene (Harleco, Gibbstown, NJ), decreasing grades of reagent 
alcohol (Harleco, Gibbstown, NJ), and then a final wash in water before staining them 
with hematoxylin (Gill’s hematoxylin, Harleco, Gibbstown, NJ). Excess hematoxylin was 
removed by subjecting the slides to acid alcohol and the blue hue of hematoxylin affected 
by this step was restored by Scott’s solution (NaHCO3 +MgSO4.7H2O+dH2O). Excess 
Scott’s solution was removed by washing followed by treatment with 95% alcohol to 
subject the slides to eosin. Eosin (Harleco, Gibbstown, NJ) is highly soluble in water; 
hence it is used along with 95% alcohol. The sections were finally dehydrated in 
ascending grades of alcohol and then cleared in xylene. The sections were then 
coverslipped (VWR, Suwanee, GA) using a solvent based mounting medium (Cytoseal 
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60, Richard allen scientific, Kalamazoo, MI). The entire stain was performed 
automatically using an autostainer (Leica, Vashaw Scientific, Norcross, GA) in the 
histology laboratory (Georgia Tech., Atlanta, GA).  The slides were allowed to dry 
overnight before viewing. A Nikon imaging microscope (Southern Microscope 
Instruments, Inc., Marietta, GA) was used to view the slides, and a Q-Imaging camera, 
Retiga 1300C (Southern Microscope Instruments, Inc., Marietta, GA) was used to take 
the pictures. 
 
4.3.3.2. Cell proliferation: anti- 5-Bromodeoxyuridine Immunohistochemistry 
Labeling cells, which are active in the cell cycle, can assess the growth fraction of a 
tissue section. Cells in the synthesis phase will take up thymidine or analogs of thymidine 
such as 5-Bromodeoxyuridine (BrdU). Incorporated molecules can be identified by 
immunohistochemistry or flow cytometry using an anti-BrdU antibody. Counting the 
proportion of labeled cells will give an estimate of the synthesis phase fraction. 
Deparaffinized sections were pretreated with proteinase K and subjected to 4N HCl 
(Sigma, St.Louis, MO).  The acid served to dissolve histones associated with DNA.  This 
permitted uncoiling of the DNA and accessibility of reagents to all parts of the nuclei 
acids. The sections were then subjected to Tris buffered EDTA (Sigma, St.Louis, MO) 
which acts to neutralize the acid step previously performed. Blocking was performed 
once the pH was in the range of 7.0-7.5, which was determined using a pH indicator strip. 
The primary antibody, anti-BrdU (Dako, Carpinteria, CA) at a concentration of 1:20 in 
1% crystalline grade bovine serum albumin (BSA, Sigma, St.Louis, MO) in PBS, was 
applied to the sections and incubated for an hour at room temperature. The sections were 
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then washed with PBS, and a working dilution (1:400) of secondary antibody, 
biotinylated horse anti-mouse IgG in 1%BSA/PBS along with 2% normal horse serum, 
was applied. The sections were then incubated with ABC reagent prepared from an 
alkaline phosphatase standard kit (Vector laboratories, Burlingame, CA). The slides were 
washed in PBS and 100mM tris (Sigma, St.Louis, MO), which served to raise the pH to 
the functioning range of the enzyme.  The substrate made up with 5ml of tris at pH of 8.2, 
levamisole (Vector laboratories, Burlingame, CA) and reagents one, two, and three from 
an alkaline phosphatase substrate kit (Vector laboratories, Burlingame, CA) was 
immediately applied to the sections. Levamisole was used to inactivate endogenous 
alkaline phosphatase, which induces non-specific staining in the sections. After the 
application of the substrate solution, the slides were incubated in the dark for 20-30 
minutes and were checked periodically under the microscope for color reaction. The 
substrate reaction was terminated by blotting off the solution and rinsing the sections in 
tap water.  The sections were finally counterstained in an autostainer with hematoxylin.  
The counterstaining protocol employs hematoxylin, acid alcohol and Scott’s solution 
steps before dehydrating the sections using graded alcohol and xylene. The sections were 
then cover slipped and allowed to dry overnight.  
 Proliferating cells were observed as red nuclei. The total number of positive cells 
was quantified using Image Pro software (Image pro plus software 4.0 from Media 
Cybernetics, Meyer Instruments, Houston, TX). Photographs of each section were taken 
at three different locations along the length of the section and total cell nuclei (> 500) in 
each photograph were determined by defining a threshold pixel size and color. The total 
cell nuclei were averaged over the images taken at different locations of the same tissue 
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section. Positive cells were counted manually by tagging the cells using the software. The 
percentage of positive cells was calculated for each group, and statistical analysis was 
performed to determine the difference between the groups. 
 
 4.3.3.3. Cell apoptosis: anti- Caspase 3 Immunohistochemistry 
Apoptosis or programmed cell death is a crucial process in development, normal cellular 
differentiation, and tissue homeostasis in all multicellular organisms. Apoptosis can be 
triggered by a variety of cellular death stimuli including tumor necrosis factor. Among 
the many known effectors and regulators of apoptosis, the caspases play a crucial role in 
almost every cell type. There are about 13 different caspases, which can be grouped into 
3 different subfamilies based on their substrate specificities. Caspase 3 (also called 
CPP32, Yama, apopain) is one of the key effectors of the apoptotic pathway. Caspase 3 is 
a cytosolic protein found in cells as an inactive 32kDa proenzyme. It is activated by 
proteolytic cleavage into 17-19 kDa and 12 kDa active subunits only when cells undergo 
apoptosis. These apoptotic cells can be identified by anti-caspase 3, active antibody, 
which can be detected by immunoblotting, indirect immunofluoroscence and 
immunohistochemistry. The staining method for activated anti- caspase 3 is similar to 
that of BrdU with a difference in two steps. The blocked sections were subjected to a 
working dilution of 1:400 of rabbit anti-human caspase 3 (Sigma, St.Louis, MO) in 
1%BSA/PBS. Then a working dilution of 1: 400 of biotinylated goat anti- rabbit IgG 
antibody in 1% BSA/PBS and 2% normal goat serum was applied on them. These steps 
were followed by application of ABC and substrate solutions as done in BrdU staining. 
Then the slides were counterstained to see the cell nuclei and cover slipped. Apoptotic 
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cells were seen as red nuclei and the total number of apoptotic cells was quantified using 
the method described in the previous section. 
 
4.3.3.4. Double immunofluoroscence: von Willebrand Factor and α-Smooth muscle actin 
Immunohistochemistry 
Endothelial cells lining the surfaces of valvular leaflets secrete glycoproteins such as von 
Willebrand Factor (vWF). vWF is a 270 kDa multimeric plasma glycoprotein and is also 
present in platelets and megakaryocytes. It mediates platelet adhesion to injured vessel 
walls and serves as a carrier and stabilizer for coagulation factor VIII. vWF in valvular 
tissue sections can be determined by using anti-vWF which can be detected by 
immunofluoroscence.  
 Actin is a contractile protein present in muscle and some non- muscular tissue. 
Six major isoforms of actin have been described, some of which are restricted to muscle 
cells. Monoclonal antibodies are present with general muscle and smooth muscle 
specificity. These antibodies are used as sensitive markers for muscle cells 
differentiation. Actin in valvular leaflets was detected using an α- smooth muscle actin 
antibody. A double immunofluorescence procedure using two biotinylated antibodies and 
avidin D fluorochrome conjugates was used to detect cells expressing vWF and α- 
smooth muscle actin (α-SMA) on the same tissue section. This procedure was employed 
to reduce the time required for staining and it also gave a good signal to noise ratio. 
Deparaffinized slides were treated with 100ug/ml of protease and blocked using 
1%gelatin/PBS mixture. The slides were incubated with primary antibody at a working 
dilution of 1:800 anti-vWF (Sigma, St.Louis, MO) in 1%BSA/PBS mixture followed by 
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secondary antibody at a working dilution of 1:400 goat anti-rabbit in 1%BSA/PBS along 
with 2%  normal goat serum.  After the secondary antibody was washed off, the sections 
were incubated in the dark with avidin D-Texas red (Vector laboratories, Burlingame, 
CA) at a concentration of 1:100 in 1%BSA/PBS. The sections were again blocked using 
2% normal horse serum in 1% BSA/PBS with ~200µL of avidin D in the dark. Primary 
antibody of α-SMA (DAKO, Carpinteria, CA) was then applied at a working dilution of 
1:800 in 1%BSA/PBS along with ~200µL of biotin to the sections and incubated in the 
dark. The slides were washed in PBS at which point the secondary antibody, horse anti-
mouse IgG, was applied at a working dilution of 1:400 in 1%BSA/PBS along with 2% 
normal horse serum.  Next, the second fluorochrome, avidin D-fluoroscein (Vector 
laboratories, Burlingame, CA) was applied to the sections at a dilution of 1:100 in 
1%BSA/PBS. The sections were then counter-stained with 4',6-Diamidino-2-
phenylindole (DAPI, Sigma, St.Louis, MO) at a working dilution of 0.25 µg/ml of PBS 
and cover slipped with Aquamount mounting media. The sections were then refrigerated 
at 4oC until viewed under the microscope. 
 
4.3.3.5. Scanning electron microscopy (SEM) 
SEM was used to observe the valvular tissue surface for the presence of endothelial cells, 
since it produces high resolution images enabling examination of closely spaced features 
under high magnification. Tissue harvested from the valves was initially rinsed with 
0.2M sodium cacodylate buffer (Electron microscopy sciences, Hatfield, PA) at pH =7.2 
and fixed in 2.5% gluteraldehyde in cacodylate buffer (Electron microscopy sciences, 
Hatfield, PA). The tissue was dehydrated in varying grades of alcohol followed by 
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changes in varying grades of hexamethyldisilazane (HMDS) (Electron microscopy 
sciences, Hatfield, PA). The tissue was then dried overnight in 100% HMDS. The dry 
tissue samples were placed on aluminum stubs (SPI supplies, West Chester, PA) using 
conductive, double sided, carbon adhesive tape (SPI supplies, West Chester, PA). The 
samples themselves were made conductive by coating the samples with a thin layer of 
gold (about 100Ao) in a sputter coater. The coated samples were then left in a desiccator 
until viewed under the SEM (Leo 1530 thermally assisted field emission gun SEM, MSE 
Dept., Georgia Tech., Atlanta, GA).  
 
4.3.4. Statistical analysis 
4.3.4.1. Paired t-test 
Paired t-test is used for testing the difference between two means when the data are 
paired and the paired differences follow a normal distribution. This test was used to 
analyze the sterility data obtained in the study. A hypothesis test of the difference 
between population means when observations are paired was used.  
For a paired t-test: 
H0: h1 = h2     versus     H1: h1 ≠ h2        where h is the population mean 
A confidence interval of 95% was used in the analysis, which was done using Minitab 
software (Minitab release 12, Minitab Inc. State Collage, PA). The data from each sample 
must be in separate numeric columns of equal length. Each row contains the paired 
measurements for an observation. If either measurement of a row is missing, Minitab 
automatically omits that row from the calculations. The difference between the samples 
at t = 0 and t = 96 hours was considered significant if p-value < 0.05. 
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4.3.4.2. Mann-Whitney non-parametric analysis 
Mann-Whitney non-parametric analysis is used to analyze independent sample 
populations that are not normally distributed. This method was employed in the study 
since control and cultured valve leaflets were obtained from different animals and the 
data were not normally distributed. The Mann-Whitney test performs a hypothesis test of 
the equality of two population medians and calculates the corresponding point estimate 
and confidence intervals. In this analysis, the data from two populations that have the 
same distribution are assumed to be independent random samples. The hypotheses for the 
analysis are shown as, 
H0: h1 = h2   versus  H1: h1 ≠ h2 ,   where h is the population median. 
A confidence interval of 95% was used in the analysis, which was done using Minitab.  
Two columns, which can be of same or different lengths, containing numeric data are 
needed from two populations. Minitab automatically omits missing data from the 
calculations when the sample size is different in the two columns, and ranks the two 
combined samples with the smallest observation given rank 1, the second smallest, rank 
2, etc. If two or more observations are tied, the average rank is assigned to each. The test 
statistic is the sum of the ranks of the first sample and the point estimate of the population 
median, which is the median of all the pairwise differences between observations in the 
first sample and the second sample. The test statistic (U) can be represented as, 
                n1 
Ucalc = n1n2 + n2(n2+1)/2 – Σ  Ri 
                      i=1  
 
where n1 = size of larger sample 
 n2 = size of smaller sample 
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 R = ranks of smaller sample 
Utable is obtained from table of critical values for U based on the sample size of each 
group. 
  If Ucalc > Utable at α = 0.05, then reject H0. 
I.e., if U exceeds the critical value for U at significance level of 0.05, it means that there 
is evidence to reject the null hypothesis in favor of the alternative hypothesis. Mann-
Whitney determines the attained significance level of the test using a normal 
approximation with a continuity correction factor. If there are ties in the data, Minitab 
adjusts the significance level. 
 The data collected from the assays and images of BrdU and activated caspase-3 
were put in columns in the Minitab worksheet, and analysis was done with two columns 
at one time for all the leaflets (i.e right coronary, left coronary and non-coronary) in all 
the groups. The average and standard deviation values of the data were calculated and 
plotted in an Excel graph, and the differences between the data were considered 






5.1. Physiological flow and pressure waveforms 
Mechanical validation of the organ culture system was done with respect to maintaining 
normal physiological flow and pressure waveforms for a duration of over 48 hours. The 
system was tested with a Starr-Edwards ball and cage mechanical valve, a pericardial 
bioprosthetic valve and a native porcine aortic valve. All the experiments were conducted 
at a cardiac output of 3.8-4.5 L/min, a mean aortic pressure of 100 mmHg and at a 
frequency of 1.167 Hz (70 beats/min). The flow probe and pressure transducers were 
calibrated with water, which has the same viscosity as the culture medium, as described 
in the previous chapter. The flow and pressure waveforms with the mechanical, 

















































Figure 5.1: Flow and pressure waveforms of the Starr-Edwards ball and cage mechanical 
valve in the organ culture system with water as the circulating fluid. The curves are 
physiological and consistent over a period of 48 hours. 
 
 
The flow and pressure waveforms seen above are comparable to normal 
physiological waveforms and are consistent throughout the experimental time period.  
The curves are smooth with minimum backflow in the flow waveform and very few 
oscillations in the pressure waveform. The mechanical performance of the system was 
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also tested with a pericardial bioprosthetic valve for a period of 48 hours. The mechanical 













































Figure 5.2: Flow and pressure waveforms of the pericardial bioprosthetic valve in the 
organ culture system with water as the circulating fluid. The curves are physiological and 





 The waveforms shown above are consistent and closely approximate to normal 
physiological curves throughout the duration of the experiment. The flow curves show 
backflow of fluid during diastolic phase due to improper leaflet coaptation present in the 
bioprosthetic valve, which was not system induced. The pressure waveforms have 120/80 
mmHg systolic/diastolic phase pressures, which are in the range of normal blood 
pressure. 
 The next step in the mechanical validation procedure was to test the sterility of the 
system for a duration of 96 hours. This was achieved by circulating sterile DMEM in the 
system with the mechanical valve placed in the aortic valve holder. The mechanical 
conditions of the system were monitored and recorded using DAQ-ANAL and the 






















































Figure 5.3: Flow and pressure waveforms of a Starr-Edwards ball and cage mechanical 
valve in the sterile organ culture system and DMEM as the circulating fluid. The curves 
are physiological and consistent over a period of 96 hours. 
 
 
 From the above figure it can be seen that the system was capable of maintaining 
consistent mechanical conditions over a period of 96 hours. The sterility data for the 
system will be shown in section 5.2. 
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Once the system was mechanically validated, it was tested biologically using 
native porcine aortic valves. The aortic flow and pressure curves with native valve are 
shown in Figure 5.4. The coronary arteries of the valve were ligated before the valve was 
placed in the holder to prevent backflow of the medium from the sinuses of the valve. 
However, minimal backflow of medium along inside of the walls of the holder caused the 
negative flow rates noticed in the flow curve. Also, some pressure oscillations were 
evident between 100-190 msec during the beginning of the systolic phase due to 
turbulence created in the system by the outward movement of the piston to pump the 























































Figure 5.4: Flow and pressure waveforms for a native porcine aortic valve in the sterile 
organ culture system and DMEM as the circulating fluid. The curves are physiological 




 From the above waveforms with mechanical, bioprosthetic and native aortic 
valves it can be inferred that the system is capable of maintaining normal physiological 
mechanical conditions for up to 96 hours of operation without any sudden fluctuations in 
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the values. Thus, it can be said that the developed organ culture system has been 
mechanically validated.  
 
5.2. Sterility measurements 
A sterility test was performed with a Starr-Edwards mechanical valve for a period of 96 
hours as indicated in section 5.1. The medium was tested for contamination by 
microscopic examination and also by measuring the absorbance of the medium before 
and after the experiment, as described in the methods chapter. 
 Medium samples were taken at time t = 0 hour and t = 96 hours to test for 
evidence of microbial contamination in the system. Intermittent sampling was not prudent 
as this compromised the sterility of the system. Contaminated medium was characterized 
by increased turbidity, a color change from dark red to orange-yellow, and an unpleasant 
odor depending on the level of contamination. After 96 hours, gross examination of the 
medium showed a clear liquid without any color change or turbidity. Additionally, the 
medium absorbance was measured and samples underwent microscopic examination. 


























Figure 5.5: Absorption values of the medium samples at t = 0 hour and t = 96 hours at a 
wavelength of 364 nm. The data are expressed as the average value + one standard 




 The results show that there was no significant difference between the samples at t 
= 0 hour and t = 96 hours with p > 0.05 (p-value = 0.1).  Microscopic examination of the 
medium showed a clear medium through out the section with no microbes. This suggests 
that the organ culture system was able to maintain sterility for a duration of 96 hours and 
can hence be used for long term valvular culture studies. 
 
5.3. Gas exchange in the organ culture system 
Preliminary experiments with aortic valves cultured in the organ culture system showed 
cell death due to adverse environmental conditions in the system. Hence changes in the 
pH and oxygen transfer were characterized to address these concerns. The pH of the 
medium was recorded at the end of every trial. Results from three experiments showed 
that the pH was 7.36 ± 0.11. This value is within the physiological range of 7.2-7.4. To 
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ensure sufficient oxygen transfer, gas permeable silicon tube was used as a gas exchanger 
in the system. Silicon tube with a 0.16" inner diameter was wound in a coil supported in 
place by three hollow polyvinyl chloride rings. The tubing was connected between the 
two ports of a lid assembly at the side arm of the compliance tank. To determine the 
oxygen required by the system, four porcine aortic valves were used to calculate the 
uptake rate as described in section 4.2.3.  The oxygen uptake rate (OUR) was measured 
by noting the dissolved oxygen (DO2) content over a period of 48 hours (Figure 5.6) and 
fitting a second order rate equation to the data (Figure 5.7). 
 Figure 5.6 shows that the oxygen content of the media follows a rectangular 
hyperbolic trend, as seen with nutrient uptake studies in cell culture. The amount of DO2 
reduces to half its value within the first 4 hours suggesting that most of the oxygen is 
taken up by the valve during that time period, after which time the uptake rate is 
drastically reduced and decreases to about 0.0232 mg of O2/gm of tissue/L of medium at 
the end of 48 hours. The graph below indicates that oxygen limitation may occur in the 



















































Figure 5.6: Dissolved oxygen content in the medium (400mL) with porcine aortic valves. 
Oxygen content decreases to half its value in the first four hours and then decreases 
slowly until it levels off around 48 hours. 
 
  
 The wet weight of the aortic valve was determined to normalize the OUR of the 
valve, which was 29.23 ± 1.64 gm. The OUR of the aortic valve was found by finding the 
slope by plotting a curve of DO2 Vs time for the first 6 hours. It can be seen from Figure 
5.6 that DO2 concentration decreases to 50% of its value in the first 6 hours, hence this 
time span was chosen for calculating the OUR. The assumption involved in this 
calculation is that, oxygen becomes limiting in the medium before the nutrients, hence 
the reaction follows zero order kinetics. The OUR of the valve was found to be 0.0305 
mg of O2/gm of tissue/L of media/hour (or) 8.472 ×10-6 mg of O2/gm of tissue/L of 
media/sec (or) 9.9023 ×10-5 mg/sec.  This value was comparable to the value of 3.05 ×10-
5 ± 1.37 ×10-5 ml of O2/ml of tissue/sec found in the literature [Wend, 2001].  
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Figure 5.7: OUR plot of the DO2 concentration data. Slope of the graph yields oxygen 
uptake rate of the aortic valve, which was 3.1×10-3 mg/sec for a 29 gm aortic valve. 
 
 
 After establishing the OUR of the aortic valve, the required oxygen transfer rate 
in the system was calculated. The length of the tubing and gas flow rate calculated using 
equations 4.2 and 4.3 were found to be 2 m and 0.2 L/min, respectively. These 
calculations were validated by measuring gas transfer into the system. The DO2 of the 
degassed medium was measured every hour until saturation (Figure 5.8), and the transfer 
rate was calculated using equation 4.4.  It can be observed from the graph that the DO2 
value reached 95% of the saturated value in the first hour after which the increase was 




























Figure 5.8: Oxygen exchanged into the organ culture system over a period of 5 hours. 





 The mass-transfer coefficient was calculated from the slope obtained by plotting 
the logarithm of % O2 saturation versus time (Figure 5.9). A steep increase in oxygen 
content in the medium during the first hour of gas-exchange (Figure 5.8) caused a 
significant shift in the linear fit leading to a low R2 value seen in the graph (Figure 5.9). 
However, a linear fit to the data was best fit when compared to a quadratic fit. 
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Figure 5.9: Percentage saturation of oxygen transferred into the system. The slope 
obtained from the graph was 0.8273 hour-1. 
 
  
 The value of the slope obtained from Figure 5.9 was 0.8273 hour -1.  Using 
equation 4.6, the transfer coefficient was found to be 49.54 mm/hr, or 0.0013761 cm/sec.  
From equation 4.4 a gas transfer rate of 4.74 ×10-3 mg/sec was calculated. Since the gas 
transfer rate is greater than the OUR, the theoretical calculations are valid. Hence, a 5% 
CO2 gas flow rate of 0.2 L/min circulating through a 0.16" diameter by 2 m length silicon 
tube provided the required oxygen to maintain valve viability in the organ culture system. 
  
5.4. Extracellular matrix components 
Measurement of total amount of extracellular matrix components in the cultured valve 
leaflets and comparison with control (fresh and statically incubated) leaflets shows the 
ability of the system to retain the native synthetic activity of the cultured leaflets. A total 
of 10 experiments were conducted with valves cultured in the organ culture system, and 
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of these, 9 data sets have been analyzed here. Data from one valve was not analyzed since 
visual observation of the valve in the holder revealed the presence of excess sinus tissue, 
which formed folds inside the valve holder and prevented proper opening and closing of 
the leaflets. Cardiac output and aortic pressure conditions monitored during the nine 
experiments are summarized in Table 5.1. 
  
Table 5.1: Cardiac output and aortic pressure values measured downstream of the aortic 
valve cultured in the organ culture system at a cardiac rate of 70 beats/min. 
 
Expt # Cardiac output (L/min) Mean Aortic pressure (Systolic/Diastolic) mmHg 
1 4.09 90 120/60 
3 3.85 90 120/60 
4 3.84 95 120/70 
5 4.72 95 120/70 
6 3.99 100 120/80 
7 3.82 95 120/70 
8 4.26 90 120/60 
9 4.28 100 120/80 
10 4.50 100 120/80 
 
 
 The mean values for flow rate and aortic pressure were in the range of 3.8-4.5 
L/min and 90-100 mmHg suggesting that normal mechanical conditions have been 
maintained for all the valves cultured in the organ culture system. 
 
5.4.1. Collagen content 
The total collagen content in the leaflets was measured using the Sircol collagen assay kit 
as described in section 4.3.2.1. The results from this test are shown in Figure 5.10. The 
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data for individual valves are given in Table 5.2, and the p-values for the data are given 


























Figure 5.10: Collagen contents in left, right, non-coronary and mean content in all the 
three leaflets of the valve. The data are represented as average value + one standard 
deviation. No significant difference was observed between the three groups of the leaflets 














Table 5.2: Collagen data from left, right and non coronary leaflets of fresh (F), cultured 
(C) and static (S) control valves used in the study. The data are expressed as µg of 
collagen present in mg of dry leaflet tissue. 
 
Left coronary leaflet Right coronary leaflet Non coronary leaflet Expt
. No. F C S F C S F C S 
1 42.15 14.64 55.32 19.37 47.67 24.71  3.67 25.34 31.21 
3 24.80 6.84 6.02 20.89 12.13 12.96  14.62 25.68 6.99 
4 75.62 18.80 7.56 20.54 21.64 3.58  7.11 17.88 24.04 
5 14.76 17.95 6.89 14.64 38.04 26.63  6.83 19.69 4.31 
6 16.60 16.08 12.28 30.72 14.27 11.71  24.78 8.27 12.80 
7 39.76 30.70 17.20 22.88 8.24 47.06  13.99 7.27 13.10 
8 20.18 8.31 28.65 6.08 11.28 6.84  8.52 27.78 10.58 
9 18.65 35.01 18.66 33.12 19.95 26.68  16.19 14.97 27.01 
10 31.95 33.49 13.71 37.83 36.16 5.32  13.11 13.27 26.52 
Avg. 31.60 20.20 18.48 22.90 23.26 18.39 12.09 17.79 17.40 
Std.
Dev. 











Table 5.3: p-values for the collagen data comparisons between all three groups of the 






 Results for each leaflet (left, right and non-coronary leaflets) from each group 
(fresh, cultured and static control) and mean collagen content for all the leaflets (total) 
were averaged for each group. Standard deviations for the results were calculated for all 
the leaflets in each group, and the data was expressed in the graph as average value + one 
standard deviation. From the figure and Table 5.3 it can be inferred that there is no 
significant difference in collagen content between the fresh, cultured and static control 
leaflets (p>0.05). This shows that the organ culture system is able to maintain collagen 
synthesis at native levels. Collagen content in the static control leaflet, although reduced 
compared to the fresh and cultured leaflets, was not statistically different from the two 
groups at α=0.05. However if α=0.1, then from the p-value of Table 5.3 a significant 
decrease (p=0.0521) in left coronary static leaflets compared to fresh leaflets can be 
observed. This result was different from that seen in previous studies on porcine aortic 
valve leaflets [Weston, 2001], where collagen synthesis during static incubation increased 
Leaflet  Fresh Vs Cultured Fresh Vs Static Cultured Vs Static 
Left 0.1333 0.0521 0.3772 
Right 0.8598 0.3772 0.4268 
Non 0.0774 0.4268 0.7911 
Total 0.5918 0.1772 0.3157 
113 
significantly compared to fresh leaflets. This may be due to differences in analysis 
procedures. Measuring collagen synthesis is more sensitive than measuring collagen 
content in the leaflet as the latter test measures newly synthesized collagen, soluble by 
pepsin. Also, the leaflets differ biologically between the groups since they are from 
different animals although the statistical analysis method takes into account the 
differences between the populations. The large standard deviations seen with data are 
also due to the variability in collagen content seen between the individual data sets shown 
in Table 5.2. 
 
5.4.2. sGAG content 
Sulfated glycosaminoglycan (sGAG) content in the leaflet was measured using the 
Blysclan sGAG kit as described in section 4.3.2.2. The results shown in Figure 5.11 are 
expressed as the average value + one standard deviation for all the groups. The individual 
data sets for each valve involved in the study are given in Table 5.4 and the p-values 








































Figure 5.11: sGAG content in left, right, non-coronary and mean content in all the three 
leaflets of the valve. The data are represented as average value + one standard deviation. 
No significant difference was observed between the cultured and fresh control leaflets 
(p>0.05). Static control leaflets have significantly reduced sGAG content compared to 















Table 5.4: sGAG data from left, right and non coronary leaflets of fresh (F), cultured (C) 
and static (S) control valves used in the study. The data are expressed as µg of sGAG 
present in mg of dry leaflet tissue.  
 
Left coronary leaflet Right coronary leaflet Non coronary leaflet Expt
. No. F C S F C S F C S 
1 16.31 18.22 11.15 18.40 15.18 4.02 12.96 17.08 17.05 
3 27.05 12.23 14.17 23.30 10.23 8.48 32.59 12.07 15.26 
4 37.16 17.40 17.59 18.10 15.71 8.06 33.89 21.77 11.35 
5 21.00 21.99 14.74 22.56 20.92 10.96 30.14 22.83 14.08 
6 13.96 19.81 10.49 13.37 18.05 15.04 11.06 15.45 15.32 
7 25.51 14.10 7.88 18.31 12.15 14.75 18.54 22.77 11.61 
8 30.72 15.94 24.79 20.49 20.32 19.29 9.31 27.27 18.69 
9 15.72 18.08 18.94 16.12 17.03 9.55 17.39 31.52 16.33 
10 16.69 18.77 16.78 13.09 39.36 16.36 13.76 22.42 16.95 
Avg. 22.68 17.40 15.17 18.19 18.77 11.84 19.96 21.46 15.18 
Std.
Dev. 











Table 5.5: p-values for the sGAG data comparisons between all three groups of the 






 The results suggest that sGAG content in the cultured leaflets is not significantly 
different (p>0.05) from that in fresh valve leaflets. However, static controls show 
significantly less sGAG content compared to both fresh controls and cultured leaflets 
(p<0.05). The left coronary leaflets do not show a significant difference (p>0.05) between 
the three groups at α=0.05, while the right and non coronary leaflets in the static controls 
have 35%, 37%  and 24%, 29.3%  less sGAG content compared to fresh control and 
cultured leaflets, respectively. A reduction of 30.65% and 26.8% in total sGAG content 
averaged over all the three leaflets of the valve was found in the static control leaflets 
compared to fresh control and cultured leaflets. When α=0.1, the sGAG content is found 
to be significantly reduced in left coronary static leaflet when compared to fresh leaflet. 
This shows that mechanical forces are required for normal synthesis of GAG in the 
leaflets.  
 
Leaflet  Fresh Vs Cultured Fresh Vs Static Cultured Vs Static 
Left 0.2893 0.0637 0.2510 
Right 0.4799 0.0171 0.0273 
Non 0.5962 0.5962 0.0134 
Total 0.7293 0.0028 0.0008 
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5.4.3. Elastin content 
Elastin content results obtained using the Fastin elastin kit as described in section 
4.3.2.3., are shown in Figure 5.12.  Individual data sets for all the groups of the leaflets 
are given in Table 5.6, and the p-values for elastin data comparisons between the groups 





























Figure 5.12: Elastin content in the left, right, non-coronary leaflets and mean content in 
all three leaflets of the valve. The data are represented as average value + one standard 
deviation. No significant difference was observed between the cultured and fresh control 
leaflets (p>0.05). Static control leaflets have significantly reduced elastin content 









Table 5.6: Elastin data from left, right and non coronary leaflets of fresh (F), cultured (C) 
and static (S) control valves used in the study. The data are expressed as µg of elastin 
present in mg of dry leaflet tissue. 
 
Left coronary leaflet Right coronary leaflet Non coronary leaflet Expt
. No. F C S F C S F C S 
1 108.86 336.79 115.6 85.57 232.6 107.2 88.72 137.3 92.72 
3 77.57 116.09 70.45 147.65 91.13 47.67 83.71 133.4 105.4 
4 118.86 70.82 172.3 152.49 117.5 56.65 67.58 115.8 39.98 
5 160.93 109.43 52.35 69.38 166.5 50.43 132.6 503.2 79.19 
6 173.84 53.11 47.19 278.40 98.90 65.15 211.7 77.44 104.4 
7 144.54 59.79 54.09 131.04 75.29 74.11 64.79 127.7 107.2 
8 216.82 92.34 216.7 92.45 138.6 65.12 202.2 123.4 139.6 
9 134.65 201.94 57.72 64.50 90.81 46.64 87.34 82.24 113.3 
10 88.08 84.30 81.00 52.90 117.3 79.37 59.32 90.06 123.6 
Avg. 136.02 124.96 96.38 119.38 125.4 65.82 110.9 154.5 100.6 
Std. 
Dev. 












Table 5.7: p-values for the elastin data comparisons between all three groups of the 






 It can be seen from the figure that the elastin content in the cultured and fresh 
control leaflets is not significantly different in total valve and in different leaflets 
(p>0.05). However, the static control leaflets do show a significant decrease in elastin 
content in the right coronary leaflet and in average elastin content for all three leaflets of 
the valve (p<0.05). Elastin content in the static control for the left and non coronary 
leaflets was not significantly different from that in the fresh and cultured leaflets. 
(p>0.05). However, for the right coronary leaflet, a significant reduction in elastin content 
of 44.87% and 47.52% was observed compared to fresh controls and cultured leaflets, 
respectively. A reduction of 28.25% and 35.1% for the static control versus the fresh 
control and cultured leaflets, respectively, was observed in total elastin content averaged 
over all three leaflets of the valve.  At α=0.1 significant reduction can be seen in the left 
leaflet of the static control compared to fresh leaflet, which suggests that static incubation 
of the leaflet alters the structural protein synthesis in the leaflets. 
Leaflet  Fresh Vs Cultured Fresh Vs Static Cultured Vs Static 
Left 0.2164 0.0637 0.2893 
Right 0.5365 0.0341 0.0020 
Non 0.2893 0.6588 0.3314 
Total 0.8627 0.0110 0.0043 
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 In conclusion, the total amount of ECM components of the cultured valve leaflets 
was maintained at native levels in the organ culture system, which suggests that the 
natural architecture of the leaflet is retained. Static controls showed reduced sGAG and 
elastin contents compared to fresh and cultured leaflets, which suggests that a dynamic 
environment is required by the leaflets in order to maintain the native synthetic activity of 
the valvular cells. 
 
5.5. Qualitative studies of the leaflet 
5.5.1. Hematoxylin and Eosin stain 
Structural integrity of the leaflet was assessed by examining the morphology of the 
leaflets after staining with Hematoxylin and Eosin (H&E). As described in section 
4.3.3.1, the stain was used to observe any remodeling in the tissue structures. Pictures of 
representative H&E stains for fresh, cultured and static control leaflets are shown in 
Figure 5.13, taken at 20X magnification. Cell nuclei in the tissue are stained blue and the 
cytoplasm is pink. Tissue structures such as collagen crimp in the fibrosa (F), and elastic 
fibers in the ventricularis (V) region have a dark pink color and hence are differentiated 
from the ECM. Spongiosa (S) has a loose tissue structure, which is characterized by light 




Figure 5.13: From left to right: Left, Right and Non coronary leaflets. H & E stains of 
fresh (A), cultured (B) and static (C) control leaflets. Cell nuclei are blue, and ECM are 
pink. Images were taken at 20X magnification. The morphology of the cultured leaflets 
was preserved in the system, which is comparable to the fresh and static control leaflets. 


































 The images show that valve leaflets cultured in the organ culture system have a 
three layer tissue structure similar to fresh and statically incubated leaflets. There is no 
apparent change in the cellular distribution or thickness of the leaflet layers. The gross 
morphology of the leaflets suggests that there is no remodeling in the tissue structure 
when compared to the fresh and static controls. This suggests that the system is capable 
of preserving leaflet morphology when cultured under normal physiological conditions 
for a period of 48 hours. 
 
5.5.2. Cell proliferation: 5-Bromo deoxyuridine stain 
Cell proliferation in the valve leaflets was observed by marking proliferating cells with 
an anti- BrdU antibody. Proliferating cells show up as red nuclei while the rest of the 
cells are stained blue (Figure 5.14).  Positive cells (indicated by black arrows) can be 
observed in both the cultured and static control leaflets with no specific distribution of the 
cells in the leaflets. All the images were taken under 20X magnification.  
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Figure 5.14: From left to right: Left, Right and Non coronary leaflets. BrdU IHC images 
of fresh (A), cultured (B) and static (C) control leaflets. Cell nuclei are shown in blue and 
proliferating cells as red nuclei. Images were taken at 20X magnification. Positive cells 
(indicated by black arrows) were found in cultured and static control leaflets scattered 





































Few cells compared to the total number of cells on the leaflets were found to be 
proliferating in both the cultured valve and static leaflets. The fresh control leaflets, 
shown in Figure 5.14, were fixed in formalin instead of incubation in medium containing 
BrdU. Thus, there was no BrdU incorporation in the cells, and no proliferating cells were 
identified in the fresh leaflets. 
 Proliferating cells in both groups were quantified by cell counting using Image 
Pro software, as detailed in the methods chapter. The number of proliferating cells in 
cultured leaflets was 0.17% ± 0.33% compared to 0.096% ± 0.11% in the static control 
leaflets. Data presented in Figure 5.15 shows that there is no statistically significant 
difference between the cultured and static control leaflets (p>0.05). Data sets 
corresponding to the graph shown below are given in Table 5.8, with p-values for data 







































Figure 5.15: Percentage population of proliferating cells in the left, right, non-coronary 
leaflets and mean content in all three leaflets of the valve. The data are represented as 
average value + one standard deviation. No significant difference was observed between 

















Table 5.8: Cell proliferation data from left, right and non coronary leaflets of fresh (F), 
cultured (C) and static (S) control valves used in the study. The data is expressed as 
percentage population of total cells that are proliferating. Blank cells specify that data has 
not been analyzed for that valve. 
 
Left coronary leaflet Right coronary leaflet Non coronary leaflet Expt. 
No. F C S F C S F C S 
1 0 0 0 0 0.079 0.26 0 0 0 
3 0 0 0.109 0 0 0 0 0.645 0.110 
4  0.927   0   0  
5     0.076     
Avg. 0 0.309 0.055 0 0.026 0.13 0 0.215 0.055 
Std. 
Dev. 




Table 5.9: p-values for the cell proliferation data comparisons between all three groups of 
















5.5.3. Cell apoptosis: Caspase 3 stain 
Leaflets cultured in the organ culture system were tested for apoptosis to ensure that there 
was no system-induced injury to the leaflets by adverse mechanical or biochemical 
factors. Apoptotic cells in the leaflet containing activated caspase 3 cleavage sites are 
marked by red nuclei using an activated caspase 3 antibody, and the rest of the cell nuclei 




Figure 5.16: From left to right: Left, Right and Non coronary leaflets. Shown here are 
Activated caspase 3 IHC images of fresh (A), cultured (B) and static (C) control leaflets. 
Cell nuclei are shown in blue and apoptotic cells as red nuclei. Images were taken at 20X 
magnification. Positive cells (indicated by black arrows) were found in fresh, cultured 
































Apoptotic cells were found scattered in all three layers of the three groups of the 
leaflets. To provide an estimate of increase or decrease in number of apoptotic cells in 
cultured leaflets compared to fresh valve leaflets, cells were counted in the leaflets and 
the data was expressed as a percentage of the population of cells undergoing apoptosis. 
The apoptosis data is shown in Figure 5.17 and the corresponding data sets are given in 
Table 5.10. The p-values for all three leaflet group comparisons are given in Table 5.11. 
Apoptosis in the cultured leaflets (1.64% ± 1.04%) was not statistically different than that 
in the fresh control leaflets (1.96% ± 0.41%), but it was significantly less than in the 





















Figure 5.17: Percentage population of apoptotic cells in the left, right, non-coronary 
leaflets and mean content in all three leaflets of the valve. The data are represented as 
average value + one standard deviation. No significant difference was observed between 
fresh and cultured valve leaflets. Apoptosis in the static control leaflets was significantly 
greater than in the cultured valve leaflets (p<0.05) but not statistically different from 








Table 5.10: Cell apoptotic data from left, right and non coronary leaflets of fresh (F), 
cultured (C) and static (S) control valves used in the study. The data is expressed as 
percentage population of total cells that are undergoing apoptosis. Blank cells specify that 
data has not been analyzed for that valve. 
 
Left coronary leaflet Right coronary leaflet Non coronary leaflet Expt. 
No. F C S F C S F C S 
1 2.02 1.94 3.46 1.90 0.19 1.73 2.49 0.53 4.54 
3 1.18 2.17 3.18 1.81 2.00 2.33 1.58 1.77 2.20 
4 2.31 0.80 2.34 2.13 0.28   3.52  
5 2.44 1.32        
6 1.74 2.19        
7  2.93        
Avg. 1.94 1.89 2.99 1.95 0.82 2.03 2.04 1.94 3.37 
Std. 
Dev 









Table 5.11: p-values for the cell apoptosis data comparisons between all three groups of 





5.5.4. α-Smooth muscle cell actin immunohistochemistry 
Phenotypical changes in the leaflet were observed through the expression of α-SMC actin 
by interstitial cells in the leaflet. Immunofluoroscence images of the leaflet shown in 
Figure 5.18 were taken at a magnification of 20X. α-SMC actin expression was green 
(indicated by white arrows) and surrounded the cells expressing it. The cell nuclei were 
counterstained in blue.  
Leaflet  Fresh Vs Cultured Fresh Vs Static Cultured Vs Static 
Left 0.9273 0.0736 0.0528 
Right 0.3827 1.000 0.3865 
Non 1.000 0.6985 0.3865 
Total 0.4483 0.0570 0.0251 
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Figure 5.18: From left to right: Left, Right and Non coronary leaflets. α-SMC actin 
immunofluoroscence images of fresh (A), cultured (B) and static (C) control leaflets. 
Green indicates α-SMC actin expressed by interstitial cells and blue indicates cell nuclei. 
Images were taken at 20X magnification. Actin expression (indicated by white arrows) 
was comparable between fresh and cultured valve leaflets but was reduced in static 

























In the images it can be seen that α-SMC actin was expressed predominantly in the 
ventricularis region of all three leaflets in the three groups. Actin expression in the 
cultured valve leaflets was similar to that of fresh valve leaflets. However, expression in 
the static control leaflets was less than both the fresh and cultured valve leaflets. This 
suggests that the native phenotype of the leaflets was maintained in the cultured valves 
exposed to normal mechanical conditions for 48 hours. 
 
5.5.5. Endothelial cells: von Willebrand factor stain 
Double immunofluroscence was used to stain for both EC expressing vWF and IC 
expressing α-SMC actin. vWF in the EC marked using texas red fluorochrome is red in 
the images shown in Figure 5.19. Cell nuclei were counterstained blue, and the images 
were taken at a magnification of 20X. ECs are indicated with white arrows. It can be seen 
that the ECs on both cultured and static control leaflets were reduced compared to fresh 
control leaflets. To confirm this observation, SEM was performed on all leaflet samples. 
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Figure 5.19: From left to right: Left, Right and Non coronary leaflets. vWF 
immunofluoroscence images of fresh (A), cultured (B) and static (C) control leaflets. EC 
are indicated by red and cell nuclei were counterstained with blue. Images were taken at 
20X magnification. vWF expression (indicated by white arrows) is reduced in cultured 
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5.5.6. Scanning electron microscopy: Endothelial cells 
SEM was used to observe endothelial cells on the ventricularis surface of aortic valve 
leaflets. Images were taken at a magnification of 1000X and are shown in Figure 5.20. 
 
 
Figure 5.20: SEM images of the ventricularis surface of the aortic leaflets taken at 1000X 
resolution. EC were aligned in circumferential direction on cultured leaflets and looked 
similar to those on fresh leaflets. Shown from left to right and top to bottom are fresh, 
cultured, static and denuded leaflets, respectively. 
 
 
 EC on the cultured valve leaflets were found to be comparable to those on the 
fresh control leaflets. EC aligned in the circumferential direction of the leaflets, 
perpendicular to the flow. The EC on the static control leaflets were not as clearly defined 
as those on the fresh and cultured leaflets, but this may be an artifact that occurred during 
 1000 x 1000 x 






leaflet processing. Shown in the images from left to right are fresh, cultured, static and 
denuded leaflets. The denuded image has been adopted from unpublished data generated 
in our laboratory from a different study and has been used here to provide a comparison 
between leaflets populated with and without EC. These images show that the EC were 
retained by the valve leaflets cultured in the organ culture system for a period of 48 





The experimental results presented in Chapter 5 demonstrate that the ex vivo organ 
culture system is capable of maintaining normal physiological pressure and flow 
conditions, and sterility for a period of 96 hours. The system has also been shown to 
maintain physiological pH and provide adequate oxygen for sustaining the viability of the 
porcine aortic valve. Biological studies of the valve leaflets cultured in the system 
indicate that collagen, sGAG and elastin content were maintained at native levels in the 
organ culture system. A significant decrease in sGAG and elastin content was observed in 
the static control leaflets compared to native levels. The cell phenotype of the cultured 
valve leaflets was comparable to that of fresh valve leaflets, and there were no gross 
changes in the morphology of the cultured leaflets. The ECs were retained on the leaflet 
surfaces after 48 hours of organ culture. A comparable amount of cell apoptosis between 
the fresh and cultured valve leaflets showed that the system was able to maintain the 
viability of the leaflet tissue without causing any adverse environmental changes, such as 
oxygen limitation or detrimental pH levels.  
 
6.1. Mechanical performance of the system 
The organ culture system was developed to simulate the physiological and mechanical 
environments experienced by the native aortic valve. The closed flow loop is constructed 
of biocompatible components that are capable of withstanding the high temperatures and 
pressures of repeated autoclave cycles. The system is compact to enable it to be contained 
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in an incubator in order to maintain the temperature at 37oC. Silicone tubing, situated 
inside the compliance tank of the system, provides oxygen to the culture medium, thus 
ensuring that the nutritional requirements of the valve are met. The flow rate and pressure 
in the system could be controlled independently of each other, enabling a wide range of 
clinically relevant mechanical conditions to be studied aseptically [Warnock, 2005]. In 
addition, the flow and pressure waveforms shown in Figures 5.1-5.4 are very similar to 
the physiological waveforms shown in Figure 4.1. In the flow waveforms of Figures 5.1-
5.4, the peak flow rates obtained were between 22.0-24.0 L/min, which is comparable to 
29.0 L/min seen in Figure 4.1.  The peak pressure was 120 mmHg, the same as that of a 
normal human adult heart under resting conditions. The duration of the systolic and 
diastolic phases in the pressure waveform was also comparable with the physiological 
values of 300 and 550 ms, respectively. 
The flow waveform obtained by testing a ball and cage mechanical heart valve in 
the organ culture system showed negative flow rates during diastole due to paravalvular 
leakage. This was possibly due to a slight tilt of the valve in the valve holder caused by a 
mismatch between the size of the valve (25mm) and the inflow diameter (33mm) of the 
central component of the aortic valve holder, despite the use of a 35mm external diameter 
support ring to hold the valve in place. Additionally minimal fluid flow reversal was 
observed due to the backward movement (diastolic phase) of the piston causing negative 
flow rates. It can also be seen from the pressure waveforms in Figures 5.1 and 5.3 that the 
pressure gradient (i.e.magnitude of the waveforms) was large (60-65 mmHg) when 
compared to the waveforms obtained with the pericardial bioprosthetic valve or the native 
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porcine aortic valve. This may be to due to the lower effective orifice area of the valve 
causing larger pressure gradients.  
The negative flow rates seen in the flow waveform for the pericardial 
bioprosthetic valve were due to backflow of fluid through a small coaptation gap between 
the closed leaflets and flow reversal causing the fluid to leak back along the inside wall of 
the valve holder during the diastolic phase of the cardiac cycle. The disturbances in the 
pressure waveform in this case were reduced when compared to the waveforms seen with 
the mechanical valve. The flow waveforms of the native porcine aortic valves, seen in 
Figure 5.4, showed reduced backflow compared to flow waveforms obtained with either 
the mechanical or the bioprosthetic valves, shown in Figures 5.1-5.3. The lower values of 
negative flow rates seen in the waveform may have been due to fluid flow reversal 
leading to leakage of the fluid between the aortic root and the inside wall of the aortic 
valve holder during backward movement of the piston. Leakage through the aortic valve 
was minimized by ligating the coronary arteries and also fixing the excess aortic tissue 
between the outflow side of the central component and outflow components of the valve 
holder. This also prevented the aorta from bending on to the leaflets. In all the pressure 
waveforms in Figures 5.1-5.4, fluctuations can be seen at the beginning of systole. This 
may be due to turbulence created by the forward movement of the piston to push the fluid 
through the flow loop. Overall, the flow and pressure waveforms were consistent 
throughout the experimental duration with minimal variation between the curves acquired 
at different time points. Thus, the organ culture system was able to maintain consistent 
physiological mechanical conditions for a period of 96 hours. 
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The system was shown to maintain a physiological pH level and provide 
sufficient oxygen transport to the valve. pH values outside of the physiological range of 
7.2-7.4 induce significant cell death in the leaflet tissue, thus changing the biological 
properties of the leaflets. A lack of oxygen transport to the valves in the organ culture 
system decreased the viability of the cells as shown in Appendix D. The incorporation of 
a gas-exchanger in the system was able to maintain leaflet cell viability with cell 
apoptosis comparable to fresh leaflets as seen in Figures 5.16 and 5.17. The oxygen 
uptake rate obtained in this study compares well with the value obtained in the oxygen 
diffusion study of aortic valve leaflets conducted by Wend et al [Wend, 2001]. However, 
the method of calculating the oxygen uptake rate of the valve and oxygen transfer rate 
into the medium is not accurate since oxygen seepage into the closed systems will occur 
during DO2 measurements with the probe. This is due to the presence of large oxygen 
concentration gradients between the inside of the system and the outside atmosphere. 
Further, the closed system used for oxygen uptake measurements may have allowed 
minimal oxygen exchange into the system through the polystyrene gasket located in the 
lid of the culture flask. The amount of leakage of oxygen into the culture flask may be 
determined by degassing the medium in the flask with N2 and periodically recording the 
DO2 values for long enough time. Thus, the error in measuring the oxygen uptake rate 
may be minimized. The gas-flow rate in the gas-exchanger was calculated based on 
normal cardiac pressure and flow conditions. This value depends upon the pressure and 
flow conditions in the system and changes to meet the oxygen uptake requirements of the 
valves due to changes in the convective mass transport rate. Additionally, the oxygen 
exchange rate into the medium contained in the organ culture system was 4.74 ×10-3 
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mg/sec, which is two orders (i.e. 100 times) of magnitude greater than the oxygen uptake 
rate of the valve, 9.90 ×10-5 mg/sec. The oxygen uptake rate of the valve was established 
when it was cultured under static, atmospheric pressure with no mechanical loading. 
However, when the valve is cultured under dynamic conditions the oxygen requirement 
increases. This increase in demand for oxygen is met by gas that is transferred into the 
medium in the system. Hence, the gas-flow rate in the gas-exchanger was calculated such 
that the amount of oxygen supplied is greater than the uptake rate. Also, there was no 
increase in cell death, as seen in Figure 5.16, due to excess oxygen to the valve, 
suggesting that adequate amount of oxygen was provided to the organ culture system.  
This organ culture system is the first system to address the issue of providing the 
required level of oxygen to maintain the viability of native aortic valves. Previous in vitro 
bioreactors that were used for producing and preconditioning tissue engineered valve 
constructs under dynamic conditions did not address the issue of oxygen transport in the 
closed set up of the systems [Dumont, 2002; Hoerstrup, 2000a; Hoerstrup, 2000b; 
Sodian, 2000]. The earliest of these bioreactors was developed by Hoerstrup et al to 
produce tissue engineered valvular constructs under aortic flow and pressure conditions. 
This bioreactor could attain a maximum flow rate of 2.0 L/min and a maximum pressure 
of 240 mmHg. Although the pressure could be adjusted to physiological ranges, the flow 
rate was much less than the physiological value. Also, since the constructs were not 
anchored to a support to simulate the physiological leaflet movement, they were not 
subjected to bending or cyclic flexure. When implanted in vivo in a lamb model, the 
tissue engineered valve leaflets produced in this bioreactor developed regurgitation 
within 4 months of implantation [Hoerstrup, 2000a; Sodian, 2000]. This result suggests 
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that the valve leaflets require greater mechanical strength to withstand in vivo 
hemodynamic conditions. Another recent study to develop an in vitro bioreactor for 
dynamic seeding and conditioning of tissue engineered constructs was undertaken by 
Hildebrand et al [Hildebrand, 2004]. The system was capable of operating under various 
mechanical loading conditions and visual examination of the medium showed that the 
system could be operated aseptically for 21 days. However, the study did not address 
maintenance of the pH level or nutrient sufficiency (specifically oxygen) as only 2L of 
culture medium was used in the closed system for 21 days without perfusion. The results 
from the current study suggest that an aortic valve weighing ~30 g will reach limiting 
oxygen conditions in 3 hours when cultured in 400 mL of medium. Hence, with an 
operating volume of 2 L in a closed system, oxygen transport to the tissue constructs will 
become limited within a short time. Furthermore, the medium may require periodic 
replenishment to prevent depletion of other nutrients such as glucose. 
The ex vivo organ culture system developed in the current study provides 
consistent physiological loading conditions with independent control of the flow rate, 
pressure and frequency to reproduce clinically relevant mechanical conditions. In 
addition, the ability of the system to provide adequate oxygen transport to the valve at 
physiological pH level enables the system to culture native porcine aortic valves for a 






6.2. Role of dynamic environment on leaflet biology 
6.2.1. Extracellular matrix components 
The results from the biological study of the valve leaflets show that the collagen, sGAG 
and elastin content of the cultured valve leaflets were not significantly different from that 
of the fresh control leaflets, while the sGAG and elastin content in the static leaflets were 
significantly lower when compared to both the fresh and cultured valve leaflets. These 
results highlight the importance of mechanical forces in maintaining the ECM. Cultured 
valve leaflets were subjected to a mean flow rate of 3.8-4.5 L/min, and systolic/diastolic 
pressure of 120/80 mmHg at a frequency of 1.167 Hz representing the normal 
mechanical/physiological conditions of the aortic valve. Since the cultured valve leaflets 
were exposed to the same physiological forces as the in vivo hemodynamic environment 
there was no change in the leaflet biology compared to fresh leaflets. However, the 
disturbances in fluid flow upstream of the aortic valve might have induced some changes 
in the biology of the three leaflets of the same valve as seen by the elastin contents of the 
right and non coronary leaflets as shown in Figure 5.12. However, these changes in ECM 
components within the leaflets of the cultured valve were not significant at a p-value of 
0.05. The orientation of the three leaflets of the valve in the aortic valve holder was 
randomized during the study. Hence the effects of disturbed fluid flow were randomized 
over the three leaflets.  Further, the ligation of left and right coronary arteries might have 
induced slight deviation in fluid flow on the aortic side of the left and right coronary 
leaflets leading to an altered shear stress distribution on the leaflets. This however, did 
not affect the cultured leaflets’ biological properties as seen in Figures 5.10, 5.11 and 
5.12.  
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Collagen, a structural protein of the valve leaflet, is synthesized by the valvular 
cells in the leaflets as a response to the flexure and bending that occur during the cardiac 
cycle. During this process they are exposed to pressure and shear stresses, which have 
been shown to regulate collagen synthesis in the leaflets [Weston, 2001; Xing, 2004a; 
Xing, 2004b]. Although the mechanisms by which mechanical forces affect cells are not 
fully understood, the observed biosynthetic activity of the leaflets is thought to be due to 
the synergetic action of the three components of the leaflets: ECs, ICs and ECM. As 
illustrated in Figure 6.1, the ECs are the prime receptors of the mechanical forces on the 
leaflets and they respond to the forces by releasing cytokines or growth factors that effect 
the metabolism of underlying ICs, which are responsible for matrix production. The ECM 
serves as a connection between the ECs and ICs via cell-cell and cell-ECM junctions and 
transmits the mechanical stresses to ICs. The ICs react by constantly producing ECM 
components in response to the mechanical forces experienced by the leaflets. This 
process may involve many biochemical factors. The observed similarity in ECM 
components between the fresh and cultured leaflets in the current study could be due to a 
balance between synthesis and degradation of the ECM components. The mechanism of 
this balance can be further elucidated by studying changes in gene expression as well as 
enzymatic activities in the valvular cells. Based on the results from this study and 
previous investigations conducted in our laboratory a pathway for changes in valvular 
biology under the influence of physiological mechanical forces can be proposed as shown 
in Figures 6.1 and 6.3. Mechanical forces such as shear stresses and pressure exert 
loading on leaflet tissue, which in turn are communicated to both ECs and ICs. In 
response, the ECs and ICs may undergo some cytoskeletal reorganization or open/close 
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their mechanosensitive ion-channels. Consequently, this may lead to a series of 
intracellular events such as stimulation/inhibition of lysosomal proteases in ICs (e.g. 
cathepsin S, L and D) as observed in studies carried out in our laboratory [Xing, 2004c]. 
The inhibition of lysosamal proteases leads to a slower degradation of collagen or other 
matrix proteins, eventually resulting in higher matrix synthesis and vice versa. Other 
mechanical forces, such as bending stresses and cyclic tensile stretch, on the valve 
leaflets are hypothesized to maintain the contractile phenotype of the leaflets. However, 
the mechanisms of cell signaling and phenotypical changes in myofibroblasts during 
leaflet contractility are poorly understood. ICs are a dynamic population of specific cell 
types, which communicate with each other, ECs, and ECM through the release of growth 
factors, integrin interaction, calcium signaling and intracellular tension as shown in 
Figure 6.1 [Taylor, 2003]. Further studies are required to understand these complex 
mechanisms of cell-cell and cell-matrix interaction that involve activation of ECM-
regulated kinases and integrin-mediated mechanotransdcution, including activation of 
various kinases (i.e. FAK, c-Src, and Fyn), adaptor molecules (i.e. CAS and Shc), 
guanine nucleotide exchange factors (GEFs) (i.e. C3G and son of sevenless [Sos]), and 
small GTPases (i.e. Rap1 and Ras) [Xing, 2004c]. Additionally investigating the 
mechanisms of gene regulation within the valvular cells will help in understanding the 
contribution of these cells to maintain the physiological function of valves and re-








Figure 6.1: This is a schematic that illustrates the transduction of mechanical forces. 
Mechanical forces acting on the valve leaflets are communicated to ECs and ICs via cell-
cell and cell-ECM junctions. The cells reorganize cytoskeleton or open/close 
mechanosensitive ion channels and consequently stimulate or inhibit lysosomal proteases 
































The valve leaflets in the organ culture system were exposed to physiological 
forces such as pressure, shear and bending stresses, flow, and cyclic flexure. These 
mechanical conditions maintained the collagen content in the cultured valve leaflets at 
comparable amounts to fresh leaflets as seen in Figure 5.10. The collagen content from 
individual leaflets of the cultured valves is not only comparable to each other but also is 
not significantly different from that of the fresh and static leaflets at p=0.05. However, 
large standard deviations in the collagen content were observed for all the leaflets in the 
three groups. This is because of the variation in collagen content between the valves from 
different animals. At a p-value of 0.1, there was a significant difference in collagen 
content between: (i) the non-coronary leaflets of the cultured and fresh valves, and (ii) the 
left coronary leaflets of static and fresh leaflets. The difference seen in the first case is 
due to the low collagen content seen in the fresh non-coronary leaflet of the first valve 
shown in Table 5.2. Since this value is very low compared to the rest of the values, the 
average value of collagen content in the leaflets is reduced causing a significant 
difference between the cultured and fresh leaflets. The non-coronary static leaflets also 
exhibit low collagen content causing the difference between the fresh and static non-
coronary leaflets to be non-significant (p>0.1). The same trend is seen with the left 
coronary static leaflets. Due to low values of collagen content in valves 3, 4 and 5, a 
significant decrease can be seen in the leaflets when compared to the fresh leaflets. The 
results from the remaining types of the leaflets suggest that the collagen content of the 
cultured, fresh and static leaflets are comparable to each other when analyzed at a p-value 
of 0.1. The results from this study are consistent with the results seen in previous 
physiological flow and shear stress studies on porcine aortic valve leaflets. The previous 
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study showed that collagen synthesis was maintained at native levels when the leaflets 
were subjected to fluid flow and shear stress but increased under static incubation 
[Weston, 2001]. In another study, exposing the aortic valve leaflets to cyclic and static 
pressures at a mean value of 100 mmHg resulted in collagen synthesis comparable to that 
of static leaflets with collagen synthesis increasing at higher pressure in a magnitude 
dependent manner [Xing, 2004a; Xing, 2004b]. The current study has also shown that 
collagen data is comparable between the static and cultured valve leaflets (p>0.05), which 
is the same result as the pressure study. Another in vitro study on the effect of mechanical 
stretch on cardiac fibroblasts showed an increase in the ratio of collagen type III to 
collagen type I in mechanically stretched cells. Type III collagen mRNA levels increased 
in response to cyclic mechanical stretch for durations as short as 12 hours, while type I 
collagen mRNA levels were not found to change under the stretch conditions used in the 
study [Carver, 1991]. These results emphasize the potential regulatory role of mechanical 
stimulation in the expression of specific genes in cardiac cells. An in vivo study, 
complimentary to the above mentioned in vitro study, was performed to investigate the 
effect of hypertensive pressures on structural alterations of the aortic valve in rats. At 
aortic pressures of 160-180 mmHg there was an increase in the tensile strains within the 
valve leaflet. Hypertensive rats were found to posses greater mRNA for collagen types I 
and III, suggesting increased collagen turnover [Willems, 1994]. These results suggest 
that type I and type III collagen synthesis are both affected by pressure overload. 
sGAG is predominantly present in the spongiosa and is constantly synthesized 
under the influence of normal hemodynamic forces. They function as a lubricant to 
reduce the internal shear between the ventricularis and the fibrosa during leaflet bending 
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and cyclic flexure. Mechanical forces in the organ culture system facilitate physiological 
movement of the leaflets, thus maintaining GAG synthesis at native levels. Table 5.5 
shows that the sGAG content in the cultured and fresh valve leaflets were comparable 
within statistical significance at p-values of both 0.05 and 0.1. sGAG content in the right-
coronary static leaflets was significantly decreased when compared to both the cultured 
and fresh leaflets (p<0.05), while sGAG in the non-coronary static leaflets was 
significantly decreased when compared to the cultured valves leaflets (p<0.05). The 
reduction in sGAG content in the right and non-coronary static leaflets led to an overall 
decrease in sGAG content of the static leaflets in comparison to both the fresh and 
cultured valve leaflets. This is because the sGAG content in the right coronary leaflets of 
static valves 1, 3, 4 and 9 (Table 5.4) is very low when compared to the rest of the valves, 
consequently decreasing the average value and increasing the standard deviation in 
comparison to the left and non-coronary static leaflets. The sGAG content of the cultured 
non-coronary leaflets has a higher average value than that of the fresh leaflet, although 
the difference is not significant (p>0.05). This increase in sGAG results in a significant 
difference between the cultured and static non-coronary leaflets (p<0.05). However, the 
difference in sGAG content between the fresh and static non-coronary leaflets was not 
statistically significant (p>0.05). At p-value=0.1, there is a significant difference between 
the left coronary static and fresh leaflets, which is again due to the large variations in the 
individual valves. The significant decrease in sGAG content seen in the statically 
incubated leaflets is due to the absence of a dynamic environment. This explanation is 
valid based on the results seen in the study by Weston et al wherein aortic valve leaflets 
subjected to fluid flow and shear stress maintained sGAG synthesis at native levels, but 
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significantly increased the synthesis when statically incubated [Weston, 2001]. The result 
with the static leaflets seen in the current study is contrary to that seen in Weston’s study; 
however, both results draw the same conclusion that the absence of mechanical forces 
alters GAG synthesis in aortic valve leaflets. In vivo studies have been conducted using 
an autoradiography technique to identify sites of protein, GAG, and DNA synthesis in rat 
aortic valve leaflets [Schneider, 1981]. The attachment zone of the leaflet had the highest 
GAG synthesis, while the region between the attachment and the midpoint showed the 
greatest protein synthesis. They attributed the patterns of protein and GAG synthesis to 
difference in the functional stresses of the valve, suggesting that the structural 
components of the valve are constantly renewed in vivo in response to mechanical 
loading. These studies suggest that increased tensile forces increase collagen synthesis 
and GAG synthesis. Their study, however, did not show any variation in GAG synthesis 
between the three leaflets in response to mechanical forces. Hence, the reduction of 
sGAG content in the right and non-coronary static leaflets and not in left-coronary 
leaflets in comparison with fresh and cultured leaflets seen in the current study are due to 
variations in sGAG content of individual valves. 
Elastin fibers maintain the structural integrity of the leaflets by stretching and 
recoiling during cyclic flexure. Similar to collagen and sGAG content, elastin content in 
the valve leaflets is also affected by mechanical forces. As shown in Figure 5.12, the 
leaflets cultured under normal physiological conditions in the organ culture system 
maintained their elastin content at levels comparable to fresh leaflets (p>0.1). However, 
the right coronary static leaflets showed a significant decrease in elastin content 
compared to both the cultured and fresh valve leaflets (p<0.05). This decrease in elastin 
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content resulted in an overall decrease in elastin content for the static leaflets compared to 
both the cultured and fresh valve leaflets (p<0.05). The reduced elastin content in the 
static leaflets is due to the absence of a dynamic environment during leaflet culture. The 
difference in responses seen between the three static leaflets is due to the large variability 
within the individual leaflets seen in the elastin data given in Table 5.6. At a p-value of 
0.1, a significant difference was seen between the left coronary static and fresh leaflets in 
addition to the right coronary static leaflets. This observation was similar to that seen 
with the sGAG content in Table 5.5. Thus, lack of mechanical stimulus alters the 
structural composition of the aortic valve leaflets. 
Heart valves leaflets have a complex tri-layered architecture composed of highly 
specialized, functionally adapted cells and ECM. The ECM elements (collagen, GAG and 
elastin) provide the mechanical characteristics vital for sustaining the dynamic behavior 
of the valve leaflets to accommodate cyclic changes in leaflet shape and dimensions 
throughout the cardiac cycle. ICs synthesize the ECM thereby mediating the ongoing 
repair and remodeling of the valve leaflets to provide durability. Aortic valves ICs, which 
are a mixed population of fibroblasts, myofibroblasts and smooth muscle cells, are 
interspersed throughout the ECM, while ECs are present only on the outer surfaces of the 
leaflets providing a non-thrombogenic surface. The ICs communicate with each other and 
the ECM through the release of growth factors, integrin interaction, calcium signaling 
and intracellular tension [Taylor, 2003]. Under normal conditions valvular cells are 
quiescent, and the ECM is well adapted to the surrounding hemodynamic environment. 
When stimulated by mechanical loading, the ICs are activated and mediate connective 
tissue remodeling to restore the normal stress profile in the tissue. In this process the IC 
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phenotype also changes in response to different mechanical forces. When equilibrium is 
restored in the mechanical environment, the cells return to the quiescent state [Aikawa, 
2004]. During valvular pathologies IC dysfunction sometimes results in thickening of 
leaflets and a highly abnormal layered architecture, as seen in myxomatous leaflets. 
Under these conditions ICs exhibit activated myofibroblasts’ features, express elevated 
levels of proteolytic enzymes, retain the ability to express interstitial collagen, and 
significantly increase in number in the spongiosa [Rabkin, 2001]. These findings suggest 
that matrix metabolism dysfunction modulates the abnormalities in collagen and other 
ECM components under pathological conditions.  
 The results obtained in the current study suggest that the normal physiological 
mechanical forces provided by the organ culture system are required to maintain the 
valvular cells’ biosynthetic properties at native levels thereby increasing the durability of 
the leaflet tissue.  
 
6.2.2. Hematoxylin and Eosin stain 
Hematoxylin and Eosin (H & E) staining was used to observe any morphological changes 
in the valve leaflets. H & E staining of the tissue sections in Fig 5.15 shows that the 
three-layered aortic leaflet architecture was preserved in the cultured valve leaflets and 
was comparable to fresh leaflets. Elastic fibers can be observed along the ventricularis 
region, and the collagen crimp was observed in the fibrosa. The spongiosa layer can be 
seen as a loose tissue structure, distinctly separating the ventricularis and fibrosa. There 
was also no observable change in the thickness of the three layers compared to the fresh 
control leaflets. In a previous study, aortic valve leaflets when subjected to constant static 
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hypertensive and sever hypertensive pressures showed a decrease in thickness and cell 
number of the spongiosa layer compared to static control leaflets [Xing, 2004a]. The 
decrease in thickness was attributed to greater compression of the spongiosa (since it 
consists of 70% water) compared to the fibrosa or ventricularis. Cell numbers in the 
current study could not be compared between the valves of the three groups as they were 
from different animals with unique cellular distributions. The static control samples in the 
current study also had similar tissue architecture as compared to fresh and cultured valve 
leaflets. This observation was consistent with that seen in the previous studies.  
 Preserved leaflet morphology indicates structural integrity of the leaflets. Since 
there was no remodeling observed in the leaflets, it can be concluded that the system 
preserved the morphology of the leaflets. 
 
6.2.3. Cell proliferation 
Valve leaflets cultured in the ex vivo system were stained for proliferating cells to test 
whether the system provided a conducive environment for cell growth. Anti-BrdU stains 
of the leaflets, as seen in Figure 5.16, show proliferating cells distributed in all three 
layers of the cultured and static leaflets. This suggests that the system, apart from 
maintaining the viability of the cells, also provided the biochemical environment for cell 
proliferation. Cell proliferation in the aortic valve leaflets has not been demonstrated in 
the past. The result from the current study could not be compared to fresh leaflets since 
the leaflets were immediately fixed in formalin upon harvest. The cell proliferation 
protocol requires incubation of the leaflets in medium containing BrdU for at least 24 
hours so that BrdU can be incorporated into proliferating cells. However, as this study 
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showed altered biological properties of the leaflet under static incubation, fresh leaflets 
were not incubated in the medium. Other methods previously studied in our laboratory to 
assess cell proliferation used a radio labeling technique. This method also requires 
incubation of the leaflets with the radiolabeled precursor. Hence, cell proliferation in 
fresh leaflets was not studied. Schneider and Deck have studied tissue and cell renewal, 
utilizing an autoradiography technique to identify DNA synthesis in rat aortic valve 
leaflets. They observed that DNA synthesis was more pronounced in growing rats than in 
mature rats. The pigs used in the study were mature pigs 2-3.5 years of age; hence only 
few cells were found proliferating. However, without any previous knowledge of valvular 
cell proliferation rate, a conclusion cannot be drawn on the total population size of 
proliferating cells in the current study. Additionally, it has been seen that ICs are 
quiescent when there are no changes in the surrounding mechanical environment of the 
cells [Aikawa, 2004].  ICs exhibit varied biological responses in accordance with changes 
in the surrounding mechanical environment and return to their quiescent state once they 
attain equilibrium in the new state. When cultured in the organ culture system valve 
leaflets experience a change from the previous in vivo environment to the new ex vivo 
environment. Thus, in this new mechanical environment, the cells might require longer 
than 48 hours to return to a quiescent state, which may explain the proliferation rates 
observed in this study. 
 Since the fresh leaflets in the current study did not contain BrdU in their 
proliferating cells, the leaflets were used as negative control to determine any background 
effects present in the cultured and static leaflets due to the staining. Quantitative analysis 
of the percent of proliferating cells showed that there was no significant difference 
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between the cultured and static leaflets suggesting that mechanical forces do not have any 
effect on the cell proliferation after 48 hours of ex vivo culture. 
 
6.2.4. Cell apoptosis 
Apoptosis in the valve leaflets was measured to test the ability of the system to maintain 
the viability of the valves without causing damage to the leaflet cells as a result of 
mechanical or biochemical conditions in the system. Figure 5.18 shows the presence of 
apoptotic cells distributed throughout the three layers of leaflets in the three study groups. 
Quantitative analysis of the percent population of apoptotic cells showed comparable 
levels of apoptosis between the fresh and cultured valve leaflets while static control 
leaflets showed a significant increase in apoptotic cells compared to the cultured  
(p<0.05) and fresh leaflets (p<0.1, p=0.057).  
 The absence of an increase in cell apoptosis in leaflets cultured in the organ 
culture system compared to the fresh leaflets suggests that there were no adverse changes 
in pH or nutrient transport, especially oxygen that would lead to cell death in the leaflet 
tissue. If there was insufficient oxygen in the system, ICs located in the interior of the 
leaflets would be less likely to survive as they are located farthest away from the oxygen 
and nutrient rich medium. Also, preliminary studies of valves cultured in the organ 
culture system without a gas exchanger showed increased cell death in all three layers of 
the leaflets compared to fresh control leaflets (data shown in Appendix D). In addition, 
cells from the interior of the leaflets appeared to be migrating towards either of the leaflet 
surfaces. Long term cell viability has always been an important design criterion for in 
vitro bioreactors. Hence, analysis of cell apoptosis is critical in the biological validation 
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of ex vivo organ culture systems. The small percentage of apoptosis seen in the cultured 
(1.64% ± 1.04%) and fresh valve leaflets (1.96% ± 0.41%) might have been induced 
during tissue harvest or handling while trimming and suturing the valve to the support 
ring. This is based on the argument that apoptosis in fresh valve leaflets can occur only 
during tissue harvesting and handling since the tissue was fixed within 3 hours after 
harvest. Comparable cell apoptosis between the fresh and cultured leaflets suggests that 
the apoptosis induced by the ex vivo organ culture system was negligible since tissue 
harvest and handling was performed using the same protocol for all the valves. 
 The increase in apoptotic cells observed in the static control leaflets is most likely 
due to the smaller volume of medium (10ml) used in the tissue culture plates, which 
possibly resulted in nutrient and/or oxygen limiting conditions. Also, altered metabolic 
activity in the valvular cells due to the absence of mechanical forces might have 
contributed to an increase in apoptosis compared to native tissue. Thus the amount of 
media and oxygen provided by the gas exchanger in the culture system was adequate and 
necessary for cell viability for a duration of 48 hours. 
 
6.2.5. Cell phenotype 
According to the current study’s hypothesis, the cells in the cultured valve leaflets should 
not only maintain viability but also retain their native phenotype when subjected to 
physiological mechanical forces. An α- SMC actin immunofluoroscence stain of leaflet 
sections shown in Figure 5.20 suggests that the IC phenotype of the cultured valve 
leaflets was maintained at native levels in the organ culture system. Microscopic 
observation showed comparable actin expression in the ventricularis region of both fresh 
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and cultured leaflets. ICs exhibit different phenotypes depending on the surrounding 
microenvironment, and α- SMC actin is related to the contractile phenotype of SMC and 
myofibroblasts. α- SMC actin, which has an ability to polymerize under contraction, has 
two components; a monomeric form of globular protein called G-actin and a polymeric 
form of fibrous protein called F-actin. Since the leaflets in vivo have the ability to 
contract and relax, a dynamic equilibrium exists between polymerization of G-actin and 
depolymerization of F-actin to maintain the phenotype of the cells. The leaflets in the 
organ culture system, seen by visual observation, are subjected to similar movement as 
that experienced in vivo. Hence, the ICs in the cultured valve leaflets express actin in 
amounts comparable to those in fresh leaflets. Static leaflets, on the other hand, have no 
contractility once harvested from the body. Thus the equilibrium favors the 
depolymerization process, resulting in decreased F-actin. Also, polymerization of G-actin 
is absent in the cells leading to a low actin expression in the static leaflets as shown in the 
Figure 5.20. This observation was consistent with previous shear and pressure studies on 
valve leaflets [Weston, 2001; Xing, 2004a]. These studies showed that the effect of 
steady shear stress or pressure alone could not maintain the phenotype of the valvular 
cells at native levels, and the actin expression in these leaflets was comparable to 
statically incubated leaflets used in the studies. In another study cardiac fibroblasts were 
studied for α- SMC actin expression under the influence of mechanical stretch. The 
results showed that mechanical stretch down regulated α- SMC actin mRNA and protein 
content [Wang, 2001] in the fibroblasts. This suggests that mechanical forces others than 
pressure, shear stress or stretch must be affecting the cell phenotype of the leaflets. 
Studying the effects of isolated bending stresses or cyclic flexure on the leaflets may 
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provide information on the contractile phenotype of ICs. It has also been observed that 
SMC actin expression was altered by changes in culture conditions and mechanical and 
biochemical stimulation in cultured vascular cells [Stegemann, 2003a; Stegemann, 
2003b]. Similar behavior was observed in a study with valvular ICs in 3D static collagen 
gel culture, which showed a reduction in α- SMC actin expression [Butcher, 2004a]. This 
suggests that matrix interaction plays a significant role in modulating cell phenotype. The 
results observed from 3D static culture of ICs were similar to those seen in the current 
study. Both studies noted a decrease in α-SMC actin compared to native levels, which 
suggests that mechanical forces are required to maintain the cell phenotype. Thus, 
another unique feature of the ex vivo organ culture system is that it provided the required 
mechanical environment to maintain the cell phenotype of the leaflets while preserving 
cell viability.  
 
6.2.6. Endothelial cells 
ECs on valvular surfaces provide a non-thrombogenic surface, transport nutrients, and 
facilitate transduction of mechanical and biochemical signals via the leaflet ECM.  
Presence of ECs on the leaflet surface was analyzed by immunohistochemical staining for 
vWF expressed by the cells. Figure 5.21 shows a weak stain for vWF on the valve leaflets 
in the three groups, which may be because of the choice of antibody used in the stain. 
Hence, scanning electron microscopy (SEM) was used to observe the surface of the 
leaflet tissue for the presence of ECs. SEM results presented in Figure 5.22, show ECs on 
all the three leaflet groups. ECs on the leaflet surfaces had a flattened morphology with a 
monolayer distribution of cells on the ventricularis surface The cells were 
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circumferentially aligned perpendicular to the flow direction, as observed in studies 
conducted by Deck [Deck, 1986]. All the SEM pictures taken were of the ventricularis 
surface of the valve leaflet because the fluid flow is in the radial direction on ventricularis 
surface thus providing a better representation of cell alignment with flow.  
 ECs on cultured valve leaflets appeared to be comparable to those on fresh control 
leaflets while those on static control leaflets lacked the flattened morphology of fresh 
leaflet ECs. This appearance of the cells might have been induced when the leaflets were 
placed in the culture plate for sectioning. Retention of ECs on the surface of the leaflets is 
important to provide appropriate cellular responses when culturing the tissue in the organ 
culture system. Absence or dysfunction of ECs adversely affects the biosynthetic, 
morphologic and metabolic functions of the valvular cells implicated in valvular diseases. 
Previous studies done in our laboratory have shown that denudation of the endothelium 
on valvular leaflets alters their biosynthetic response to shear stress. The denuded leaflets 
have shown an increase in sGAG synthesis with a concomitant decrease in collagen 
synthesis compared to leaflets with intact ECs. When subjected to steady laminar shear 
stress at 20 dyne/cm2, valvular ECs showed different organization of focal adhesion 
complexes and cell alignment than those in static culture. This suggests that mechanical 
forces have a unique influence on the phenotype of valvular ECs [Butcher, 2004b]. Also, 
it was observed that the valvular ECs were aligned perpendicular to the flow unlike 
vascular cells, which align parallel to the flow. This alignment corresponds to the 
circumferential alignment of the ECs in valve leaflets, since the fluid flow is in radial 
direction. The EC alignment on valve leaflets cultured in the organ culture system in the 
current study is in agreement with the result seen above with valvular EC culture. 
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Additionally, no altered biological responses compared to fresh leaflets were observed in 
cultured valve leaflets in the current study. Hence, it can be concluded that normal 
function of ECs was maintained in the organ culture system. However, there might have 
been a change in EC function in static leaflets in the current study that may have lead to 
the differences in sGAG, elastin, α-SMC actin, cell apoptosis compared to cultured and 
fresh leaflets. Hence, it can be inferred from this study that the sterile ex vivo organ 
culture system preserved the native morphology of the leaflets by maintaining the 
valvular cells in their normal microstructural environment.  
The valve leaflets are dense, heterogeneous, layered structures with cells within 
each layer having different viabilities and phenotypes. If these cells are cultured in a 
monolayer, they are unlikely to behave in a similar fashion as when cultured along with 
their native 3D ECM. In vivo studies, on the other hand, provide the advantage of 
studying various biological mechanisms in native mechanical and biomechanical 
environments. However, they are limited due to the expenses incurred in conducting the 
experiments. Also, the mechanical conditions involved in the study cannot be closely 
controlled or regulated. Organ culture studies incorporate advantages of both in vitro and 
in vivo studies and provide well-controlled biomimetic micro-environments resembling 
the native state. These systems are economical and provide independent control of 
mechanical forces facilitating the simulation of clinically relevant mechanical conditions 
to study valvular diseases pathogenesis and development to provide a comprehensive 




6.3. Model of cellular responses to forces 
The results from this study suggest that normal physiological forces are required by the 
aortic valve leaflets to maintain the native biosynthetic activity of the leaflets and 
preserve the normal interstitial cell phenotype without remodeling of the leaflet tissue.  A 
schematic of the action of mechanical forces on the valve leaflet is shown in Figure 6.1, 
and a mechanism of interaction of valvular cells with the ECM in response to the 
mechanical forces is illustrated in Figure 6.2. Valve leaflets subjected to shear and 
bending stresses, pressure, fluid flow and cyclic flexure during each cardiac cycle 
transmit the forces to the cells within the ECM of the leaflet via cyclic tensile 
deformation of the matrix.  Valvular cells are linked to the collagen fibers of the leaflet 
matrix, and when mechanical forces on the leaflet surface cause deformation of the leaflet 
matrix, the cells experience the tensile forces created by the deformation. Mechanical 
forces on the aortic and ventricular surfaces of the leaflet stretch the surfaces relative to 
each other creating a certain degree of tension within the fiber network of the tissue. 
These tensile forces may then be communicated to individual cells and, subsequently, to 
the cell nuclei. Thus, mechanical stimulation may affect the biosynthetic activity, cell 
proliferation and death, cell phenotype, tissue remodeling, cellular secretions and 
immune responses of tissues.  
Since the cultured valve leaflets in the organ culture system experience similar 
mechanical conditions to in vivo valve leaflets, they also express similar biological 
responses to those of fresh control leaflets. Altered biological responses in the static 









Figure 6.2: This schematic shows forces acting on the valve leaflet. Black arrows indicate 
fluid flow direction. Shear stresses act on both ventricularis and fibrosa surfaces 
(indicated by a curved arrow). Bending stresses on the leaflet are shown in blue. Pressure 
forces act on both the ventricularis and fibrosa surfaces during the diastolic and systolic 
phases of the cardiac cycle. Tensile strain on the leaflet is shown in red. 
 










Figure 6.3: This schematic illustrates a cell within the tissue structure, which is 
mechanically linked to the connective tissue by fibers. The figure is a small section of the 
whole leaflet, which has many cells scattered throughout the matrix. When the leaflets 
are stretched, the cells mechanically linked to matrix by fibers, experience the tensile 
forces induced by the stretching. The cells respond to these forces by producing ECM 
components, cell proliferation and death, changes in cell phenotype, tissue remodeling, 

















6.4. Limitations of the study 
The limitation of the current study can be divided into two areas: (1) Organ culture 
system; and (2) Cell proliferation and apoptosis. 
 The first limitation of the study was the complication in design of the organ 
culture system preventing periodic withdrawal of samples to check the pH, oxygen and 
glucose content in the medium. This limited a regulated control of pH and CO2/O2 level 
in the system. However, the pH readings of the medium at the end of the experiments 
showed the values were within the physiological range, and the histological results 
indicated that there were no adverse changes in the biochemical conditions of the system. 
But periodic check of the values will provide detailed information of the biochemical 
environment of the system. Another limitation was the size of the aortic valve holder. The 
holder was designed for 25 mm root diameter valves, which prevented valves having an 
aortic root diameter greater than 25 mm from being placed in the valve holder. The 
ligated coronary arteries of the aortic valve with bigger aortic root diameters created folds 
in the aorta when placed in the valve holder. These folds obstructed the aortic orifice area 
and thus restricted proper leaflet movement. The reduction in orifice area and impaired 
movement of the valve leaflets caused an increase in pressure load on the leaflets leading 
to tears in the leaflets. Hence, the valves used for the study were carefully chosen before 
suturing.  
 Cell proliferation in the current study could not be compared to that of fresh 
leaflets as it was undesirable to incubate fresh leaflets under static conditions. Hence, the 
study was limited in this aspect since there was no method of studying cell proliferation 
in fresh native leaflets. Apoptosis observed in the cultured leaflets is believed to be 
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induced during tissue harvest and suturing of the valve to the support ring for culture in 
the system. This assessment is based on comparison of the results with those of fresh 
leaflets. Fresh leaflets were fixed within 3 hours of harvest, and the percentage of 
apoptotic cells for the fresh and cultured leaflets was comparable. Thus, the apoptosis in 
the cultured leaflets most likely occurred during tissue harvest and was not system 
induced. The elevated level of apoptosis in the static leaflets is most likely due to nutrient 
limitation as opposed to a lack of mechanical stimulation, which is a drawback of the 
experimental protocol. Additionally, the activated caspase-3 IHC used for analyzing 
apoptotic cells might have underestimated the actual number of apoptotic cells, as 
caspase-3 belongs to a subclass of a wide range of caspases that are activated during 
apoptosis occurring via various pathways. This narrowed the study to apoptotic cells that 
follow the pathway leading to the activation of caspase-3. A live/dead stain would have 
provided more accurate results, but preliminary studies with such a stain overestimated 
the number of dead cells by staining cells positive for necrosis. Further studies to 
optimize the apoptosis stain should be done to obtain a closer approximation of apoptotic 
cells. Finally, the medium used for culture did not have the same viscosity as that of 
blood. It is known that changes in fluid viscosity alter the shear stresses acting on the 
valve leaflets. Experiments have not been conducted in the past or in the current study to 
investigate the effects of viscosity on changes in biological properties induced by shear 





6.5. Significance of the study 
The ex vivo organ culture system developed in this study is novel with respect to the 
following features; (1) controllable flow and pressure conditions; (2) sterility for 96 
hours; (3) provided adequate oxygen transport to the valve; (4) cell viability for 48 hours; 
and (5) preserved morphology and cell phenotype. Results from the study showed that 
under normal physiological conditions the cells maintain their native biosynthetic 
activity, morphology, and contractile phenotype compared to cells cultured under static 
atmospheric conditions. This suggests that physiological mechanical forces are required 
to maintain the structural integrity of the leaflet tissue and regulate cell signaling within 
the matrix for proper functioning of the leaflets. Further, the organ culture system can be 
used to simulate clinically relevant mechanical conditions to study the effects of altered 
mechanical forces or EC dysfunction on valve leaflets that are implicated in various 
aortic valve leaflet pathologies. Recent studies have shown that aortic cusp tissue has 
regional and directional contractile responses to different vasoactive agents [Kershaw, 
2004]. Similar studies done in a circulation system mimicking the physiological 
conditions such as this organ culture system could provide a better understanding of the 
contractile effects to help predict in vivo valvular mechanisms. Such studies can then be 
extended to study the effect of pharmacological stimuli on the biology of native valve 
leaflets. Since native phenotypic characteristics of the leaflets can be maintained in the 
system for a minimum of 48 hours, and the system has been shown to sustain long term 
culture periods, the system can be used to improve the mechanical characteristics of 
tissue engineered valve constructs. This can be achieved either by dynamic seeding of 
acellular scaffolds in the system or mechanical conditioning of engineered constructs. 
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Also, the system can be used to test the structural integrity of different scaffolds or 





The work done for this thesis successfully developed a novel ex vivo organ culture system 
that is capable of simulating normal physiological mechanical forces for a duration of 96 
hours while maintaining consistency in the flow and pressure waveforms. The system 
was able to attain a cardiac output of 3.8-4.2 L/min with a peak flow rate of 24 L/min and 
systolic/diastolic pressures of 120/80 mmHg, 160/120 mmHg and 190/150 mmHg at a 
frequency of 1.167 Hz as well as a cardiac output of 7.5 L/min at a mean aortic pressure 
of 100 mmHg and heart rate of 2 Hz. Additionally, flow rate, pressure and heart rate can 
be controlled independent of each other to reproduce different clinically relevant 
mechanical conditions. Oxygen exchange in the system was also able to meet the 
required oxygen consumption by aortic valve leaflets while maintaining sterility to 
maintain the viability of the valvular cells. The pH at the end of experiments was found 
to be in the range of 7.3-7.5, which is in physiological range for the valve leaflets. The 
system did not induce any adverse mechanical and environmental effects on the native 
valve leaflets and provided sufficient nutrient transport to the valves under normal 
mechanical loading. This is the first work to address oxygenation of medium in a closed 
system to ensure sufficient transport of nutrients to the aortic valve for extended periods 
of operation. The system has also been shown to retain native morphology, ECM 
structural integrity, and cell phenotype of the leaflets for a period of 48 hours.  
  The results of the biological study prove that a dynamic mechanical 
environment is required to maintain the native biological characteristics of porcine aortic 
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heart valves when cultured under ex vivo conditions.  In the absence of the appropriate 
mechanical signals, cells undergo a phenotypical change and loose their contractility. In 
addition, the ECM content undergoes significant changes, possibly due to a reduction in 
cellular biosynthetic activity. The current system preserved the morphology and leaflet 
architecture without any remodeling in the tissue. The cells were viable and retained their 
native phenotype in the leaflets. Finally, this study highlights the utility of dynamic ex 
vivo organ culture studies since cells are retained in their natural 3-D environment, and 







The ex vivo organ culture system offers the ability to independently control flow rate, 
pressure, and heart rate in the system. This can potentially be used to operate the system 
at elevated mechanical conditions to simulate hypertensive, severe hypertensive, and 
elevated heart rate conditions ex vivo. Hypertensive and severe hypertensive blood 
pressures are related to heart failure, stroke, coronary and peripheral vascular diseases, 
valve calcification as well as other cardiovascular pathologies. Characterizing the 
biological properties of native aortic valves at such elevated conditions can provide 
insight into the biological changes of the leaflets following exposure to extreme 
conditions that may lead to valve failure. Experiments that subjected aortic valve leaflets 
to constant and mean pulsatile pressures of 140 and 170 mmHg showed increase in the 
protein and sGAG syntheses of the leaflets in response to increase in pressure [Xing, 
2004a; Xing, 2004b]. This suggests that leaflets remodel in response to mechanical 
loading. An in-depth understanding of the biological changes in the leaflets can be 
attained by studying the valve leaflet biology in the pulsatile organ culture system at 
clinically relevant mechanical conditions. Further, carrying out the study at a genetic 
level in addition to a molecular level would enable an understanding of cross talk within 
the leaflets in response to physiological and pathophysiological forces. In addition 
knowledge on mechanotransduction within the cells, and changes in responses of the 
genes and protein expression, which are responsible for triggering the synthetic activity, 
protein degradation, and remodeling in the leaflets can be attained. Thus, these 
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experiments, apart from increasing the basic understanding of heart valve function, can 
be used to study the effects of hemodynamics on cell-cell interactions, cell-ECM 
interaction, ECM deformation affecting cell growth and gene expression. 
 Another area of study is to understand the effect of endothelial dysfunction on 
valvular pathogenesis. Endothelial dysfunction caused by mechanical forces, bacterial 
infection, autoantibodies, and circulating modulators of ECs has adverse effects on the 
biosynthetic, morphologic and metabolic functions of the valvular cells. Valvular 
diseases such as senile degenerative valve diseases, myxomatous (or floppy) valves, 
rheumatic and infective endocarditis valves are actively related to endothelial 
dysfunction. Disruption of ECs by mechanical stresses or other factors causes injury to 
the leaflets allowing inflammatory cells to enter and thus develop valvular diseases. 
Conditions of endothelial injury can be simulated ex vivo by denuding the leaflets and 
subjecting them to mechanical stresses. Preliminary studies in our laboratory have shown 
altered responses of denuded leaflets to shear stresses causing an increase in sGAG 
synthesis and decrease in collagen synthesis compared to leaflets with intact endothelium. 
Hence, studies done by denuding one, two or three of the leaflets of the aortic valve in a 
randomized manner would provide an understanding on changes in valvular responses to 
mechanical forces and physiological repair processes of the valve. 
 A third area of study is to investigate the mechanical forces responsible for 
maintaining the cell phenotype of the aortic valve ICs. It has been seen that the cell 
phenotype can be maintained at the native level in the leaflets cultured under 
physiological forces in the organ culture system. While valve leaflets subjected to 
isolated effects of shear stress, fluid flow, and constant and cyclic pressure decreased 
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their native content of α-SMC actin. Hence further experiments should be done to study 
the effects of bending stresses or cyclic flexure on cell phenotype of the valve leaflets. 
Previous studies on the effect of mechanical stretch on cardiac fibroblasts showed that α-
SMC actin mRNA decreased in the in vitro cell culture compared to native amounts -
[Wang, 2001]. However, cyclic tensile stretch of the leaflets is important in maintaining 
proper coaptation of the valve and is also known to regulate collagen synthesis in the 
valve leaflets [Carver, 1991]. Hence, the effect of cyclic tensile stretch at different 
frequencies should be studied to characterize the biological responses of the leaflet. 
 A recent study on the effects of vasoactive agents on contractility of aortic valves 
[Kershaw, 2004] suggests regional variation in leaflet contraction. Similar studies could 
be done in the organ culture system to investigate the effects of pharmacological stimuli 
on valve leaflets under physiological conditions. Further, the system could be used to test 
the structural integrity of acellular constructs under mechanical loading. The results from 
all these studies could be used as a standard of comparison while testing the performance 






A.1. Machine drawings of the aortic valve holder 
This section includes machine drawings of aortic valve holder components. The inlet, 
center and outlet component drawings of the holder are shown respectively. All the 
dimensions in the drawings are given in inches. 
 
 
Figure A.1. Drawing shows inlet component of the aortic valve holder. All the 











Figure A.2. Drawing shows center component of the aortic valve holder. All dimensions 












Figure A.3. Drawing shows outlet component of the aortic valve holder. All dimensions 







A.2. Machine drawings of the membrane chamber 
The drawings of the water side and membrane side of the membrane chamber, 
respectively, are show in this section. All the dimensions are in inches. 
 
 
Figure A.4. Drawing of membrane chamber component on the water side of the organ 











Figure A.5. Drawing of the membrane chamber component on the medium side of the 






A.3. Machine drawing of the pump head 











The sections B.1, B.2, B.3 below outline the protocols used for estimating collagen, 
sGAG and elastin contents respectively in the valve leaflets. 
 
B.1. Estimation of Collagen content 
1) Determine dry weight of the tissue sample and digest the tissue with pepsin 
dissolved in 0.5M acetic acid (buffer) for 48 hours at 37oC or 24 hours at 60oC. 
The ratio of dry tissue weight : enzyme weight is 1:3. 
2) Prepare reagent blank (0.5 M acetic acid), collagen standards (aliquots containing 
5, 10, 25, 50µg) and test samples (100µl) and bring the solutions to 100µl using 
buffer in a 1.5ml micro centrifuge tubes. 
3) To each tube add 1 ml of Sircol Dye reagent and cap all the tubes to mix the 
contents on a vortex mixer for 30 minutes at room temperature. 
4) Transfer the tubes to micro centrifuge and spin the tubes at >10000 × g for a 10 
minute period. 
5) The unbound dye solution is removed by carefully inverting and draining the 
tubes. Any remaining droplets are removed from the tubes by gently tapping the 
inverted tube on a paper tissue, or a cotton wool bud is used for removing the 
droplets from the rim of the tubes. 
6) To each tube add 1ml of alkali reagent and then mix the contents on a vortex 
mixture until the bound dye is dissolved. 
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7) Transfer 200µl aliquots of samples from tubes to the wells of a 96 well, multiwell 
plate and absorbance readings are taken using spectrophotometer set at a 
wavelength of 540nm. 
8) Subtract the reagent blank reading from the standard and test sample readings. 
9) Plot standards on graph and use the graph to calculate content of the test sample. 
 
B.2. Estimation of sGAG content 
1) Determine dry weight of the tissue sample and digest the tissue with protease 
dissolved in 0.1M tris- acetate with 10mM calcium acetate (buffer) for 48 hours at 
37oC or 24 hours at 60oC. The ratio of dry tissue weight : enzyme weight is 1:30. 
2) Prepare reagent blank (buffer), sGAG standards (aliquots containing 1, 2, 3, 4, 
5µg) and test samples (100µl) and bring the solutions to 100µl using buffer in a 
1.5ml micro centrifuge tubes. 
3) To each tube add 1ml of Blyscan dye reagent and cap all the tubes to mix the 
contents on a vortex mixer for 30 minutes at room temperature. 
4) Transfer the tubes to micro centrifuge and spin the tubes at >10000 × g for a 10 
minute period. 
5) The unbound dye solution is removed by carefully inverting and draining the 
tubes. Any remaining droplets are removed from the tubes by gently tapping the 
inverted tube on a paper tissue, or a cotton wool bud is used for removing the 
droplets from the rim of the tubes. 
6) To each tube add 1ml of dissociation reagent and then mix the contents on a 
vortex mixture until the bound dye is dissolved. 
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7) Transfer 200µl aliquots of samples from tubes to the wells of a 96 well, multiwell 
plate and absorbance readings are taken using spectrophotometer set at a 
wavelength of 656nm. 
8) Subtract the reagent blank reading from the standard and test sample readings. 
9) Plot standards on graph and use the graph to calculate content of the test sample. 
 
B.3. Estimation of Elastin content 
1) Determine dry weight of the tissue sample and digest the tissue with protinase K 
dissolved in 50mM tris-HCl, 0.1M EDTA and 0.2M NaCl (buffer) for 48 hours at 
37oC or 24 hours at 60oC. To each sample add 0.5mg/mL of enzyme and 
0.1mg/mL of SDS. 
2) Precool elastin precipitating reagent in fridge before use. 
3) Prepare reagent blank (buffer), elastin standards (aliquots containing 12.5, 25, 50, 
75µl) and test samples (100µl) and bring the solutions to 100µl using buffer in a 
1.5ml micro centrifuge tubes. 
4) Add 1ml of cold elastin precipitating reagent to each tube and incubate the tubes 
in ice-water overnight. 
5) After incubation, change the tubes from ice-water to ice and incubate for 30 
minutes to bring samples to 0oC. 
6) Centrifuge tubes and gently tap on paper towel to remove excess supernatant. 
7) Add 1ml of Fastin dye reagent and 200µl of 90% saturated ammonium sulfate and 
cap the tubes to vortex the solution until elastin is back in solution. 
8) Mix the contents at room temperature on a vortex mixer for 1 hour. 
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9) Transfer the tubes to micro centrifuge and spin the tubes at >10000 × g for a 10 
minute period. 
10) The unbound dye solution is removed by carefully inverting and draining the 
tubes. Any remaining droplets are removed from the tubes by gently tapping the 
inverted tube on a paper tissue, or a cotton wool bud is used for removing the 
droplets from the rim of the tubes. 
11) To each tube add 1ml of dissociation reagent and then mix the contents on a 
vortex mixture until the bound dye is dissolved. 
12) Transfer 200µl aliquots of samples from tubes to the wells of a 96 well, multiwell 
plate and absorbance readings are taken using spectrophotometer set at a 
wavelength of 513nm. 
13) Subtract the reagent blank reading from the standard and test sample readings. 














This appendix outlines the protocols used for the various histological stains and SEM 
study for valve leaflet analysis. 
 
C.1. Hematoxylin and Eosin stain 
This stain is done automatically in an autostainer. The protocol is as follows: 
1) Immerse the slides in xylene substitute three times for 5 minutes each at room 
temperature. 
2) Immerse the slides to 100% alcohol three times at room temperature. The first 
treatment is for 3 minutes followed by 2 minutes for the other two treatments. 
3)  Immerse the slides in 95% alcohol for 2 minutes at room temperature. 
4) Wash the slides in 70% alcohol for 2 minutes at room temperature. 
5) Wash the slides in water for 2 minutes at room temperature. 
6) Immerse the slides in hemotoxylin for 30 seconds at room temperature. 
7) Wash the slides in water for 1 minute at room temperature. 
8) Immerse the slides in acid alcohol for only 1 second at room temperature. 
9) Wash the slides in water for 1 minute at room temperature. 
10) Immerse the slides in Scott’s solution for 30 seconds at room temperature. 
11) Wash the slides in water for 2 minutes at room temperature. 
12) Immerse the slides in 95% alcohol for 1 minute at room temperature. 
13) Immerse the slides in alcoholic eosin for 30 seconds at room temperature. 
14) Immerse the slides in 95% alcohol for 30 seconds at room temperature. 
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15) Immerse the slides in 100% alcohol three times at room temperature. The first 
treatment is for 1 minute and the other two are for 2 minutes each. 
16) Immerse the slides in xylene substitute twice for 2 minutes each at room 
temperature. 
17) Finally, immerse the slides in xylene for 1 minute at room temperature. 
 
Reagents and Solutions 
Hematoxylin 
Dilute Gill’s hematoxylin no.2 (Polysciences #04570) one to one with dH2O before use. 
1% Acid Alcohol 
2ml HCl (Fisher #A144s) in 198ml of 70% ethanol. 
Scott’s Solution 
NaHCO3  2g 
MgSO4.7H2O  20g 
dH2O   1000ml 
Mix until dissolved. 
Alcoholic Eosin 
1% alcoholic eosin (VWR # VW3403-2). 
 
C.2. 5-Bromo deoxyuridine immunohistochemistry 
1) Deparaffinize slides in xylene substitute and rehydrate fixed paraffin embedded 
tissue in descending grades of alcohol.  Wash sections in 1X PBS for 5minutes. 
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2) Proteolyse fixed, paraffin embedded sections by typically treating with 1µg/ml 
proteinase K for 10 minutes at room temperature. 
3) Wash slides in 1X PBS twice for 5 minutes each at room temperature. 
4) Immerse slides in 4N HCl for 10 minutes at room temperature. 
5) Immerse slides in 1X TBE, pH 8.4 for 5 minutes at room temperature. 
6) Immerse slides in 1X PBS.  Check pH of buffer after 2 minutes. Apply primary 
antibody once pH is 7.0-7.5. 
7) Prepare the working dilution of the primary antibody in 1% crystalline grade BSA 
in 1X PBS.  Use anti-BrdU (Dako #M744) at 1:20 dilution. Blot off PBS and 
apply 150µl of working dilution. Incubate sections in a humid chamber for 1hour 
at room temperature. 
8) Blot of excess antibody and wash slides in 1X PBS twice for 5 minutes each at 
room temperature. 
9) Prepare working dilution of the secondary antibody (Vector #BA2001: 
biotinylated horse anti-mouse IgG) in 1% BSA/PBS and add 2% normal horse 
serum. Prepare the secondary antibody at a 1/400 dilution. Apply 150µl of 
antibody and incubate 30 minutes at room temperature in a humid chamber. 
10) Prepare the working dilution of ABC-Vector Red complex from the alkaline 
phosphatase standard kit (Vector #AK-5000) after application of secondary 
antibody.  Mix 5ml of 1X  PBS, one drop of reagent A, and one drop of reagent B 
and allow to sit at room temperature, 30minutes prior to use. 
11) Blot off excess antibody and wash slides in 1X PBS twice for 5 minutes each at 
room temperature. 
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12) Apply 150µl of prepared ABC mixture to each slide. Incubate in a humid 
chamber 1hour at room temperature. 
13) Blot off excess solution and wash slides in 1X PBS twice for 5 minutes each, 
followed by one wash in 100mM tris pH 8.2 for 5 minutes. 
14) Make up alkaline phosphatase substrate solution (Vector #SK-5100) immediately 
before use.  Add 5ml of 100mM tris pH 8.2, one drop levamisole (Vector #SP-
5000), two drops each of reagent one, two, and three to a foil wrapped bottle.  
Mix and apply 2-3 drops per  section. Incubate slides in the dark for 20-30 
minutes, checking color reaction periodically. Stop reaction by blotting off 
substrate and rinsing in tap water twice for 5 minutes each. 
15) Lightly counter stain sections with Gill’s hematoxylin (about 20 seconds). Rinse 
slides well in water until water is clear.  Dip once in 1% acid alcohol and rinse 
well in water.  Immerse in Scott’s solution 20 seconds and rinse in water.  
Dehydrate through graded alcohols, then xylene and coverslip for viewing. 
 
Reagents and Solutions 
Anti-BrdU:  DAKO #M0744 Clone Bu20a 
Proteinase K 
Dissolve proteinase K (Sigma # P-4914) in dH2O for a stock concentration of 20mg/ml.  
Aliquot and store at -20 C. 
1%BSA/PBS 
1g fraction V BSA (Sigma #A2153) in 100ml 1X PBS. 
Mix until fully dissolved. Aliquot into 5ml volumes and store at -20 C. 
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C.3. Activated caspase 3 immunohistochemistry 
1) Deparaffinize and rehydrate fixed paraffin embedded tissue in descending grades 
of alcohol.  Wash sections in 1X PBS 5minutes. 
2) Antigen retrieval:  treat tissue sections with 1µg/ml proteinase K for 10 minutes at 
room temperature.  
3) Wash slides in 1X PBS twice for 5 min. each at room temperature. 
4) Block tissue using 1% gelatin/PBS mixture for 20 minutes at room temperature.  
5) Prepare the working dilution of rabbit anti-human caspase 3, activated 
(Sigma#C8487) in 1%BSA in 1X PBS at a dilution of 1:400.  Blot off 
gelatin/PBS and apply primary antibody.  Incubate sections in a humid chamber 
for 1hour at room temperature. 
6) Blot of excess antibody and wash slides in 1X PBS twice for 5 minutes each at 
room temperature. 
7) Prepare working dilution of  biotinylated goat anti-rabbit IgG antibody in 1%BSA 
in 1X PBS, and add 2% of normal goat serum.  Prepare secondary antibody at 
1/400 dilution.  Apply antibody and incubate 30 minutes at room temperature in a 
humid chamber. 
8) Prepare the working solution of ABC-alkaline phosphatase complex from the 
Vectastain ABC-alkaline phosphatase standard kit (Vector #AK-5000) after 
application of secondary antibody.  Mix 5ml of 1X PBS, one drop of reagent A, 
and one drop of reagent B and allow to sit at room temperature 30 minutes prior 
to use. 
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9) Blot off excess antibody and wash slides in 1X PBS twice for 5 minutes each at 
room temperature. 
10) Apply prepared ABC mixture to each slide.  Incubate in a humid chamber 
for1hour at room temperature. 
11) Blot off excess solution and wash slides in 1X PBS twice for 5 minutes each, 
followed by one wash in 100mM tris pH 8.2 for 5 minutes. 
12) Make up alkaline phosphatase substrate solution (Vector Red #SK-5100) 
immediately before use.  Add 5ml of 100mM tris pH 8.2, one drop levamisole 
(Vector #SP-5000), two drops each of reagent one, two, and three to a foil 
wrapped bottle.  Mix and apply 2-3 drops per section.  Incubate slides in the dark 
for 20-30 minutes, checking color reaction periodically up to 1 hour.  Stop 
reaction by blotting off substrate and rinsing in tap water twice for 5 minutes 
each. 
13) Lightly counter stain sections with hematoxylin.  Rinse slides well in water until 
water is clear.  Dehydrate through graded alcohols, then xylene and coverslip for 
viewing.   
 
Reagents and Solutions 
Proteinase K 
Dissolve proteinase K (Sigma # P-4914) in dH2O for a stock concentration of 20mg/ml.  
Aliquot and store at -20ºC. 
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C.4. Double immunofluoroscence: von Willebrande Factor and α-smooth muscle 
actin 
1) Deparaffinize and rehydrate fixed paraffin embedded tissue in descending grades 
of alcohol.  Sections are washed in 1X PBS for 5minutes. 
2) Antigen retrieval: Treat tissues with 100µg/ml protease for 10 minutes at room 
temperature.  
3) Wash slides in 1X PBS twice for 5 minutes each at room temperature. 
4) Block tissue using 1% gelatin/PBS mixture for 20 minutes at room temperature.   
5) Prepare the working dilution of the primary antibody rabbit anti-vWF in 1% BSA 
in 1X PBS at a dilution of 1:800. Blot off gelatin/PBS and apply primary 
antibody.  Incubate sections in a humid chamber for 1hour at room temperature. 
6) Blot of excess antibody and wash slides in 1X PBS twice for 5 minutes, each at 
room temperature. 
7) Prepare working dilution of the biotinylated secondary antibody, goat anti-rabbit 
in 1%BSA in 1X PBS at 1:400 dilution, and add 2% of normal goat serum. Apply 
antibody and incubate the section for 30 minutes at room temperature in a humid 
chamber.  Prepare the working dilution of ABC-Vector Red complex from the 
alkaline phosphatase standard kit (Vector #AK-5000) after application of 
secondary antibody.  Mix 5ml of 1X PBS, one drop of reagent A, and one drop of 
reagent B and allow to sit at room temperature 30 minutes prior to use. 
8) Blot off excess antibody and wash slides in 1X PBS twice for 5 minutes each at 
room temperature. 
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9) Incubate sections with Avidin D- Texas red at 1:100 dilution in 1%BSA/PBS for 
30 minutes.  Incubate this step and all subsequent in the dark and preferably 
refrigerated. 
10) Blot off excess solution and wash slides in 1X PBS for 5 minutes, twice in the 
dark. 
11) Block tissue using 2% normal horse serum along with 8 drops of Avidin D and 
incubate for 20 minutes in the dark. 
12) Prepare the working dilution of the second primary antibody, α- smooth muscle 
actin in 1%BSA in 1X PBS at 1:800 dilution along with 8 drops of biotin.  Blot 
off serum, apply primary antibody, and incubate sections in a humid chamber in 
dark for 1hour at room temperature. 
13) Blot off excess antibody and wash slides in 1X PBS twice for 5 minutes each at 
room temperature. 
14) Incubate sections with horse anti- mouse secondary antibody at 1:400 dilution in 
1%BSA/PBS and 2% normal horse serum in dark for 30 minutes. 
15) Blot off excess solution and wash slides in 1X PBS for 5 minutes, twice. 
16) Incubate with avidin D- fluoroscein in 1%BSA/PBS at a dilution of 1:100 for 30 
minutes in the dark. 
17) Wash the slides in 1X PBS twice for 5minutes each in the dark. 
18) Counter stain with DAPI at a working dilution of 0.25µg/ml in 1%BSA/PBS for 5 
minutes in the dark. 
19) Rinse the slides in 1X PBS for 5 minutes in the dark. 
20) Mount the slides with Aquamount mounting media and refrigerate. 
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C.5. Scanning electron microscopy 
1) Harvest tissue and rinse briefly in 0.2 M sodium cacodylate buffer at a pH 7.2. 
2) Fix tissue in 2.5% gluteraldehyde in cacodylate buffer at pH 7.2 for 1-2 hours. 
Dilute the stock of 8% gluteraldehyde using 0.2M cacodylate buffer at pH 7.2 
immediately before use. 
3) Rinse in 0.2M cacodylate buffer, pH 7.2 three times for 10 minutes. 
4) Dehydrate tissue sample using the following protocol, each for 0.5-1 hour. 
25% alcohol, 50% alcohol, 70% alcohol, twice with 90% alcohol and twice with 
100% alcohol. 
5) Dry the sample using hexamethyldisilazane (HMDS). The protocol used is, 
100% ethanol: 100% HMDS = 2:1 for 30 minutes 
100% ethanol: 100% HMDS = 1:1 for 30 minutes 
100% ethanol: 100% HMDS = 1:2 for 30 minutes 
6) Rinse in 100% HMDS three times for 30 minutes each. 
7) Dry the tissue from the last 100% HMDS. The level of HMDS should just cover 
the tissue sample. Leave the tube containing the sample open in the fume hood 
and allow HMDS to evaporate and thus dry the tissue. Depending on the sample 
size, drying should occur overnight. 
8) Adhere the sample to an aluminum stub using conductive, double sided carbon 
adhesive tape. 
9) Sputter-coat the sample using gold to a thickness of approximately 100 Ao. 
10) Desiccate the sample until ready to analyses. Keep tissue in desiccators before 




The data presented in this section was obtained during the preliminary studies conducted 
while developing the organ culture system for maintaining consistency in the mechanical 
conditions and viability of aortic valves for over a period of 48 hours.  
 
D.1. Mechanical performance of the organ culture system 
Mechanical performance of the system was tested with a Starr-Edwards ball and cage 
mechanical valve and a pericardial bioprosthetic valve before biologically validating the 
system with native porcine aortic valves. The system was operated at a cardiac output of 
3.8-4.5 L/min, mean pressure of 100 mmHg and at a frequency of 1.167 Hz. Figure D.1 
shows the initial flow and pressure waveforms obtained with a ball and cage mechanical 



















































Figure D.1: Initial aortic flow and pressure waveforms of the Starr-Edwards ball and cage 
mechanical valve in the organ culture system with water as the circulating fluid. The 
curves were physiological and consistent over a period of 48 hours. 
 
 
Observing the flow waveform, we can see that the waveforms were consistent 
over the period of 48 hours. Some amount of back flow is evident, which may be due to 
leakage when the valve closed. The waveforms were comparable to the physiological 
waveforms; however the pressure waveform had a much larger magnitude when 
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compared to the physiological pressure curve. Large pressure oscillations were also 
evident between 600-700 msec, and these were reduced by injecting air into the 
compliance tank, increasing the fluid volume in the system and tightening the clamps 
downstream of the compliance. The system was adjusted with the above mentioned 
changes, and the waveforms were recorded for the same duration of 48 hours. The new 























































Figure D.2: Modified flow and pressure waveforms of the Starr-Edwards ball and cage 
mechanical valve in the organ culture system with water as the circulating fluid. The 
curves were physiological and consistent over a period of 48 hours. 
 
 
The waveforms seen above are more comparable to physiological waveforms than 
those in Figure D.1.  The backflow although present was less than in the earlier 
waveform, and the pressure oscillations are less severe. Thus, the adjustments enabled the 
flow loop to better approximate flow and pressure waveforms.  
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The system was then operated with a pericardial bioprosthetic valve, which was 
ultimately used to test the sterility of the system for a period of 96 hours. These 













































Figure D.3: Flow and pressure waveforms of a pericardial valve in the sterile organ 
culture system with DMEM as the circulating fluid. The curves were physiological and 





 The waveforms were consistent and closely approximated physiological curves 
throughout the duration of the experiment.  The backflow observed in the flow waveform 
was due to improper coaptation of the valve leaflets which was not system induced. After 
the consistency in mechanical conditions of the system was established, native porcine 
aortic valves were cultured in the system for a duration of 48 hours to characterize their 
biological properties under the influence of mechanical conditions. The flow and pressure 


























































Figure D.4: Flow and pressure waveforms for the native porcine aortic valve in the sterile 
organ culture system with DMEM as the circulating fluid. The curves were physiological 
and consistent over a period of 48 hours. 
 
 
The waveforms have been shown to consistent during the experimental time 
period. Preliminary experiments with native aortic valves showed the presence of oxygen 
transfer limitations in the system (which was studied by a Live/Dead stain shown in 
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section D.5). This was overcome by incorporating a gas permeable silicon tubing 
connected to a 5% CO2 gas cylinder. 
 The biological data obtained by culturing native aortic valves is shown in the 
following sections. 
 
D.2. Extracellular matrix components data 
The methods used to obtain the biological data are same as those described in chapter 4. 
Figures D.4-D.6 show the differences in collagen, sGAG and elastin contents between the 
three groups of the leaflets from 5 experiments.  
 The differences in ECM components between cultured valve leaflets and control 


































Figure D.5: Collagen content in the left, right, non-coronary leaflets and average value 
over the valve (total). Data is shown as average value + one standard deviation. (n=5). No 






































Figure D.6: sGAG content in the left, right, non-coronary leaflets and average value over 
the valve (total). Data is shown as average value + one standard deviation. (n=5). No 







































Figure D.7: Elastin content in the left, right, non-coronary leaflets and average value over 
the valve (total). Data is shown as average value + one standard deviation. (n=5). No 




D.3. Hematoxylin and Eosin stain 
This section shows the pictures of H & E stained sections of the cultured and control 
valves leaflets.  
 
 
Figure D.8. From left to right: Left, Right and Non coronary leaflets. Shown here are the 
H & E stains of fresh (A), cultured (B) and static (C) control leaflets. Cell nuclei are 
shown in blue and ECM in pink. Images were taken at 20X magnification. The 
morphology of the cultured leaflets was preserved in the system, which is comparable to 
























 The leaflets showed no difference in morphology between the cultured and 
control valves leaflets. The leaflet cellularity and three-layered architecture of the leaflet 
was retained suggesting preservation of morphology of leaflets in the system. 
 
D.4. α-smooth muscle actin immunohistochemistry 
Leaflets cultured in the organ culture system were stained for presence of α-SMC actin in 
the leaflets and were compared to fresh valve leaflets. Static control leaflets were not 











Figure D.9. From left to right: Left, Right and Non coronary leaflets. Shown here are α-
SMC actin immunofluoroscence images of fresh (A), and cultured (B) valve leaflets. 
Brown indicates α-SMC actin expressed by interstitial cells and blue indicates cell nuclei. 
Images were taken at 20X magnification. Actin expressing cells are indicated by black 
arrows. (F-Fibrosa, S-Spongiosa, V-Ventricularis). 
 
  
 Since this stain produced a lot of back ground effects as seen in fresh control 
leaflets, no proper inference could be attained. Hence, immunofluoroscence technique 
was used for further analysis. 
 
D.5. Ethidium homodimer immunofluoroscence 
To see the presence of dead cells in the leaflets ethidium homodimer (Ethd) 
immunofluoroscence was used. The leaflets, after 48 hours of culture in the system, were 
harvested from the valves by cutting along the attachment region and incubated in 

















vectashield mounting media. Figure D.9, shows Ethd stained sections of fresh (A), 
cultured (B) and static control (C) valves leaflets. The dead cells are indicated by red 
color while blue indicates the live cells. Red cells were found in all the three layers of the 
leaflets for all the groups of the valves. Observing the pictures, it can be seen that the 
number of red cells are greater in cultured valve leaflets compared to fresh and static 
control leaflets and also static control leaflets have greater number of red cells than the 
fresh control leaflets. This suggests that increase in cell death in cultured valve leaflets 
was induced in the ex vivo system due to oxygen limiting condition in the system.  Also 
the incubation of leaflets in a small volume of media (for Ethd) after the culture may have 
also increased the cell death as seen in static control leaflets. To prevent this, a gas 
exchanger was incorporated in the system which maintained the cells viable (shown in 
figure 5.17) and also cell death was analyzed by immediately fixing the leaflets in 




Figure D.10. From left to right: Left, Right and Non coronary leaflets. Shown here are 
ethidium homodimer images of fresh (A), cultured (B) and static (C) control leaflets. 
Dead cells are shown in red while live cells are shown in blue. Images were taken at 20X 
magnification. Positive cells (red cells) were found in fresh, cultured and static control 
leaflets scattered through the ECM of the leaflets. Cultured valve leaflets showed greater 
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